Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 1019 articles:
HTML format
Text format



Single Articles


    March 2017
  1. WORLD HEALTH ORGANIZATION
    Dengue vaccine: WHO position paper, July 2016 - recommendations.
    Vaccine. 2017;35:1200-1201.
    PubMed     Text format     Abstract available


  2. FUCHS LI, Fort MC, Cano D, Bonetti CM, et al
    Clearance of Tritrichomonas foetus in experimentally infected heifers protected with vaccines based on killed-T. foetus with different adjuvants.
    Vaccine. 2017;35:1341-1346.
    PubMed     Text format     Abstract available


  3. NARWANEY KJ, Breslin K, Ross CA, Shoup JA, et al
    Vaccine adverse events in a safety net healthcare system and a managed care organization.
    Vaccine. 2017;35:1335-1340.
    PubMed     Text format     Abstract available


    February 2017
  4. XU H, Li X, Cui Z
    Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles. Ruwona TB, Xu H, Li X, Taylor AN, Shi Y, Cui Z. Vaccine 2016;34:3059-67.
    Vaccine. 2017;35:1102-1103.
    PubMed     Text format    


  5. MOLD M, Shardlow E, Exley C
    Toward understanding the mechanisms underlying the strong adjuvant activity of aluminium salt nanoparticles. Ruwona TB, Xu H, Li X, Taylor AN, Shi Y, Cui Z. Vaccine 2016;34:3059-67.
    Vaccine. 2017;35:1101.
    PubMed     Text format    


  6. TRINH L, Macartney K, McIntyre P, Chiu C, et al
    Investigating adverse events following immunisation with pneumococcal polysaccharide vaccine using electronic General Practice data.
    Vaccine. 2017 Feb 12. pii: S0264-410X(17)30143.
    PubMed     Text format     Abstract available


  7. KHAN AI, Ali M, Chowdhury F, Saha A, et al
    Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh.
    Vaccine. 2017 Feb 11. pii: S0264-410X(17)30160.
    PubMed     Text format     Abstract available


  8. MEIJER WJ, Wensing AM, Bos AA, Kuiphuis JC, et al
    Influenza vaccination in healthcare workers; comparison of side effects and preferred route of administration of intradermal versus intramuscular administration.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30145.
    PubMed     Text format     Abstract available


  9. ESQUERRE M, Momot M, Goubier A, Gonindard C, et al
    GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30154.
    PubMed     Text format     Abstract available


  10. TAHA MK, Hawkins JC, Liberator P, Deghmane AE, et al
    Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30146.
    PubMed     Text format     Abstract available


  11. MCHUGH L, Andrews RM, Lambert SB, Viney KA, et al
    Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30155.
    PubMed     Text format     Abstract available


  12. POLLET J, Versteeg L, Rezende W, Strych U, et al
    A simple fluorescence-based assay for quantification of the Toll-Like Receptor agonist E6020 in vaccine formulations.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30157.
    PubMed     Text format     Abstract available


  13. YANG FL, Lou TC, Kuo SC, Wu WL, et al
    A medically relevant capsular polysaccharide in Acinetobacter baumannii is a potential vaccine candidate.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30126.
    PubMed     Text format     Abstract available


  14. CHAPPUIS F, Farinelli T, Deckx H, Sarnecki M, et al
    Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30080.
    PubMed     Text format     Abstract available


  15. LARROUY-MAUMUS G, Layre E, Clark S, Prandi J, et al
    Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30159.
    PubMed     Text format     Abstract available


  16. JARRAHIAN C, Rein-Weston A, Saxon G, Creelman B, et al
    Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV).
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30050.
    PubMed     Text format     Abstract available


  17. LENNY BJ, Sonnberg S, Danner AF, Friedman K, et al
    Evaluation of multivalent H2 influenza pandemic vaccines in mice.
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30061.
    PubMed     Text format     Abstract available


  18. SCHAID DJ, Haralambieva IH, Larrabee BR, Ovsyannikova IG, et al
    Heritability of vaccine-induced measles neutralizing antibody titers.
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30158.
    PubMed     Text format     Abstract available


  19. MADAN A, Ferguson M, Sheldon E, Segall N, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial.
    Vaccine. 2017 Feb 7. pii: S0264-410X(17)30119.
    PubMed     Text format     Abstract available


  20. ZHENG X, Yang X, Li X, Qiu GH, et al
    Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice.
    Vaccine. 2017 Feb 7. pii: S0264-410X(17)30147.
    PubMed     Text format     Abstract available


  21. BALASUBRAMANIAN P, Kumar R, Williams C, Itri V, et al
    Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.
    Vaccine. 2017 Feb 6. pii: S0264-410X(17)30089.
    PubMed     Text format     Abstract available


  22. PEREZ AC, Murphy TF
    Do we need a vaccine against Moraxella catarrhalis in chronic lung disease? What are the options and opportunities?
    Vaccine. 2017 Feb 6. pii: S0264-410X(16)31300.
    PubMed     Text format     Abstract available


  23. MCCLENATHAN BM, Stewart DA, Spooner CE, Pathmasiri WW, et al
    Metabolites as biomarkers of adverse reactions following vaccination: A pilot study using nuclear magnetic resonance metabolomics.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30122.
    PubMed     Text format     Abstract available


  24. WUMKES ML, van der Velden AM, de Bruin E, Meerveld-Eggink A, et al
    Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30088.
    PubMed     Text format     Abstract available


  25. YUK SS, Erdene-Ochir TO, Kwon JH, Noh JY, et al
    Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30082.
    PubMed     Text format     Abstract available


  26. BERENSON AB, Croisant S
    Early sexual debut warrants HPV vaccination at an earlier age.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30123.
    PubMed     Text format    


  27. BAXTER R, Eaton A, Hansen J, Aukes L, et al
    Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30128.
    PubMed     Text format     Abstract available


  28. SANCHEZ-RAMOS EL, Monarrez-Espino J, Noyola DE
    Impact of vaccination on influenza mortality in children <5years old in Mexico.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30087.
    PubMed     Text format     Abstract available


  29. BAKER JA, Lewis EL, Byland LM, Bonakdar M, et al
    Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30078.
    PubMed     Text format     Abstract available


  30. HEATON A, Krudwig K, Lorenson T, Burgess C, et al
    Doses per vaccine vial container: An understated and underestimated driver of performance that needs more evidence.
    Vaccine. 2017 Feb 2. pii: S0264-410X(16)31137.
    PubMed     Text format     Abstract available


  31. CROCE E, Hatz C, Jonker EF, Visser LG, et al
    Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and cas
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30113.
    PubMed     Text format     Abstract available


  32. BARMAN S, Krylov PS, Turner JC, Franks J, et al
    Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30127.
    PubMed     Text format     Abstract available


  33. LIU G, Yin J, Barkema HW, Chen L, et al
    Development of a single-dose recombinant CAMP factor entrapping poly(lactide-co-glycolide) microspheres-based vaccine against Streptococcus agalactiae.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30102.
    PubMed     Text format     Abstract available


  34. HAMBIDGE SJ, Ross C, Shoup JA, Wain K, et al
    Integration of data from a safety net health care system into the Vaccine Safety Datalink.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30076.
    PubMed     Text format     Abstract available


  35. PERO SC, Sun YJ, Shukla GS, Carman CL, et al
    Vaccine draining lymph nodes are a source of antigen-specific B cells.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30085.
    PubMed     Text format     Abstract available


  36. CAMPOS IB, Herd M, Moffitt KL, Lu YJ, et al
    IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30079.
    PubMed     Text format     Abstract available


  37. LIU Y, Wang J, Liu S, Du J, et al
    Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30083.
    PubMed     Text format     Abstract available


  38. CONTRERAS M, de la Fuente J
    Control of infestations by Ixodes ricinus tick larvae in rabbits vaccinated with aquaporin recombinant antigens.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30117.
    PubMed     Text format     Abstract available


  39. BERENSON AB, Hirth JM, Fuchs EL
    US medical students' willingness to offer the HPV vaccine by vaccination status.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30077.
    PubMed     Text format     Abstract available


    January 2017
  40. XING Y, Schmitt HJ, Arguedas A, Yang J, et al
    Tick-borne encephalitis in China: A review of epidemiology and vaccines.
    Vaccine. 2017 Jan 30. pii: S0264-410X(17)30032.
    PubMed     Text format     Abstract available


  41. BEGIER E, Seiden DJ, Patton M, Zito E, et al
    SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
    Vaccine. 2017 Jan 28. pii: S0264-410X(17)30043.
    PubMed     Text format     Abstract available


  42. SUTCLIFFE K, Kilgore PE, DeHoff K, Evans R, et al
    Survey of vaccination knowledge and acceptance among adults admitted to an urban emergency department.
    Vaccine. 2017 Jan 28. pii: S0264-410X(17)30031.
    PubMed     Text format     Abstract available


  43. BENN CS, Jacobsen LH, Fisker AB, Rodrigues A, et al
    Campaigns with oral polio vaccine may lower mortality and create unexpected results.
    Vaccine. 2017 Jan 27. pii: S0264-410X(16)31035.
    PubMed     Text format     Abstract available


  44. ZHOU J, Li S, Wang X, Zou M, et al
    Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus.
    Vaccine. 2017 Jan 25. pii: S0264-410X(17)30005.
    PubMed     Text format     Abstract available


  45. HUANG Y, Zhang L, Janes H, Frahm N, et al
    Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials.
    Vaccine. 2017 Jan 25. pii: S0264-410X(16)30879.
    PubMed     Text format     Abstract available


  46. ALAN H, Ian B, Nancy C, Ruben O D, et al
    Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.
    Vaccine. 2017 Jan 25. pii: S0264-410X(17)30037.
    PubMed     Text format     Abstract available


  47. HOONAKKER ME, Verhagen LM, van der Maas L, Sloots A, et al
    Reporter cell lines for detection of pertussis toxin in acellular pertussis vaccines as a functional animal-free alternative to the in vivo histamine sensitization test.
    Vaccine. 2017 Jan 24. pii: S0264-410X(17)30016.
    PubMed     Text format     Abstract available


  48. WIJAYA L, Tham CY, Chan YF, Wong AW, et al
    An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers.
    Vaccine. 2017 Jan 21. pii: S0264-410X(16)31256.
    PubMed     Text format     Abstract available


  49. SMALL PA JR, Cronin BJ
    The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection.
    Vaccine. 2017 Jan 21. pii: S0264-410X(17)30041.
    PubMed     Text format    


  50. JONES RM, Burke M, Dubose D, Chichester JA, et al
    Stability and pre-formulation development of a plant-produced anthrax vaccine candidate.
    Vaccine. 2017 Jan 20. pii: S0264-410X(16)31206.
    PubMed     Text format     Abstract available


  51. SCHEIBLHOFER S, Strobl A, Hoepflinger V, Thalhamer T, et al
    Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30058.
    PubMed     Text format     Abstract available


  52. ABARA WE, Collier MG, Teshale EH
    Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30039.
    PubMed     Text format     Abstract available


  53. XIAO Y, Daniell H
    Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
    Vaccine. 2017 Jan 19. pii: S0264-410X(16)31295.
    PubMed     Text format     Abstract available


  54. POSTON TB, Gottlieb SL, Darville T
    Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30042.
    PubMed     Text format     Abstract available


  55. WALZ PH, Givens MD, Rodning SP, Riddell KP, et al
    Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-liv
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30009.
    PubMed     Text format     Abstract available


  56. MORIYAMA M, Chino S, Ichinohe T
    Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge.
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30046.
    PubMed     Text format     Abstract available


  57. DAVID SC, Lau J, Singleton EV, Babb R, et al
    The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.
    Vaccine. 2017 Jan 18. pii: S0264-410X(16)31269.
    PubMed     Text format     Abstract available


  58. NAKAYAMA M, Itoh Y, Shichinohe S, Nakabayashi R, et al
    Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus.
    Vaccine. 2017 Jan 18. pii: S0264-410X(17)30013.
    PubMed     Text format     Abstract available


  59. SUNDARAM N, Chen C, Yoong J, Luvsan ME, et al
    Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.
    Vaccine. 2017 Jan 18. pii: S0264-410X(17)30010.
    PubMed     Text format     Abstract available


  60. WEINBERG M, Dietz S, Potter R, Swanson R, et al
    Vaccine shot-limiting: Estimating the prevalence, indicators, and impact on vaccination status - Michigan, 2012.
    Vaccine. 2017 Jan 17. pii: S0264-410X(17)30019.
    PubMed     Text format     Abstract available


  61. ACKERSON B, Hechter R, Sidell M, Sy LS, et al
    Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization.
    Vaccine. 2017 Jan 13. pii: S0264-410X(17)30011.
    PubMed     Text format     Abstract available


  62. YANG L, Nan H, Liang J, Chan YH, et al
    Influenza vaccination in older people with diabetes and their household contacts.
    Vaccine. 2017 Jan 13. pii: S0264-410X(17)30007.
    PubMed     Text format     Abstract available


  63. QUINN SC, Jamison A, Freimuth VS, An J, et al
    Exploring racial influences on flu vaccine attitudes and behavior: Results of a national survey of White and African American adults.
    Vaccine. 2017 Jan 13. pii: S0264-410X(16)31271.
    PubMed     Text format     Abstract available


  64. KURUKULASURIYA S, Ahmed KA, Ojkic D, Gunawardana T, et al
    Modified live infectious bursal disease virus (IBDV) vaccine delays infection of neonatal broiler chickens with variant IBDV compared to turkey herpesvirus (HVT)-IBDV vectored vaccine.
    Vaccine. 2017 Jan 12. pii: S0264-410X(17)30008.
    PubMed     Text format     Abstract available


  65. ABHYANKAR MM, Noor Z, Tomai MA, Elvecrog J, et al
    Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.
    Vaccine. 2017 Jan 12. pii: S0264-410X(16)31290.
    PubMed     Text format     Abstract available


  66. LUO J, Zhang B, Wu Y, Tian Q, et al
    Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine.
    Vaccine. 2017 Jan 12. pii: S0264-410X(17)30006.
    PubMed     Text format     Abstract available


  67. HOEST C, Seidman JC, Lee G, Platts-Mills JA, et al
    Vaccine coverage and adherence to EPI schedules in eight resource poor settings in the MAL-ED cohort study.
    Vaccine. 2017;35:443-451.
    PubMed     Text format     Abstract available


  68. DE BENEDETTO G, Alfini R, Cescutti P, Caboni M, et al
    Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella.
    Vaccine. 2017;35:419-426.
    PubMed     Text format     Abstract available


  69. CHIU C
    Novel immunological insights in accelerating RSV vaccine development.
    Vaccine. 2017;35:459-460.
    PubMed     Text format    


  70. GARGANO LM, Hajjeh R, Cookson ST
    Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan.
    Vaccine. 2017;35:435-442.
    PubMed     Text format     Abstract available


  71. TREANOR JJ, Chu L, Essink B, Muse D, et al
    Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
    Vaccine. 2017 Jan 11. pii: S0264-410X(16)31286.
    PubMed     Text format     Abstract available


  72. ZHANG W, Hirve S, Kieny MP
    Seasonal vaccines - Critical path to pandemic influenza response.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31289.
    PubMed     Text format    


  73. CARO-AGUILAR I, Indrawati L, Kaufhold RM, Gaunt C, et al
    Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31288.
    PubMed     Text format     Abstract available


  74. SARFRAZ M, Suleman M, Tikoo SK, Wheler C, et al
    Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31230.
    PubMed     Text format     Abstract available


  75. DAGAN R, Juergens C, Trammel J, Patterson S, et al
    PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated children.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31277.
    PubMed     Text format     Abstract available


  76. KAPETANOVIC MC, Nagel J, Nordstrom I, Saxne T, et al
    Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Vaccine. 2017 Jan 9. pii: S0264-410X(17)30002.
    PubMed     Text format     Abstract available


  77. MORGEAUX S, Poirier B, Ragan CI, Wilkinson D, et al
    Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31264.
    PubMed     Text format     Abstract available


  78. CORNICK JE, Tastan Bishop O, Yalcin F, Kiran AM, et al
    The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31262.
    PubMed     Text format     Abstract available


  79. GOWTAGE S, Williams GA, Henderson R, Aylett P, et al
    Testing of a palatable bait and compatible vaccine carrier for the oral vaccination of European badgers (Meles meles) against tuberculosis.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31198.
    PubMed     Text format     Abstract available


  80. WANG Y, Chen T, Lu LL, Wang M, et al
    Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31296.
    PubMed     Text format     Abstract available


  81. KUMAR S, Sunagar R, Pham G, Gosselin EJ, et al
    Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31260.
    PubMed     Text format     Abstract available


  82. CHEGE GK, Burgers WA, Muller TL, Gray CM, et al
    DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31294.
    PubMed     Text format     Abstract available


  83. PAINTER JE, Plaster AN, Tjersland DH, Jacobsen KH, et al
    Zika virus knowledge, attitudes, and vaccine interest among university students.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31275.
    PubMed     Text format     Abstract available


  84. ARSENAULT C, Harper S, Nandi A, Mendoza Rodriguez JM, et al
    Monitoring equity in vaccination coverage: A systematic analysis of demographic and health surveys from 45 Gavi-supported countries.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31266.
    PubMed     Text format     Abstract available


  85. HEDBERG AL, Pauksens K, Enblad P, Soderberg J, et al
    Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31299.
    PubMed     Text format     Abstract available


  86. KARLSEN M, Tingbo T, Solbakk IT, Furevik A, et al
    Response to request for Corrigendum to "Efficacy and safety of an inactivated vaccine against Salmonid alphavirus (family Togaviridae)". [Vaccine 30(38) (2012) 5688-5694].
    Vaccine. 2017;35:204.
    PubMed     Text format    


  87. GRISEZ L, Frost P
    Efficacy and safety of an inactivated vaccine against Salmonid alphavirus (family Togaviridae) [Vaccine 30 (2012) 5688-5694].
    Vaccine. 2017;35:203.
    PubMed     Text format    


  88. MILLIGAN P, Flach C, Theisen M
    Efficacy of the GMZ2 malaria vaccine in African children.
    Vaccine. 2017;35:202.
    PubMed     Text format    


  89. EJIGU DA
    When should a time at risk start in efficacy malaria vaccine trials?
    Vaccine. 2017;35:201.
    PubMed     Text format    


  90. NEROME K, Matsuda S, Maegawa K, Sugita S, et al
    Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31291.
    PubMed     Text format     Abstract available


  91. LOWELL GH, Ziv S, Bruzil S, Babecoff R, et al
    Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31297.
    PubMed     Text format     Abstract available


  92. GESSNER BD, Knobel DL, Conan A, Finn A, et al
    Could the RTS,S/AS01 meningitis safety signal really be a protective effect of rabies vaccine?
    Vaccine. 2017 Jan 5. pii: S0264-410X(17)30001.
    PubMed     Text format     Abstract available


  93. CESPEDES PF, Rey-Jurado E, Espinoza JA, Rivera CA, et al
    A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31273.
    PubMed     Text format     Abstract available


  94. SASAKI E, Kuramitsu M, Momose H, Kobiyama K, et al
    A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests.
    Vaccine. 2017 Jan 4. pii: S0264-410X(16)31261.
    PubMed     Text format     Abstract available


  95. FU LY, Zimet GD, Latkin CA, Joseph JG, et al
    Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents.
    Vaccine. 2017 Jan 4. pii: S0264-410X(16)31270.
    PubMed     Text format     Abstract available


  96. YUDIN MH, Mistry N, De Souza LR, Besel K, et al
    Text messages for influenza vaccination among pregnant women: A randomized controlled trial.
    Vaccine. 2017 Jan 3. pii: S0264-410X(16)31195.
    PubMed     Text format     Abstract available


  97. YU Q, Spatz S, Li Y, Yang J, et al
    Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Vaccine. 2017 Jan 2. pii: S0264-410X(16)31263.
    PubMed     Text format     Abstract available


  98. THARMAPHORNPILAS P, Jiamsiri S, Boonchaiya S, Rochanathimoke O, et al
    Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy.
    Vaccine. 2017 Jan 2. pii: S0264-410X(16)31268.
    PubMed     Text format     Abstract available


    December 2016
  99. DAI Z, Huang J, Lei X, Yan Y, et al
    Efficacy of an autophagy-targeted DNA vaccine against avian leukosis virus subgroup J.
    Vaccine. 2016 Dec 31. pii: S0264-410X(16)31259.
    PubMed     Text format     Abstract available


  100. ZITT E, Hafner-Giessauf H, Wimmer B, Herr A, et al
    Response to active hepatitis B vaccination and mortality in incident dialysis patients.
    Vaccine. 2016 Dec 31. pii: S0264-410X(16)31257.
    PubMed     Text format     Abstract available


  101. SAITO N, Komori K, Suzuki M, Morimoto K, et al
    Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)31071.
    PubMed     Text format     Abstract available


  102. SHIBLI R, Shemer R, Lerner-Geva L, Rishpon S, et al
    Knowledge and recommendation regarding routine childhood vaccinations among pediatric healthcare providers in Israel.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)31199.
    PubMed     Text format     Abstract available


  103. SAKAI A, Noguchi E, Fukushima T, Tagawa M, et al
    Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)30764.
    PubMed     Text format     Abstract available


  104. BOLTON DL, Song K, Tomaras GD, Rao S, et al
    Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques.
    Vaccine. 2016 Dec 29. pii: S0264-410X(16)31203.
    PubMed     Text format     Abstract available


  105. MILLMAN AJ, Reynolds S, Duffy J, Chen J, et al
    Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010-2012.
    Vaccine. 2016 Dec 29. pii: S0264-410X(16)31258.
    PubMed     Text format     Abstract available


  106. PAINTER JE, DiClemente RJ, von Fricken ME
    Interest in an Ebola vaccine among a U.S. national sample during the height of the 2014-2016 Ebola outbreak in West Africa.
    Vaccine. 2016 Dec 28. pii: S0264-410X(16)31204.
    PubMed     Text format     Abstract available


  107. WIERZBA TF, Bourgis A
    Defining cases of severe pediatric diarrhea for an efficacy trial of an enterotoxigenic Escherichia coli (ETEC) vaccine: Report on an international workshop, Washington DC, March 2016.
    Vaccine. 2016 Dec 26. pii: S0264-410X(16)31200.
    PubMed     Text format     Abstract available


  108. CHEN W, Messonnier M, Zhou F
    Corrigendum to "Trends in childhood vaccine purchase costs in the US public sector: 1996-2014" [Vaccine 34 (2016) 4706-4711].
    Vaccine. 2016 Dec 26. pii: S0264-410X(16)31217.
    PubMed     Text format    


  109. LINDGREN LM, Tingskov PN, Justesen AH, Nedergaard BS, et al
    First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccin
    Vaccine. 2016 Dec 24. pii: S0264-410X(16)31234.
    PubMed     Text format     Abstract available


  110. LEE TY, Kim CU, Bae EH, Seo SH, et al
    Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31232.
    PubMed     Text format     Abstract available


  111. DOMNICH A, Arata L, Amicizia D, Puig-Barbera J, et al
    Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31218.
    PubMed     Text format     Abstract available


  112. CAMACHO A, Eggo RM, Goeyvaerts N, Vandebosch A, et al
    Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31226.
    PubMed     Text format     Abstract available


  113. TIMMIS JK, Rigat F, Rappuoli R
    Core values for vaccine evaluation.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31082.
    PubMed     Text format     Abstract available


  114. PHELPS CE, Madhavan G, Gellin B
    Planning and priority setting for vaccine development and immunization.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31057.
    PubMed     Text format     Abstract available


  115. MATTHIESSEN L, Lang H, Klimathianaki M, Hanrahan F, et al
    European strategy for vaccine development against infectious diseases.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)30952.
    PubMed     Text format     Abstract available


  116. SAUL A, O'Brien KL
    Prioritizing vaccines for developing world diseases.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31062.
    PubMed     Text format     Abstract available


  117. SOUTHERN J, Waight PA, Andrews N, Miller E, et al
    Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3-6years.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31224.
    PubMed     Text format     Abstract available


  118. ALMOND J, Medaglini D
    The role of the vaccines industry in Mission Grand Convergence.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31058.
    PubMed     Text format     Abstract available


  119. KASLOW DC, Kalil J, Bloom D, Breghi G, et al
    The role of vaccines and vaccine decision-making to achieve the goals of the Grand Convergence in public health.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31080.
    PubMed     Text format     Abstract available


  120. RAPPUOLI R
    Introduction to the vaccine supplement.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31099.
    PubMed     Text format    


  121. BLOOM DE, Brenzel L, Cadarette D, Sullivan J, et al
    Moving beyond traditional valuation of vaccination: Needs and opportunities.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31181.
    PubMed     Text format     Abstract available


  122. KNOBLER S, Bok K, Gellin B
    Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31060.
    PubMed     Text format     Abstract available


  123. KOBAYASHI M, Schrag SJ, Alderson MR, Madhi SA, et al
    WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31236.
    PubMed     Text format     Abstract available


  124. LEE BY, Mueller LE, Tilchin CG
    A systems approach to vaccine decision making.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31081.
    PubMed     Text format     Abstract available


  125. POWELL AM, Luo Z, Martin L, Wan Z, et al
    The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31233.
    PubMed     Text format     Abstract available


  126. RUNGE S, Olbert M, Herden C, Malberg S, et al
    Viral vector vaccines protect cockatiels from inflammatory lesions after heterologous parrot bornavirus 2 challenge infection.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31229.
    PubMed     Text format     Abstract available


  127. STANFIELD BA, Pahar B, Chouljenko VN, Veazey R, et al
    Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31225.
    PubMed     Text format     Abstract available


  128. RISSMANN M, Ulrich R, Schroder C, Hammerschmidt B, et al
    Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31197.
    PubMed     Text format     Abstract available


  129. SCHAEDLER E, Remy-Ziller C, Hortelano J, Kehrer N, et al
    Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31227.
    PubMed     Text format     Abstract available


  130. REYES M, Ramirez C, Nancucheo I, Villegas R, et al
    A novel "in-feed" delivery platform applied for oral DNA vaccination against IPNV enables high protection in Atlantic salmon (Salmon salar).
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31220.
    PubMed     Text format     Abstract available


  131. PEHRSON C, Heno KK, Adams Y, Resende M, et al
    Comparison of functional assays used in the clinical development of a placental malaria vaccine.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31235.
    PubMed     Text format     Abstract available


  132. THOMAS SL, Walker JL, Fenty J, Atkins KE, et al
    Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.
    Vaccine. 2016 Dec 19. pii: S0264-410X(16)31119.
    PubMed     Text format     Abstract available


  133. FUENTES S, Arenas D, Moore MM, Golding H, et al
    Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Vaccine. 2016 Dec 15. pii: S0264-410X(16)31105.
    PubMed     Text format     Abstract available


  134. VESIKARI T, Borrow R, Da Costa X, Richard P, et al
    Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants.
    Vaccine. 2016 Dec 8. pii: S0264-410X(16)31115.
    PubMed     Text format     Abstract available


  135. STOWE J, Andrews N, Ladhani S, Miller E, et al
    The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation Ref. No: JVAC-D-16-01124.
    Vaccine. 2016;34:6115.
    PubMed     Text format    


  136. DRYSDALE SB, Pollard AJ
    Intussusception risk after rotavirus vaccination in England.
    Vaccine. 2016;34:6114.
    PubMed     Text format    


  137. CUTTS FT, Claquin P, Danovaro-Holliday MC, Rhoda DA, et al
    Reply to comments on Monitoring vaccination coverage: Defining the role of surveys.
    Vaccine. 2016;34:6112-6113.
    PubMed     Text format    


  138. POND R, Mounier-Jack S
    Comments on "Monitoring vaccination coverage: Defining the role of surveys".
    Vaccine. 2016;34:6111.
    PubMed     Text format    


  139. MARUGGI G, Chiarot E, Giovani C, Buccato S, et al
    Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens.
    Vaccine. 2016 Dec 7. pii: S0264-410X(16)31101.
    PubMed     Text format     Abstract available


  140. YOUNG B, Zhao X, Cook AR, Parry CM, et al
    Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis.
    Vaccine. 2016 Dec 7. pii: S0264-410X(16)31044.
    PubMed     Text format     Abstract available


  141. CHRISTENSEN H, Trotter CL
    Modelling the cost-effectiveness of catch-up 'MenB' (Bexsero) vaccination in England.
    Vaccine. 2016 Dec 3. pii: S0264-410X(16)31147.
    PubMed     Text format     Abstract available


  142. OPRIESSNIG T, Xiao CT, Halbur PG, Gerber PF, et al
    A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naive pigs under experimental conditions.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31157.
    PubMed     Text format     Abstract available


  143. PILKINTON MA, Nicholas KJ, Warren CM, Smith RM, et al
    Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31121.
    PubMed     Text format     Abstract available


  144. SONG JY, Cheong HJ, Hyun HJ, Seo YB, et al
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in 60-year-old adults.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31109.
    PubMed     Text format     Abstract available


  145. CHONG Y, Ikematsu H
    Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31156.
    PubMed     Text format     Abstract available


  146. HULO S, Nuvoli A, Sobaszek A, Salembier-Trichard A, et al
    Knowledge and attitudes towards influenza vaccination of health care workers in emergency services.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31158.
    PubMed     Text format     Abstract available


  147. POORE EA, Slifka DK, Raue HP, Thomas A, et al
    Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31151.
    PubMed     Text format     Abstract available


  148. XU Q, Pryharski K, Pichichero ME
    Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31108.
    PubMed     Text format     Abstract available


  149. LUQUERO FJ, Ballard A, Sack DA
    Ensuring access to oral cholera vaccine to those who need them most.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31145.
    PubMed     Text format    


  150. FAIRBROTHER JM, Nadeau E, Belanger L, Tremblay CL, et al
    Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31106.
    PubMed     Text format     Abstract available


  151. AKHTAR M, Qadri F, Bhuiyan TR, Akter S, et al
    Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31117.
    PubMed     Text format     Abstract available


  152. REYES JF, Wood JG, Beutels P, Macartney K, et al
    Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31118.
    PubMed     Text format     Abstract available


  153. VANNICE KS, Giersing BK, Kaslow DC, Griffiths E, et al
    Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)30969.
    PubMed     Text format     Abstract available


  154. VAN RIJN PA, Daus FJ, Maris-Veldhuis MA, Feenstra F, et al
    Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31153.
    PubMed     Text format     Abstract available


  155. FRENCK RW JR, Buddy Creech C, Sheldon EA, Seiden DJ, et al
    Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31041.
    PubMed     Text format     Abstract available


    November 2016
  156. IRO MA, Snape MD, Voysey M, Jawad S, et al
    Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial.
    Vaccine. 2016 Nov 30. pii: S0264-410X(16)31040.
    PubMed     Text format     Abstract available


  157. DE VRIES RD, Nieuwkoop NJ, Pronk M, de Bruin E, et al
    Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.
    Vaccine. 2016 Nov 30. pii: S0264-410X(16)31154.
    PubMed     Text format     Abstract available


  158. CHENG J, Wen S, Wang S, Hao P, et al
    gp85 protein vaccine adjuvanted with silica nanoparticles against ALV-J in chickens.
    Vaccine. 2016 Nov 29. pii: S0264-410X(16)31148.
    PubMed     Text format     Abstract available


  159. READ RC, Dull P, Bai X, Nolan K, et al
    A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B men
    Vaccine. 2016 Nov 29. pii: S0264-410X(16)31142.
    PubMed     Text format     Abstract available


  160. DATTA D, Bansal GP, Gerloff DL, Ellefsen B, et al
    Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation.
    Vaccine. 2016 Nov 29. pii: S0264-410X(16)31143.
    PubMed     Text format     Abstract available


  161. LIU X, Zhang H, Jiao C, Liu Q, et al
    Flagellin enhances the immunoprotection of formalin-inactivated Edwardsiella tarda vaccine in turbot.
    Vaccine. 2016 Nov 28. pii: S0264-410X(16)31078.
    PubMed     Text format     Abstract available


  162. CHOTPITAYASUNONDH T, Pruekprasert P, Puthanakit T, Pancharoen C, et al
    Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand.
    Vaccine. 2016 Nov 28. pii: S0264-410X(16)31133.
    PubMed     Text format     Abstract available


  163. PAN-NGUM W, Kinyanjui T, Kiti M, Taylor S, et al
    Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
    Vaccine. 2016 Nov 28. pii: S0264-410X(16)31023.
    PubMed     Text format     Abstract available


  164. JIAMING L, Yanfeng Y, Yao D, Yawei H, et al
    The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
    Vaccine. 2016 Nov 26. pii: S0264-410X(16)31135.
    PubMed     Text format     Abstract available


  165. SCHUCK-PAIM C, Taylor RJ, Simonsen L, Lustig R, et al
    Challenges to estimating vaccine impact using hospitalization data.
    Vaccine. 2016 Nov 26. pii: S0264-410X(16)31077.
    PubMed     Text format     Abstract available


  166. KHO MM, Zuijderwijk JM, van der Eijk AA, de Kuiper R, et al
    Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
    Vaccine. 2016 Nov 26. pii: S0264-410X(16)31104.
    PubMed     Text format     Abstract available


  167. ALANKO BLOME M, Bjorkman P, Flamholc L, Jacobsson H, et al
    Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31102.
    PubMed     Text format     Abstract available


  168. WORLD HEALTH ORGANIZATION
    Polio vaccines: WHO position paper, March 2016-recommendations.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31064.
    PubMed     Text format     Abstract available


  169. WANEESORN J, Wibowo N, Bingham J, Middelberg AP, et al
    Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31120.
    PubMed     Text format     Abstract available


  170. LU Y, Liang XF, Wang FZ, Yan L, et al
    Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31123.
    PubMed     Text format     Abstract available


  171. SCHULTHEIS K, Schaefer H, Yung BS, Oh J, et al
    Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31114.
    PubMed     Text format     Abstract available


  172. GALACTIONOVA K, Tediosi F, Camponovo F, Smith TA, et al
    Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31103.
    PubMed     Text format     Abstract available


  173. JIMENEZ-GARCIA R, Lopez-de-Andres A, Hernandez-Barrera V, Gomez-Campelo P, et al
    Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7years follow up study.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31100.
    PubMed     Text format     Abstract available


  174. BYBERG S, Thysen SM, Rodrigues A, Martins C, et al
    A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31111.
    PubMed     Text format     Abstract available


  175. DALE JB, Smeesters PR, Courtney HS, Penfound TA, et al
    Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31136.
    PubMed     Text format     Abstract available


  176. RUTTEN LJ, St Sauver JL, Beebe TJ, Wilson PM, et al
    Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: Association with initiation and completion rates.
    Vaccine. 2016 Nov 23. pii: S0264-410X(16)31043.
    PubMed     Text format     Abstract available


  177. HARDT K, Bonanni P, King S, Santos JI, et al
    Vaccine strategies: Optimising outcomes.
    Vaccine. 2016 Nov 22. pii: S0264-410X(16)31030.
    PubMed     Text format     Abstract available


  178. PREISS S, Garcon N, Cunningham AL, Strugnell R, et al
    Vaccine provision: Delivering sustained & widespread use.
    Vaccine. 2016 Nov 21. pii: S0264-410X(16)31031.
    PubMed     Text format     Abstract available


  179. HAIDARI LA, Brown ST, Wedlock P, Lee BY, et al
    Map of different vaccine supply chain efficiency measures.
    Vaccine. 2016 Nov 21. pii: S0264-410X(16)31072.
    PubMed     Text format    


  180. SHEN Z, Bowen RA, Ge P, Yu J, et al
    Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets.
    Vaccine. 2016;34:5953-5958.
    PubMed     Text format     Abstract available


  181. KRASZEWSKA-G OMBA B, Matkowska-Kocjan A, Mi Kiewicz K, Szyma Ska-Toczek Z, et al
    Mumps, measles and rubella vaccination in children with PFAPA syndrome.
    Vaccine. 2016;34:5903-5906.
    PubMed     Text format     Abstract available


  182. KULKARNI SP, Thanapati S, Arankalle VA, Tripathy AS, et al
    Specific memory B cell response and participation of CD4+ central and effector memory T cells in mice immunized with liposome encapsulated recombinant NE protein based Hepatitis E vaccine candidate.
    Vaccine. 2016;34:5895-5902.
    PubMed     Text format     Abstract available


  183. LEON A, David AL, Madeline B, Guianvarc'h L, et al
    The EB66(R) cell line as a valuable cell substrate for MVA-based vaccines production.
    Vaccine. 2016;34:5878-5885.
    PubMed     Text format     Abstract available


  184. FONTANELLA E, Ma Z, Zhang Y, de Castro AM, et al
    An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31067.
    PubMed     Text format     Abstract available


  185. MUKHOPADHYA I, Murdoch H, Berry S, Hunt A, et al
    Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31075.
    PubMed     Text format     Abstract available


  186. ZIMMERMAN RK, Moehling KK, Lin CJ, Zhang S, et al
    Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars practice Transformation Program.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31065.
    PubMed     Text format     Abstract available


  187. SCHWARTZ LM, Halloran ME, Rowhani-Rahbar A, Neuzil KM, et al
    Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31028.
    PubMed     Text format     Abstract available


  188. DOHERTY M, Schmidt-Ott R, Santos JI, Stanberry LR, et al
    Vaccination of special populations: Protecting the vulnerable.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31061.
    PubMed     Text format     Abstract available


  189. RADKE S, Petousis-Harris H, Watson D, Gentles D, et al
    Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31029.
    PubMed     Text format     Abstract available


  190. ZHENG D, Chen S, Qu D, Chen J, et al
    Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31073.
    PubMed     Text format     Abstract available


  191. MEARNS H, Geldenhuys HD, Kagina BM, Musvosvi M, et al
    H1:IC31 vaccination is safe and induces long-lived TNF-alpha+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31070.
    PubMed     Text format     Abstract available


  192. STERN PL
    The changing face of vaccines and vaccination.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31056.
    PubMed     Text format    


  193. JANJANAM VD, Mukherjee N, Lockett GA, Rezwan FI, et al
    Tetanus vaccination is associated with differential DNA-methylation: Reduces the risk of asthma in adolescence.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31016.
    PubMed     Text format     Abstract available


  194. SETH A, Kong IG, Lee SH, Yang JY, et al
    Modular virus-like particles for sublingual vaccination against group A streptococcus.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31039.
    PubMed     Text format     Abstract available


  195. ALLEMAN MM, Wannemuehler KA, Hao L, Perelygina L, et al
    Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)30994.
    PubMed     Text format     Abstract available


  196. LIN X, Yang J, Lu H, Zhou Y, et al
    Minimization of hepatitis B infection among children in Jiangsu, China, 12years after integration of hepatitis B vaccine into the expanded program on immunization.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31069.
    PubMed     Text format     Abstract available


  197. CREECH CB, Frenck RW Jr, Sheldon EA, Seiden DJ, et al
    Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31079.
    PubMed     Text format     Abstract available


  198. PEREIRA-MANFRO WF, Alvino RM, Cruz AC, Silva GP, et al
    Association of serum bactericidal antibody and opsonic antibody levels after Neisseria meningitidis serogroup C conjugate vaccine in Brazilian children and adolescents infected or not infected with HIV.
    Vaccine. 2016 Nov 12. pii: S0264-410X(16)31042.
    PubMed     Text format     Abstract available


  199. ADHIKARI RP, Thompson CD, Aman MJ, Lee JC, et al
    Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Vaccine. 2016 Nov 12. pii: S0264-410X(16)30897.
    PubMed     Text format     Abstract available


  200. DEMPSEY AF, Lockhart S, Campagna EJ, Pyrzanowski J, et al
    Providers' time spent and tools used when discussing the HPV vaccine with parents of adolescents.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31037.
    PubMed     Text format     Abstract available


  201. KANG J, Song YM
    Factors associated with vaccination status among Korean submariners who are eligible for free non-mandatory influenza vaccination.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31027.
    PubMed     Text format     Abstract available


  202. SORUP S, Benn CS, Poulsen A, Krause TG, et al
    Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register based cohort study.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31033.
    PubMed     Text format     Abstract available


  203. BECKER BF, Larson HJ, Bonhoeffer J, van Mulligen EM, et al
    Evaluation of a multinational, multilingual vaccine debate on Twitter.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31038.
    PubMed     Text format     Abstract available


  204. ZHAO D, Gai Tobe R, Cui M, He J, et al
    Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China.
    Vaccine. 2016 Nov 9. pii: S0264-410X(16)31025.
    PubMed     Text format     Abstract available


  205. FONTENOT HB, Fantasia HC, Vetters R, Zimet GD, et al
    Increasing HPV vaccination and eliminating barriers: Recommendations from young men who have sex with men.
    Vaccine. 2016 Nov 9. pii: S0264-410X(16)31026.
    PubMed     Text format     Abstract available


  206. OLIGBU G, Hsia Y, Folgori L, Collins S, et al
    Pneumococcal conjugate vaccine failure in children: A systematic review of the literature.
    Vaccine. 2016 Nov 9. pii: S0264-410X(16)30985.
    PubMed     Text format     Abstract available


  207. WALKER L, Newall A, Heywood AE
    Knowledge, attitudes and practices of Australian medical students towards influenza vaccination.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)31024.
    PubMed     Text format     Abstract available


  208. KRISTENSEN DD, Bartholomew K, Villadiego S, Lorenson K, et al
    What vaccine product attributes do immunization program stakeholders value? Results from interviews in six low- and middle-income countries.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)30992.
    PubMed     Text format     Abstract available


  209. HABER P, Arana J, Pilishvili T, Lewis P, et al
    Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged 19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)30987.
    PubMed     Text format     Abstract available


  210. DI PASQUALE A, Bonanni P, Garcon N, Stanberry LR, et al
    Vaccine safety evaluation: Practical aspects in assessing benefits and risks.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)30974.
    PubMed     Text format     Abstract available


  211. WIESE AD, Griffin MR, Zhu Y, Mitchel EF Jr, et al
    Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.
    Vaccine. 2016 Nov 7. pii: S0264-410X(16)30997.
    PubMed     Text format     Abstract available


  212. SHARMA M, Dixit A
    Immune response characterization and vaccine potential of a recombinant chimera comprising B-cell epitope of Aeromonas hydrophila outer membrane protein C and LTB.
    Vaccine. 2016 Nov 7. pii: S0264-410X(16)31012.
    PubMed     Text format     Abstract available


  213. DAI G, Rady HF, Huang W, Shellito JE, et al
    Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Vaccine. 2016 Nov 4. pii: S0264-410X(16)31013.
    PubMed     Text format     Abstract available


  214. HUANG CH, Chao DY, Wu CC, Hsu SY, et al
    Influenza vaccination and the endurance against air pollution among elderly with acute coronary syndrome.
    Vaccine. 2016 Nov 4. pii: S0264-410X(16)30989.
    PubMed     Text format     Abstract available


  215. VAN RAVENHORST MB, Marinovic AB, van der Klis FR, van Rooijen DM, et al
    Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.
    Vaccine. 2016 Nov 4. pii: S0264-410X(16)30984.
    PubMed     Text format     Abstract available


  216. ZIKMUND-FISHER BJ, Wittenberg E, Lieu TA
    Parental weighting of seizure risks vs. fever risks in vaccination tradeoff decisions.
    Vaccine. 2016 Nov 3. pii: S0264-410X(16)30949.
    PubMed     Text format     Abstract available


  217. POWELL GA, Zinszer K, Verma A, Bahk C, et al
    Media content about vaccines in the United States and Canada, 2012-2014: An analysis using data from the Vaccine Sentimeter.
    Vaccine. 2016 Nov 3. pii: S0264-410X(16)31015.
    PubMed     Text format     Abstract available


  218. YU C, Li X, Liu J, Diao W, et al
    Replacing the decoy epitope of PCV2b capsid protein with a protective epitope enhances efficacy of PCV2b vaccine.
    Vaccine. 2016 Nov 3. pii: S0264-410X(16)30979.
    PubMed     Text format     Abstract available


  219. RHODES SJ, Zelmer A, Knight GM, Prabowo SA, et al
    The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisions.
    Vaccine. 2016 Nov 2. pii: S0264-410X(16)30995.
    PubMed     Text format     Abstract available


  220. PIELER MM, Frentzel S, Bruder D, Wolff MW, et al
    A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection.
    Vaccine. 2016 Nov 2. pii: S0264-410X(16)30976.
    PubMed     Text format     Abstract available


  221. LUTTJEBOER J, Setiawan D, Cao Q, Cahh Daemen T, et al
    Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands.
    Vaccine. 2016 Nov 2. pii: S0264-410X(16)30935.
    PubMed     Text format     Abstract available


    October 2016
  222. PRINGLE K, Cardemil CV, Pabst LJ, Parashar UD, et al
    Uptake of rotavirus vaccine among US infants at Immunization Information System Sentinel Sites.
    Vaccine. 2016 Oct 31. pii: S0264-410X(16)30903.
    PubMed     Text format     Abstract available


  223. MAURER KA, Chen HF, Wagner AL, Hegde ST, et al
    Cost-effectiveness analysis of pneumococcal vaccination for infants in China.
    Vaccine. 2016 Oct 31. pii: S0264-410X(16)30986.
    PubMed     Text format     Abstract available


  224. PATERSON P, Meurice F, Stanberry LR, Glismann S, et al
    Vaccine hesitancy and healthcare providers.
    Vaccine. 2016 Oct 31. pii: S0264-410X(16)30977.
    PubMed     Text format     Abstract available


  225. ENDO IC, Ziegelmann PK, Patel A
    The economic promise of developing and implementing dengue vaccines: Evidence from a systematic review.
    Vaccine. 2016 Oct 31. pii: S0264-410X(16)30972.
    PubMed     Text format     Abstract available


  226. RAMEZANPOUR B, Haan I, Osterhaus A, Claassen E, et al
    Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
    Vaccine. 2016 Oct 28. pii: S0264-410X(16)30510.
    PubMed     Text format     Abstract available


  227. PACE D, Khatami A, Attard-Montalto S, Voysey M, et al
    Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy.
    Vaccine. 2016 Oct 28. pii: S0264-410X(16)30973.
    PubMed     Text format     Abstract available


  228. LIU H, Frijlink HW, Huckriede A, van Doorn E, et al
    Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30975.
    PubMed     Text format     Abstract available


  229. JONES CE, Munoz FM, Kochhar S, Vergnano S, et al
    Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30570.
    PubMed     Text format     Abstract available


  230. ZHANG X, Wei M, Sun G, Wang X, et al
    Real-time stability of a hepatitis E vaccine (Hecolin(R)) demonstrated with potency assays and multifaceted physicochemical methods.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30980.
    PubMed     Text format     Abstract available


  231. FREW PM, Chung Y, Fisher AK, Schamel J, et al
    Parental experiences with vaccine information statements: Implications for timing, delivery, and parent-provider immunization communication.
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30944.
    PubMed     Text format     Abstract available


  232. BRICKLEY EB, Coulibaly M, Gabriel EE, Healy SA, et al
    Utilizing direct skin feeding assays for development of vaccines that interrupt malaria transmission: A systematic review of methods and case study.
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30945.
    PubMed     Text format     Abstract available


  233. LOPEZ-LACORT M, Collado S, Diez-Gandia A, Diez-Domingo J, et al
    Rotavirus, vaccine failure or diagnostic error?
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30953.
    PubMed     Text format     Abstract available


  234. MANENTI A, Tete SM, Mohn KG, Jul-Larsen A, et al
    Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30940.
    PubMed     Text format     Abstract available


  235. TASHANI M, Alfelali M, Barasheed O, Alqahtani AS, et al
    Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial.
    Vaccine. 2016 Oct 22. pii: S0264-410X(16)30936.
    PubMed     Text format     Abstract available


  236. DOHERTY M, Buchy P, Standaert B, Giaquinto C, et al
    Vaccine impact: Benefits for human health.
    Vaccine. 2016 Oct 20. pii: S0264-410X(16)30943.
    PubMed     Text format     Abstract available


  237. DVALISHVILI M, Mesxishvili D, Butsashvili M, Kamkamidze G, et al
    Knowledge, attitudes, and practices of healthcare providers in the country of Georgia regarding influenza vaccinations for pregnant women.
    Vaccine. 2016 Oct 20. pii: S0264-410X(16)30954.
    PubMed     Text format     Abstract available


  238. WIJESINGHE PR, Abeysinghe MR, Yoksan S, Yao Y, et al
    Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.
    Vaccine. 2016 Oct 20. pii: S0264-410X(16)30946.
    PubMed     Text format     Abstract available


  239. VAN STRATEN M, Bardenstein S, Keningswald G, Banai M, et al
    Brucella abortus S19 vaccine protects dairy cattle against natural infection with Brucella melitensis.
    Vaccine. 2016 Oct 19. pii: S0264-410X(16)30909.
    PubMed     Text format     Abstract available


  240. CLENDINEN C, Zhang Y, Warburton RN, Light DW, et al
    Manufacturing costs of HPV vaccines for developing countries.
    Vaccine. 2016 Oct 19. pii: S0264-410X(16)30856.
    PubMed     Text format     Abstract available


  241. YANG L, Liu Y, Li S, Zhao H, et al
    A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Vaccine. 2016 Oct 19. pii: S0264-410X(16)30934.
    PubMed     Text format     Abstract available


  242. CUNNINGHAM AL, Garcon N, Leo O, Friedland LR, et al
    Vaccine development: From concept to early clinical testing.
    Vaccine. 2016 Oct 18. pii: S0264-410X(16)30917.
    PubMed     Text format     Abstract available


  243. ISENOR JE, Edwards NT, Alia TA, Slayter KL, et al
    Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis.
    Vaccine. 2016 Oct 17. pii: S0264-410X(16)30792.
    PubMed     Text format     Abstract available


  244. HERTZ T, Logan MG, Rolland M, Magaret CA, et al
    A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial.
    Vaccine. 2016 Oct 15. pii: S0264-410X(16)30880.
    PubMed     Text format     Abstract available


  245. OLOWOOKERE SA, Abioye-Kuteyi EA, Adekanle O
    Willingness to participate in Ebola viral disease vaccine trials and receive vaccination by health workers in a tertiary hospital in Ile-Ife, Southwest Nigeria.
    Vaccine. 2016 Oct 14. pii: S0264-410X(16)30900.
    PubMed     Text format     Abstract available


  246. ARNABOLDI PM, Sambir M, D'Arco C, Peters LA, et al
    Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30901.
    PubMed     Text format     Abstract available


  247. SCHMID P, MacDonald NE, Habersaat K, Butler R, et al
    Commentary to: How to respond to vocal vaccine deniers in public.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30914.
    PubMed     Text format    


  248. YANG J, Atkins KE, Feng L, Pang M, et al
    Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30911.
    PubMed     Text format     Abstract available


  249. SURENDRAN N, Nicolosi T, Pichichero M
    Infants with low vaccine antibody responses have altered innate cytokine response.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30875.
    PubMed     Text format     Abstract available


  250. SHENG Z, Gao N, Cui X, Fan D, et al
    Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
    Vaccine. 2016 Oct 12. pii: S0264-410X(16)30892.
    PubMed     Text format     Abstract available


  251. DANIEL C, Titecat M, Poiret S, Cayet D, et al
    Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30896.
    PubMed     Text format     Abstract available


  252. DAILY A, Kennedy ED, Fierro LA, Reed JH, et al
    Evaluation of scanning 2D barcoded vaccines to improve data accuracy of vaccines administered.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30878.
    PubMed     Text format     Abstract available


  253. JORRITSMA SH, Gowans EJ, Grubor-Bauk B, Wijesundara DK, et al
    Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30898.
    PubMed     Text format     Abstract available


  254. EVENSON D, Gerber PF, Xiao CT, Halbur PG, et al
    A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30874.
    PubMed     Text format     Abstract available


  255. KARKI S, Dyda A, Newall A, Heywood A, et al
    Comparison of influenza vaccination coverage between immigrant and Australian-born adults.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30910.
    PubMed     Text format     Abstract available


  256. SITARAS I, Rousou X, Peeters B, de Jong MC, et al
    Mutations in the haemagglutinin protein and their effect in transmission of highly pathogenic avian influenza (HPAI) H5N1 virus in sub-optimally vaccinated chickens.
    Vaccine. 2016 Oct 8. pii: S0264-410X(16)30894.
    PubMed     Text format     Abstract available


  257. LANKESTER FJ, Wouters PA, Czupryna A, Palmer GH, et al
    Thermotolerance of an inactivated rabies vaccine for dogs.
    Vaccine. 2016 Oct 8. pii: S0264-410X(16)30913.
    PubMed     Text format     Abstract available


  258. DUVAL L, Wolff FC, McKee M, Roberts B, et al
    The Roma vaccination gap: Evidence from twelve countries in Central and South-East Europe.
    Vaccine. 2016 Oct 7. pii: S0264-410X(16)30899.
    PubMed     Text format     Abstract available


  259. VAN KLEEF E, Deeny SR, Jit M, Cookson B, et al
    The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.
    Vaccine. 2016 Oct 7. pii: S0264-410X(16)30871.
    PubMed     Text format     Abstract available


  260. ALCOLEA PJ, Alonso A, Larraga V
    Rationale for selection of developmentally regulated genes as vaccine candidates against Leishmania infantum infection.
    Vaccine. 2016 Oct 5. pii: S0264-410X(16)30788.
    PubMed     Text format    


  261. MCPHERSON MC, Cheng HH, Delany ME
    Marek's disease herpesvirus vaccines integrate into chicken host chromosomes yet lack a virus-host phenotype associated with oncogenic transformation.
    Vaccine. 2016 Oct 5. pii: S0264-410X(16)30876.
    PubMed     Text format     Abstract available


  262. BAI X, Wang Y, Xu X, Sun Z, et al
    Commercial vaccines provide limited protection to NADC30-like PRRSV infection.
    Vaccine. 2016 Oct 3. pii: S0264-410X(16)30873.
    PubMed     Text format     Abstract available


    September 2016
  263. SPEARMAN P, Mulligan M, Anderson EJ, Shane AL, et al
    A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation.
    Vaccine. 2016 Sep 30. pii: S0264-410X(16)30855.
    PubMed     Text format     Abstract available


  264. GUPTA N, Vedi S, Kunimoto DY, Agrawal B, et al
    Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Vaccine. 2016 Sep 29. pii: S0264-410X(16)30771.
    PubMed     Text format     Abstract available


  265. NELSON KN, Wallace AS, Sodha SV, Daniels D, et al
    Assessing strategies for increasing urban routine immunization coverage of childhood vaccines in low and middle-income countries: A systematic review of peer-reviewed literature.
    Vaccine. 2016 Sep 28. pii: S0264-410X(16)30851.
    PubMed     Text format     Abstract available


  266. NTEGE EH, Arisue N, Ito D, Hasegawa T, et al
    Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Vaccine. 2016 Sep 28. pii: S0264-410X(16)30841.
    PubMed     Text format     Abstract available


  267. BRANDILEONE MC, Zanella RC, Almeida SC, Brandao AP, et al
    Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in Sao Paulo, Brazil.
    Vaccine. 2016 Sep 28. pii: S0264-410X(16)30840.
    PubMed     Text format     Abstract available


  268. GIRARD MP, Le-Grand R, Picot V, Longuet C, et al
    Report of the Cent Gardes HIV Vaccines Conference, Part 2: The cellular immune response. Fondation Merieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
    Vaccine. 2016 Sep 27. pii: S0264-410X(16)30847.
    PubMed     Text format    


  269. MELERO JA, Mas V, McLellan JS
    Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.
    Vaccine. 2016 Sep 27. pii: S0264-410X(16)30870.
    PubMed     Text format     Abstract available


  270. RAINA MACINTYRE C, Menzies R, Kpozehouen E, Chapman M, et al
    Equity in disease prevention: Vaccines for the older adults - Proceedings of a workshop, Melbourne, Australia 20 June 2014.
    Vaccine. 2016 Sep 26. pii: S0264-410X(16)30852.
    PubMed     Text format     Abstract available


  271. FITZGERALD TJ, Kang Y, Bridges CB, Talbert T, et al
    Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
    Vaccine. 2016 Sep 26. pii: S0264-410X(16)30833.
    PubMed     Text format     Abstract available


  272. CHOKEPHAIBULKIT K, Sirivichayakul C, Thisyakorn U, Pancharoen C, et al
    Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
    Vaccine. 2016 Sep 26. pii: S0264-410X(16)30831.
    PubMed     Text format     Abstract available


  273. FAASSE K, Chatman CJ, Martin LR
    A comparison of language use in pro- and anti-vaccination comments in response to a high profile Facebook post.
    Vaccine. 2016 Sep 24. pii: S0264-410X(16)30842.
    PubMed     Text format     Abstract available


  274. WU Y, Wood J, Khandaker G, Waddington C, et al
    Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30823.
    PubMed     Text format     Abstract available


  275. FRIEDRICH BM, Beasley DW, Rudra JS
    Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30858.
    PubMed     Text format     Abstract available


  276. LIN X, Fiebelkorn AP, Pabst LJ
    Trends in compliance with two-dose influenza vaccine recommendations in children aged 6 months through 8 years, 2010-2015.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30850.
    PubMed     Text format     Abstract available


  277. WILLIS E, Parkhouse K, Krammer F, Hensley SE, et al
    Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30830.
    PubMed     Text format     Abstract available


  278. HOLECHEK SA, McAfee MS, Nieves LM, Guzman VP, et al
    Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30826.
    PubMed     Text format     Abstract available


  279. FRANZO G, Tucciarone CM, Blanco A, Nofrarias M, et al
    Effect of different vaccination strategies on IBV QX population dynamics and clinical outbreaks.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30827.
    PubMed     Text format     Abstract available


  280. LEVIN Y, Kochba E, Shukarev G, Rusch S, et al
    A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30804.
    PubMed     Text format     Abstract available


  281. GRANT BD, Smith CA, Castle PE, Scheurer ME, et al
    A paper-based immunoassay to determine HPV vaccination status at the point-of-care.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30834.
    PubMed     Text format     Abstract available


  282. WONG VW, Fong DY, Lok KY, Wong JY, et al
    Brief education to promote maternal influenza vaccine uptake: A randomized controlled trial.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30832.
    PubMed     Text format     Abstract available


  283. TAN L, Zhang Y, Liu F, Yuan Y, et al
    Infectious bronchitis virus poly-epitope-based vaccine protects chickens from acute infection.
    Vaccine. 2016 Sep 21. pii: S0264-410X(16)30835.
    PubMed     Text format     Abstract available


  284. SCHAUT RG, Grinnage-Pulley TL, Esch KJ, Toepp AJ, et al
    Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
    Vaccine. 2016 Sep 21. pii: S0264-410X(16)30829.
    PubMed     Text format     Abstract available


  285. SLAUNWHITE JM, Smith SM, Halperin BA, Langley JM, et al
    The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes.
    Vaccine. 2016 Sep 21. pii: S0264-410X(16)30790.
    PubMed     Text format     Abstract available


  286. STADING BR, Osorio JE, Velasco-Villa A, Smotherman M, et al
    Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis).
    Vaccine. 2016 Sep 17. pii: S0264-410X(16)30796.
    PubMed     Text format     Abstract available


  287. NANNEI C, Goldin S, Torelli G, Fatima H, et al
    Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a survey.
    Vaccine. 2016 Sep 16. pii: S0264-410X(16)30712.
    PubMed     Text format     Abstract available


  288. STEIN DF, O'Connor D, Blohmke CJ, Sadarangani M, et al
    Gene expression profiles are different in venous and capillary blood: Implications for vaccine studies.
    Vaccine. 2016 Sep 15. pii: S0264-410X(16)30803.
    PubMed     Text format     Abstract available


  289. ROBERTSON CA, Greenberg DP, Hedrick J, Pichichero M, et al
    Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Vaccine. 2016 Sep 15. pii: S0264-410X(16)30799.
    PubMed     Text format     Abstract available


  290. BRUCKNER S, Agnandji ST, Elias J, Berberich S, et al
    A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children.
    Vaccine. 2016 Sep 15. pii: S0264-410X(16)30624.
    PubMed     Text format     Abstract available


  291. FLECHTNER JB, Long D, Larson S, Clemens V, et al
    Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial.
    Vaccine. 2016 Sep 15. pii: S0264-410X(16)30795.
    PubMed     Text format     Abstract available


  292. YANG X, Clapp B, Thornburg T, Hoffman C, et al
    Vaccination with a DeltanorD DeltaznuA Brucella abortus mutant confers potent protection against virulent challenge.
    Vaccine. 2016 Sep 14. pii: S0264-410X(16)30800.
    PubMed     Text format     Abstract available


  293. MUNIER CM, van Bockel D, Bailey M, Ip S, et al
    The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.
    Vaccine. 2016 Sep 14. pii: S0264-410X(16)30805.
    PubMed     Text format     Abstract available


  294. GATERA M, Uwimana J, Manzi E, Ngabo F, et al
    Use of administrative records to assess pneumococcal conjugate vaccine impact on pediatric meningitis and pneumonia hospitalizations in Rwanda.
    Vaccine. 2016 Sep 14. pii: S0264-410X(16)30791.
    PubMed     Text format     Abstract available


  295. JANEWONGWIROT P, Puthanakit T, Anugulruengkitt S, Jantarabenjakul W, et al
    Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
    Vaccine. 2016 Sep 12. pii: S0264-410X(16)30801.
    PubMed     Text format     Abstract available


  296. SMITH SG, Zelmer A, Blitz R, Fletcher HA, et al
    Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.
    Vaccine. 2016 Sep 9. pii: S0264-410X(16)30797.
    PubMed     Text format     Abstract available


  297. HURTGEN BJ, Castro-Lopez N, Jimenez-Alzate MD, Cole GT, et al
    Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
    Vaccine. 2016 Sep 9. pii: S0264-410X(16)30785.
    PubMed     Text format     Abstract available


  298. LI R, Fang KX, Young M Jr, Zhou X, et al
    Long-term antibody persistence study (3 years after last dose) of the 7-valent pneumococcal conjugate vaccine in young children in China.
    Vaccine. 2016 Sep 8. pii: S0264-410X(16)30766.
    PubMed     Text format     Abstract available


  299. SULLIVAN SG, Cowling BJ, Greenland S
    Frailty and influenza vaccine effectiveness.
    Vaccine. 2016;34:4645-6.
    PubMed     Text format    


  300. NANNEI C, Chadwick C, Fatima H, Goldin S, et al
    Considerations for sustainable influenza vaccine production in developing countries.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30743.
    PubMed     Text format     Abstract available


  301. COWAN AE, Clark SJ, Gordon JL, Bok K, et al
    Vaccine purchasing groups in the United States: An overview of their policies and practices.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30787.
    PubMed     Text format     Abstract available


  302. TANG VA, Renner TM, Varette O, Le Boeuf F, et al
    Single-particle characterization of oncolytic vaccinia virus by flow virometry.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30770.
    PubMed     Text format     Abstract available


  303. DHAND NK, Eppleston J, Whittington RJ, Windsor PA, et al
    Changes in prevalence of ovine paratuberculosis following vaccination with Gudair(R): Results of a longitudinal study conducted over a decade.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30760.
    PubMed     Text format     Abstract available


  304. HOWLADER DR, Sinha R, Nag D, Majumder N, et al
    Zebrafish as a novel model for non-typhoidal Salmonella pathogenesis, transmission and vaccine efficacy.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30773.
    PubMed     Text format     Abstract available


  305. CASPARD H, Coelingh KL, Mallory RM, Ambrose CS, et al
    Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States.
    Vaccine. 2016 Sep 6. pii: S0264-410X(16)30786.
    PubMed     Text format     Abstract available


  306. DOWNEY-SLINKER ED, Ridpath JF, Sawyer JE, Skow LC, et al
    Antibody titers to vaccination are not predictive of level of protection against a BVDV type 1b challenge in Bos indicus - Bos taurus steers.
    Vaccine. 2016 Sep 3. pii: S0264-410X(16)30794.
    PubMed     Text format     Abstract available


  307. COUDEVILLE L, Baurin N, L'Azou M, Guy B, et al
    Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine.
    Vaccine. 2016 Sep 3. pii: S0264-410X(16)30735.
    PubMed     Text format     Abstract available


  308. TABYNOV K, Orynbayev M, Renukaradhya GJ, Sansyzbay A, et al
    Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine.
    Vaccine. 2016 Sep 2. pii: S0264-410X(16)30768.
    PubMed     Text format     Abstract available


  309. SARAWAR S, Hatta Y, Watanabe S, Dias P, et al
    M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice.
    Vaccine. 2016 Sep 2. pii: S0264-410X(16)30757.
    PubMed     Text format     Abstract available


  310. RUDENKO L, Yeolekar L, Kiseleva I, Isakova-Sivak I, et al
    Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
    Vaccine. 2016 Sep 1. pii: S0264-410X(16)30675.
    PubMed     Text format     Abstract available


  311. PLATTEEL AC, Marit de Groot A, Keller C, Andersen P, et al
    Strategies to enhance immunogenicity of cDNA vaccine encoded antigens by modulation of antigen processing.
    Vaccine. 2016 Sep 1. pii: S0264-410X(16)30711.
    PubMed     Text format     Abstract available


    August 2016
  312. PRIDGEON JW, Klesius PH
    Retraction notice to "Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin" [Vaccine 31 (2013) 2705-2712].
    Vaccine. 2016;34:4642.
    PubMed     Text format    


  313. HENDRICKSON JE, Tormey CA
    Human papilloma virus vaccination and dysautonomia: Considerations for autoantibody evaluation and HLA typing.
    Vaccine. 2016;34:4468.
    PubMed     Text format    


  314. BRYANT K, Frenck RW Jr
    Response to Letter to the Editor regarding: Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine.
    Vaccine. 2016;34:4467.
    PubMed     Text format    


  315. FEDSON DS
    PCV13 vaccination for older adults: Another view.
    Vaccine. 2016;34:4466.
    PubMed     Text format    


  316. PHAN TL, Ho VT, Vu MH, Nguyen TN, et al
    Clinical testing of an inactivated influenza A/H5N1 vaccine candidate in a double-blinded, placebo-controlled, randomized trial in healthy adults in Vietnam.
    Vaccine. 2016 Aug 31. pii: S0264-410X(16)30742.
    PubMed     Text format     Abstract available


  317. CHITRADEVI ST, Kaur G, Sivaramakrishna U, Singh D, et al
    Development of recombinant vaccine candidate molecule against Shigella infection.
    Vaccine. 2016 Aug 31. pii: S0264-410X(16)30706.
    PubMed     Text format     Abstract available


  318. VOIGT EA, Ovsyannikova IG, Haralambieva IH, Kennedy RB, et al
    Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination.
    Vaccine. 2016 Aug 30. pii: S0264-410X(16)30756.
    PubMed     Text format     Abstract available


  319. YOSHIKAWA T, Ando Y, Nakagawa T, Gomi Y, et al
    Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan.
    Vaccine. 2016 Aug 30. pii: S0264-410X(16)30729.
    PubMed     Text format     Abstract available


  320. PROVEAUX T, Lambach P, Ortiz JR, Hombach J, et al
    Review of prescribing information for influenza vaccines for pregnant and lactating women.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30714.
    PubMed     Text format     Abstract available


  321. ASTRAY-MOCHALES J, Lopez de Andres A, Hernandez-Barrera V, Rodriguez-Rieiro C, et al
    Influenza vaccination coverages among high risk subjects and health care workers in Spain. Results of two consecutive National Health Surveys (2011-2014).
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30761.
    PubMed     Text format     Abstract available


  322. DENMAN DC, Baldwin AS, Marks EG, Lee SC, et al
    Modification and validation of the Treatment Self Regulation Questionnaire to assess parental motivation for HPV vaccination of adolescents.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30709.
    PubMed     Text format     Abstract available


  323. YEUNG KH, Tate JE, Chan CC, Chan MC, et al
    Rotavirus vaccine effectiveness in Hong Kong children.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30732.
    PubMed     Text format     Abstract available


  324. COHEN R, Varon E, Bechet S, Bonacorsi S, et al
    Comparative impact of pneumococcal conjugate vaccines on pneumococcal meningitis according to underlying conditions.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30765.
    PubMed     Text format     Abstract available


  325. ISSA MN, Ashhab Y
    Identification of Brucella melitensis Rev.1 vaccine-strain genetic markers: Towards understanding the molecular mechanism behind virulence attenuation.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30755.
    PubMed     Text format     Abstract available


  326. MCBRIDE WJ, Abhayaratna WP, Barr I, Booy R, et al
    Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30710.
    PubMed     Text format     Abstract available


  327. CRUM-CIANFLONE NF, Won S, Lee R, Lalani T, et al
    Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.
    Vaccine. 2016 Aug 28. pii: S0264-410X(16)30432.
    PubMed     Text format     Abstract available


  328. FIELDING JE, Levy A, Chilver MB, Deng YM, et al
    Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment.
    Vaccine. 2016 Aug 28. pii: S0264-410X(16)30763.
    PubMed     Text format     Abstract available


  329. JIA Q, Bowen R, Lee BY, Dillon BJ, et al
    Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Vaccine. 2016 Aug 28. pii: S0264-410X(16)30713.
    PubMed     Text format     Abstract available


  330. GADROEN K, Straus SM, Pacurariu A, Weibel D, et al
    Patterns of spontaneous reports on narcolepsy following administration of pandemic influenza vaccine; a case series of individual case safety reports in Eudravigilance.
    Vaccine. 2016 Aug 27. pii: S0264-410X(16)30758.
    PubMed     Text format     Abstract available


  331. VUTA V, Picard-Meyer E, Robardet E, Barboi G, et al
    Vaccine-induced rabies case in a cow (Bos taurus): Molecular characterisation of vaccine strain in brain tissue.
    Vaccine. 2016 Aug 27. pii: S0264-410X(16)30670.
    PubMed     Text format     Abstract available


  332. ELNEKAVE E, Dekker A, Eble P, van Hemert-Kluitenberg F, et al
    The serological response against foot and mouth disease virus elicited by repeated vaccination of dairy cattle.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30741.
    PubMed     Text format     Abstract available


  333. LEE BY, Haidari LA, Prosser W, Connor DL, et al
    Re-designing the Mozambique vaccine supply chain to improve access to vaccines.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30708.
    PubMed     Text format     Abstract available


  334. PITTET LF, Posfay-Barbe KM, Chehade H, Rudin C, et al
    Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30734.
    PubMed     Text format     Abstract available


  335. KARAFILLAKIS E, Dinca I, Apfel F, Cecconi S, et al
    Vaccine hesitancy among healthcare workers in Europe: A qualitative study.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30701.
    PubMed     Text format     Abstract available


  336. CHENG T, Wang X, Song Y, Tang X, et al
    Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30762.
    PubMed     Text format     Abstract available


  337. IDOKO OT, Hampton LM, Mboizi RB, Agbla SC, et al
    Acceptance of multiple injectable vaccines in a single immunization visit in The Gambia pre and post introduction of inactivated polio vaccine.
    Vaccine. 2016 Aug 25. pii: S0264-410X(16)30604.
    PubMed     Text format     Abstract available


  338. ANH DD, Thiem VD, Anh NT, Huong VM, et al
    Randomized safety and immunogenicity trial of a seasonal trivalent inactivated split virion influenza vaccine (IVACFLU-S) in healthy young Vietnamese adults.
    Vaccine. 2016 Aug 24. pii: S0264-410X(16)30739.
    PubMed     Text format     Abstract available


  339. OLADEJO O, Allen K, Amin A, Frew PM, et al
    Comparative analysis of the Parent Attitudes about Childhood Vaccines (PACV) short scale and the five categories of vaccine acceptance identified by Gust et al.
    Vaccine. 2016 Aug 23. pii: S0264-410X(16)30731.
    PubMed     Text format     Abstract available


  340. ROBERTS JN, Graham BS, Karron RA, Munoz FM, et al
    Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop.
    Vaccine. 2016 Aug 23. pii: S0264-410X(16)30655.
    PubMed     Text format     Abstract available


  341. STARK GV, Sivko GS, VanRaden M, Schiffer J, et al
    Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing.
    Vaccine. 2016 Aug 22. pii: S0264-410X(16)30465.
    PubMed     Text format     Abstract available


  342. SHEN C, Liu Q, Zhou Y, Ku Z, et al
    Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.
    Vaccine. 2016 Aug 22. pii: S0264-410X(16)30705.
    PubMed     Text format     Abstract available


  343. BOSE A, Munshi R, Tripathy RM, Madhusudana SN, et al
    A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes.
    Vaccine. 2016 Aug 20. pii: S0264-410X(16)30662.
    PubMed     Text format     Abstract available


  344. FAN W, Chen XF, Shen C, Guo ZR, et al
    Hepatitis B vaccine response in obesity: A meta-analysis.
    Vaccine. 2016 Aug 18. pii: S0264-410X(16)30699.
    PubMed     Text format     Abstract available


  345. CHOE YJ, Lee HJ, Lee H, Oh CE, et al
    Emergence of antibiotic-resistant non-vaccine serotype pneumococci in nasopharyngeal carriage in children after the use of extended-valency pneumococcal conjugate vaccines in Korea.
    Vaccine. 2016 Aug 18. pii: S0264-410X(16)30702.
    PubMed     Text format     Abstract available


  346. SHIH CT, Chang YC, Wang HL, Lin CC, et al
    Comparing the rubella seronegativity in pregnant women who received one dose of rubella vaccine at different ages in Taiwan.
    Vaccine. 2016 Aug 17. pii: S0264-410X(16)30696.
    PubMed     Text format     Abstract available


  347. SUMNER RP, Ren H, Ferguson BJ, Smith GL, et al
    Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.
    Vaccine. 2016 Aug 17. pii: S0264-410X(16)30659.
    PubMed     Text format     Abstract available


  348. MONEY DM, Moses E, Blitz S, Vandriel SM, et al
    HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.
    Vaccine. 2016 Aug 17. pii: S0264-410X(16)30673.
    PubMed     Text format     Abstract available


  349. LONG JE, Drayson MT, Taylor AE, Toellner KM, et al
    Corrigendum to 'Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial' [Vaccine 34 (2016) 2679-2685].
    Vaccine. 2016 Aug 16. pii: S0264-410X(16)30703.
    PubMed     Text format    


  350. SINGH SM, Alkie TN, Nagy E, Kulkarni RR, et al
    Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Vaccine. 2016 Aug 16. pii: S0264-410X(16)30666.
    PubMed     Text format     Abstract available


  351. SILLERO-ZUBIRI C, Marino J, Gordon CH, Bedin E, et al
    Feasibility and efficacy of oral rabies vaccine SAG2 in endangered Ethiopian wolves.
    Vaccine. 2016 Aug 16. pii: S0264-410X(16)30693.
    PubMed     Text format     Abstract available


  352. MCLEAN KA, Goldin S, Nannei C, Sparrow E, et al
    The 2015 global production capacity of seasonal and pandemic influenza vaccine.
    Vaccine. 2016 Aug 13. pii: S0264-410X(16)30676.
    PubMed     Text format     Abstract available


  353. CHOOTIPONGCHAIVAT S, Chantarastapornchit V, Kulpeng W, Ceria JA, et al
    Vaccination program in a resource-limited setting: A case study in the Philippines.
    Vaccine. 2016 Aug 13. pii: S0264-410X(16)30671.
    PubMed     Text format     Abstract available


  354. ARMSTRONG G, Gallagher N, Cabrey P, Graham AM, et al
    A population based study comparing changes in rotavirus burden on the Island of Ireland between a highly vaccinated population and an unvaccinated population.
    Vaccine. 2016 Aug 12. pii: S0264-410X(16)30661.
    PubMed     Text format     Abstract available


  355. CLOSE RM, Pearson C, Cohn J
    Vaccine-preventable disease and the under-utilization of immunizations in complex humanitarian emergencies.
    Vaccine. 2016 Aug 12. pii: S0264-410X(16)30697.
    PubMed     Text format     Abstract available


  356. TADDIO A, Wong H, Welkovics B, Ilersich AL, et al
    A randomized trial of the effect of vaccine injection speed on acute pain in infants.
    Vaccine. 2016 Aug 12. pii: S0264-410X(16)30695.
    PubMed     Text format     Abstract available


  357. GUERRA FM, Rosella LC, Dunn S, Wilson SE, et al
    Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.
    Vaccine. 2016 Aug 12. pii: S0264-410X(16)30677.
    PubMed     Text format     Abstract available


  358. TANNER R, O'Shea MK, Fletcher HA, McShane H, et al
    In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy.
    Vaccine. 2016 Aug 12. pii: S0264-410X(16)30656.
    PubMed     Text format     Abstract available


  359. VISSER O, Kraan J, Akkermans R, Ruiter RA, et al
    Assessing determinants of the intention to accept a pertussis cocooning vaccination: A survey among Dutch parents.
    Vaccine. 2016 Aug 11. pii: S0264-410X(16)30607.
    PubMed     Text format     Abstract available


  360. GUPTA G, Giannino V, Rishi N, Glueck R, et al
    Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine.
    Vaccine. 2016 Aug 11. pii: S0264-410X(16)30649.
    PubMed     Text format     Abstract available


  361. VALCARCEL SALAMANCA B, Hagerup-Jenssen ME, Flem E
    Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Vaccine. 2016 Aug 10. pii: S0264-410X(16)30674.
    PubMed     Text format     Abstract available


  362. WESTMAN ME, Malik R, Hall E, Harris M, et al
    The protective rate of the feline immunodeficiency virus vaccine: An Australian field study.
    Vaccine. 2016 Aug 10. pii: S0264-410X(16)30511.
    PubMed     Text format     Abstract available


  363. CHEN W, Messonnier M, Zhou F
    Trends in childhood vaccine purchase costs in the US public sector: 1996-2014.
    Vaccine. 2016 Aug 10. pii: S0264-410X(16)30669.
    PubMed     Text format     Abstract available


  364. SUAREZ V, Michel F, Toscano CM, Bierrenbach AL, et al
    Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
    Vaccine. 2016 Aug 9. pii: S0264-410X(16)30610.
    PubMed     Text format     Abstract available


  365. ELNEKAVE E, Dekker A, Eble P, van Hemert-Kluitenberg F, et al
    The long term effect of age and maternally derived antibodies against foot and mouth disease on the serological response following vaccination in young dairy calves.
    Vaccine. 2016 Aug 9. pii: S0264-410X(16)30650.
    PubMed     Text format     Abstract available


  366. HOLBROOK BC, D'Agostino RB Jr, Parks GD, Alexander-Miller MA, et al
    Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model.
    Vaccine. 2016 Aug 8. pii: S0264-410X(16)30667.
    PubMed     Text format     Abstract available


  367. GROHMANN G, Francis DP, Sokhey J, Robertson J, et al
    Challenges and successes for the grantees and the Technical Advisory Group of WHO's influenza vaccine technology transfer initiative.
    Vaccine. 2016 Aug 6. pii: S0264-410X(16)30645.
    PubMed     Text format     Abstract available


  368. HADINEGORO SR, Arredondo-Garcia JL, Guy B, Bouckenooghe A, et al
    Answer to the review from Halstead and Russell "Protective and immunological behavior of chimeric yellow fever dengue vaccine" (DOI 10.1016/j.vaccine.2016.02.004).
    Vaccine. 2016;34:4273-4.
    PubMed     Text format    


  369. VAN DAMME P, Stanley M
    Re: Letter to the Editor: P. van Damme et al., Vaccine 34 (2016) 757-761, as a reply to Ryser et al's letter in Vaccine.
    Vaccine. 2016;34:4272.
    PubMed     Text format    


  370. RYSER M, Berlaimont V, Mihalyi A
    Letter to the Editor; P. Van Damme et al. Vaccine 34 (2016) 757-761.
    Vaccine. 2016;34:4271.
    PubMed     Text format    


  371. DAGAN R, Juergens C, Trammel J, Patterson S, et al
    Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration.
    Vaccine. 2016;34:4313-20.
    PubMed     Text format     Abstract available


  372. KERN A, Zhou CW, Jia F, Xu Q, et al
    Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release.
    Vaccine. 2016 Aug 5. pii: S0264-410X(16)30657.
    PubMed     Text format     Abstract available


  373. LI X, Huang J, Zhang M, Funakoshi R, et al
    Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice.
    Vaccine. 2016 Aug 5. pii: S0264-410X(16)30663.
    PubMed     Text format     Abstract available


  374. METCALFE HJ, Steinbach S, Jones GJ, Connelley T, et al
    Protection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4+ T cells but no increase in avidity for Ag85A.
    Vaccine. 2016 Aug 4. pii: S0264-410X(16)30653.
    PubMed     Text format     Abstract available


  375. XIA Q, Geng F, Zhang FF, Liu CL, et al
    Enhancement of fibroblast activation protein alpha-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice.
    Vaccine. 2016 Aug 3. pii: S0264-410X(16)30652.
    PubMed     Text format     Abstract available


  376. PALKONYAY L, Fatima H
    A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006-2016).
    Vaccine. 2016 Aug 3. pii: S0264-410X(16)30608.
    PubMed     Text format     Abstract available


  377. OHANNESSIAN R, Yaghobian S, Verger P, Vanhems P, et al
    A systematic review of serious video games used for vaccination.
    Vaccine. 2016 Aug 3. pii: S0264-410X(16)30646.
    PubMed     Text format     Abstract available


  378. RASMUSSEN KJ, Mattsson AH, Pilely K, Asferg CA, et al
    Proteome-wide antigen discovery of novel protective vaccine candidates against Staphylococcus aureus infection.
    Vaccine. 2016 Aug 2. pii: S0264-410X(16)30589.
    PubMed     Text format     Abstract available


  379. TROGDON JG, Shafer PR, Shah PD, Calo WA, et al
    Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents?
    Vaccine. 2016 Aug 2. pii: S0264-410X(16)30654.
    PubMed     Text format     Abstract available


    July 2016
  380. ROLLIER CS, Hill AV, Reyes-Sandoval A
    Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses.
    Vaccine. 2016 Jul 30. pii: S0264-410X(16)30648.
    PubMed     Text format     Abstract available


  381. WAHID R, Holt R, Hjorth R, Berlanda Scorza F, et al
    Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers.
    Vaccine. 2016 Jul 30. pii: S0264-410X(16)30644.
    PubMed     Text format     Abstract available


  382. JONES CE, Munoz FM, Spiegel HM, Heininger U, et al
    Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women.
    Vaccine. 2016 Jul 29. pii: S0264-410X(16)30615.
    PubMed     Text format     Abstract available


  383. SIRIMA SB, Mordmuller B, Milligan P, Ngoa UA, et al
    A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.
    Vaccine. 2016 Jul 28. pii: S0264-410X(16)30625.
    PubMed     Text format     Abstract available


  384. CHOUDHRY A, Mathena J, Albano JD, Yacovone M, et al
    Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits.
    Vaccine. 2016 Jul 27. pii: S0264-410X(16)30616.
    PubMed     Text format     Abstract available


  385. FISKER AB, Biering-Sorensen S, Lund N, Djana Q, et al
    Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau.
    Vaccine. 2016 Jul 27. pii: S0264-410X(16)30617.
    PubMed     Text format     Abstract available


  386. KIM JH, Talbot HK, Mishina M, Zhu Y, et al
    High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses.
    Vaccine. 2016 Jul 26. pii: S0264-410X(16)30591.
    PubMed     Text format     Abstract available


  387. PAN Y, Deem MW
    Prediction of influenza B vaccine effectiveness from sequence data.
    Vaccine. 2016 Jul 26. pii: S0264-410X(16)30588.
    PubMed     Text format     Abstract available


  388. LINDSTRAND A, Galanis I, Darenberg J, Morfeldt E, et al
    Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden.
    Vaccine. 2016 Jul 26. pii: S0264-410X(16)30614.
    PubMed     Text format     Abstract available


  389. KRAAN H, Ten Have R, van der Maas L, Kersten G, et al
    Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.
    Vaccine. 2016 Jul 25. pii: S0264-410X(16)30613.
    PubMed     Text format     Abstract available


  390. CRAMER JP, Dubischar K, Eder S, Burchard GD, et al
    Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO(R) in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study.
    Vaccine. 2016 Jul 23. pii: S0264-410X(16)30612.
    PubMed     Text format     Abstract available


  391. RECKER M, Vannice K, Hombach J, Jit M, et al
    Assessing dengue vaccination impact: Model challenges and future directions.
    Vaccine. 2016 Jul 22. pii: S0264-410X(16)30562.
    PubMed     Text format     Abstract available


  392. VAN DAMME P, Bonanni P, Bosch FX, Joura E, et al
    Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761].
    Vaccine. 2016 Jul 22. pii: S0264-410X(16)30619.
    PubMed     Text format    


  393. HOONAKKER ME, Verhagen LM, van der Maas L, Metz B, et al
    Adaptive immune response to whole cell pertussis vaccine reflects vaccine quality: A possible complementation to the Pertussis Serological Potency test.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30584.
    PubMed     Text format     Abstract available


  394. NG E, Sanmartin C, Elien-Massenat D, Manuel DG, et al
    Vaccine-preventable disease-related hospitalization among immigrants and refugees to Canada: Study of linked population-based databases.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30559.
    PubMed     Text format     Abstract available


  395. LOUIK C, Kerr S, Van Bennekom CM, Chambers C, et al
    Safety of the 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Preterm delivery and specific malformations, a study from the case-control arm of VAMPSS.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30558.
    PubMed     Text format     Abstract available


  396. HERATH S, Le Heron A, Colloca S, Patterson S, et al
    Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30611.
    PubMed     Text format     Abstract available


  397. CHAMBERS CD, Johnson DL, Xu R, Luo YJ, et al
    Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS.
    Vaccine. 2016 Jul 20. pii: S0264-410X(16)30478.
    PubMed     Text format     Abstract available


  398. ZHANG X, Sharma PK, Peter Goedegebuure S, Gillanders WE, et al
    Personalized cancer vaccines: Targeting the cancer mutanome.
    Vaccine. 2016 Jul 20. pii: S0264-410X(16)30399.
    PubMed     Text format     Abstract available


  399. YU X, Wang Y, Xia Y, Zhang L, et al
    A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice.
    Vaccine. 2016 Jul 20. pii: S0264-410X(16)30590.
    PubMed     Text format     Abstract available


  400. LUO J, Shi H, Tan Y, Niu X, et al
    Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
    Vaccine. 2016 Jul 19. pii: S0264-410X(16)30603.
    PubMed     Text format     Abstract available


  401. BARDENHEIER BH, Duderstadt SK, Engler RJ, McNeil MM, et al
    Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting Sy
    Vaccine. 2016 Jul 19. pii: S0264-410X(16)30592.
    PubMed     Text format     Abstract available


  402. BENNETT A, Bar-Zeev N, Cunliffe NA
    Measuring indirect effects of rotavirus vaccine in low income countries.
    Vaccine. 2016 Jul 18. pii: S0264-410X(16)30564.
    PubMed     Text format     Abstract available


  403. PARSONS E, Epstein J, Sedegah M, Villasante E, et al
    Decrease in circulating CD25hiFoxp3+ regulatory T cells following vaccination with the candidate malaria vaccine RTS,S.
    Vaccine. 2016 Jul 18. pii: S0264-410X(16)30581.
    PubMed     Text format     Abstract available


  404. ANH DD, Jayadeva G, Kuriyakose S, Han HH, et al
    The safety and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) booster vaccine in healthy Vietnamese children.
    Vaccine. 2016 Jul 16. pii: S0264-410X(16)30568.
    PubMed     Text format     Abstract available


  405. HIRTH J, Kuo YF, Laz TH, Starkey JM, et al
    Concordance of adolescent human papillomavirus vaccination parental report with provider report in the National Immunization Survey-Teen (2008-2013).
    Vaccine. 2016 Jul 16. pii: S0264-410X(16)30587.
    PubMed     Text format     Abstract available


  406. DURANDO P, Esposito S, Bona G, Cuccia M, et al
    The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
    Vaccine. 2016 Jul 13. pii: S0264-410X(16)30582.
    PubMed     Text format     Abstract available


  407. MACINTYRE CR, Shaw P, Mackie FE, Boros C, et al
    Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.
    Vaccine. 2016 Jul 9. pii: S0264-410X(16)30473.
    PubMed     Text format     Abstract available


  408. SMITH AJ, Li Y, Bazin HG, St-Jean JR, et al
    Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants.
    Vaccine. 2016 Jul 8. pii: S0264-410X(16)30560.
    PubMed     Text format     Abstract available


  409. VAN DEN DOBBELSTEEN GP, Fae KC, Serroyen J, van den Nieuwenhof IM, et al
    Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models.
    Vaccine. 2016 Jul 6. pii: S0264-410X(16)30518.
    PubMed     Text format     Abstract available


  410. SOUZA AR, Maruyama CM, Safadi MA, Lopes MH, et al
    Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell disease.
    Vaccine. 2016 Jul 6. pii: S0264-410X(16)30549.
    PubMed     Text format     Abstract available


  411. DUQUE H, Naranjo J, Carrillo C, Burbano A, et al
    Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador.
    Vaccine. 2016 Jul 6. pii: S0264-410X(16)30550.
    PubMed     Text format     Abstract available


  412. CLARKE DK, Hendry RM, Singh V, Rose JK, et al
    Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.
    Vaccine. 2016 Jul 6. pii: S0264-410X(16)30548.
    PubMed     Text format     Abstract available


  413. CAROLE TEVI-BENISSAN M, Moturi E, Anya BM, Aschalew T, et al
    Contribution of polio eradication initiative to effective new vaccine introduction in Africa, 2010-2015.
    Vaccine. 2016 Jul 5. pii: S0264-410X(16)30389.
    PubMed     Text format     Abstract available


  414. MOA AM, Chughtai AA, Muscatello DJ, Turner RM, et al
    Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials.
    Vaccine. 2016 Jul 2. pii: S0264-410X(16)30515.
    PubMed     Text format     Abstract available


    June 2016
  415. YAN Q, Wu L, Chen L, Qin Y, et al
    Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges.
    Vaccine. 2016 Jun 30. pii: S0264-410X(16)30509.
    PubMed     Text format     Abstract available


  416. HANSEN J, Timbol J, Lewis N, Pool V, et al
    Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers.
    Vaccine. 2016 Jun 30. pii: S0264-410X(16)30513.
    PubMed     Text format     Abstract available


  417. GOUMA S, Ten Hulscher HI, Schurink-van 't Klooster TM, de Melker HE, et al
    Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
    Vaccine. 2016 Jun 29. pii: S0264-410X(16)30514.
    PubMed     Text format     Abstract available


  418. FAIZ NM, Cortes AL, Guy JS, Fogle JE, et al
    Efficacy of various Marek's disease vaccines protocols for prevention of Marek's disease virus-induced immunosuppression.
    Vaccine. 2016 Jun 28. pii: S0264-410X(16)30512.
    PubMed     Text format     Abstract available


  419. GRIFFITHS UK, Bozzani FM, Chansa C, Kinghorn A, et al
    Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?
    Vaccine. 2016 Jun 28. pii: S0264-410X(16)30474.
    PubMed     Text format     Abstract available


  420. VOYSEY M, Kandasamy R, Yu LM, Baudin M, et al
    The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK children.
    Vaccine. 2016 Jun 27. pii: S0264-410X(16)30475.
    PubMed     Text format     Abstract available


  421. MUSA A, Abba B, Ningi AM, Gali E, et al
    Enhancing transit polio vaccination in collaboration with targeted stakeholders in Kaduna State, Nigeria: Lessons learnt: 2014-2015.
    Vaccine. 2016 Jun 27. pii: S0264-410X(16)30390.
    PubMed     Text format     Abstract available


  422. FEKADU L, Okeibunor J, Nsubuga P, Kipela JM, et al
    Reaching the unreached with polio vaccine and other child survival interventions through partnership with military in Angola.
    Vaccine. 2016 Jun 25. pii: S0264-410X(16)30395.
    PubMed     Text format     Abstract available


  423. VAN DAMME P, Meijer CJ, Kieninger D, Schuyleman A, et al
    A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men.
    Vaccine. 2016 Jun 25. pii: S0264-410X(16)30480.
    PubMed     Text format     Abstract available


  424. CUTTS FT, Claquin P, Danovaro-Holliday C, Rhoda DA, et al
    Monitoring vaccination coverage: Defining the role of surveys.
    Vaccine. 2016 Jun 24. pii: S0264-410X(16)30477.
    PubMed     Text format     Abstract available


  425. VOYSEY M, Sadarangani M, Clutterbuck E, Bolgiano B, et al
    The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials.
    Vaccine. 2016 Jun 24. pii: S0264-410X(16)30462.
    PubMed     Text format     Abstract available


  426. KEMMEREN J, Honsbeek M, Dijkstra F, de Lange M, et al
    Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination.
    Vaccine. 2016 Jun 24. pii: S0264-410X(16)30479.
    PubMed     Text format     Abstract available


  427. CONDIT RC, Williamson AL, Sheets R, Seligman SJ, et al
    Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains.
    Vaccine. 2016 Jun 23. pii: S0264-410X(16)30225.
    PubMed     Text format     Abstract available


  428. LEE C, Whetten K, Omer S, Pan W, et al
    Hurdles to herd immunity: Distrust of government and vaccine refusal in the US, 2002-2003.
    Vaccine. 2016 Jun 22. pii: S0264-410X(16)30472.
    PubMed     Text format     Abstract available


  429. MIHIGO RM, Okeibunor JC, O'Malley H, Masresha B, et al
    Investing in life saving vaccines to guarantee life of future generations in Africa.
    Vaccine. 2016 Jun 21. pii: S0264-410X(16)30460.
    PubMed     Text format     Abstract available


  430. GORDON DL, Sajkov D, Honda-Okubo Y, Wilks SH, et al
    Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax delta inulin adjuvant.
    Vaccine. 2016 Jun 21. pii: S0264-410X(16)30397.
    PubMed     Text format     Abstract available


  431. SCHERR CL, Augusto B, Ali K, Malo TL, et al
    Provider-reported acceptance and use of the Centers for Disease Control and Prevention messages and materials to support HPV vaccine recommendation for adolescent males.
    Vaccine. 2016 Jun 20. pii: S0264-410X(16)30461.
    PubMed     Text format     Abstract available


  432. LEE SY, Ko MK, Lee KN, Choi JH, et al
    Application of mouse model for effective evaluation of foot-and-mouth disease vaccine.
    Vaccine. 2016 Jun 20. pii: S0264-410X(16)30407.
    PubMed     Text format     Abstract available


  433. SHEN C, Ku Z, Zhou Y, Li D, et al
    Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections.
    Vaccine. 2016 Jun 20. pii: S0264-410X(16)30441.
    PubMed     Text format     Abstract available


  434. KRAICER-MELAMED H, O'Donnell S, Quach C
    Corrigendum to "The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50years of age and older: A systematic review and meta-analysis" [Vaccine 34 (2016) 1540-1550].
    Vaccine. 2016 Jun 18. pii: S0264-410X(16)30469.
    PubMed     Text format    


  435. CHABOT DJ, Ribot WJ, Joyce J, Cook J, et al
    Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine.
    Vaccine. 2016 Jun 18. pii: S0264-410X(16)30455.
    PubMed     Text format     Abstract available


  436. BARBOUR EK, Abou Assi CA, Shaib H, Hamadeh S, et al
    Corrigendum to "Evaluation of a Salmonella Enteritidis vaccine and related ELISA for respective induction and assessment of acquired immunity to the vaccine and/or Echinacea purpurea in Awassi Ewes" [Vaccine 33 (2015) 2228-2231].
    Vaccine. 2016 Jun 18. pii: S0264-410X(16)30468.
    PubMed     Text format    


  437. MYERS KL
    Predictors of maternal vaccination in the United States: An integrative review of the literature.
    Vaccine. 2016 Jun 18. pii: S0264-410X(16)30466.
    PubMed     Text format     Abstract available


  438. YOSHIKAWA T, Ihara T, Watanabe M, Nishimura N, et al
    Symposium report of the 19th annual meeting of the Japanese Society for Vaccinology 2015: What is the role of clinicians in vaccinology?
    Vaccine. 2016 Jun 18. pii: S0264-410X(16)30454.
    PubMed     Text format    


  439. VALENTE C, Hinds J, Gould KA, Pinto FR, et al
    Impact of the 13-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage.
    Vaccine. 2016 Jun 17. pii: S0264-410X(16)30430.
    PubMed     Text format     Abstract available


  440. SANDBULTE MR, Gauger PC, Kitikoon P, Chen H, et al
    Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
    Vaccine. 2016 Jun 17. pii: S0264-410X(16)30400.
    PubMed     Text format     Abstract available


  441. LIVENGOOD JL, Lanka S, Maddox C, Tewari D, et al
    Detection and differentiation of wild-type and a vaccine strain of Streptococcus equi ssp. equi using pyrosequencing.
    Vaccine. 2016 Jun 17. pii: S0264-410X(16)30459.
    PubMed     Text format     Abstract available


  442. SUI J, Yang D, Qiao C, Xu H, et al
    Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice.
    Vaccine. 2016 Jun 16. pii: S0264-410X(16)30408.
    PubMed     Text format     Abstract available


  443. LV F, Lu Y, Hao ZL, Zhao YH, et al
    Preparation and heat resistance study of porcine reproductive and respiratory syndrome virus sugar glass vaccine.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30402.
    PubMed     Text format     Abstract available


  444. SANFTENBERG L, Schrors HJ, Schelling J
    Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30440.
    PubMed     Text format     Abstract available


  445. MCQUAID F, Pask S, Locock L, Davis E, et al
    Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionals.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30436.
    PubMed     Text format     Abstract available


  446. MARTINS KA, Dye JM, Bavari S
    Considerations for the development of Zika virus vaccines.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30425.
    PubMed     Text format    


  447. ROSE N, Andraud M, Bigault L, Jestin A, et al
    A commercial PCV2a-based vaccine significantly reduces PCV2b transmission in experimental conditions.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30404.
    PubMed     Text format     Abstract available


  448. XU Q, Cui N, Ma X, Wang F, et al
    Evaluation of a chimeric multi-epitope-based DNA vaccine against subgroup J avian leukosis virus in chickens.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30403.
    PubMed     Text format     Abstract available


  449. HAIDARI LA, Brown ST, Ferguson M, Bancroft E, et al
    The economic and operational value of using drones to transport vaccines.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30435.
    PubMed     Text format     Abstract available


  450. HAWKES D, Dunlop RA, Benhamu J
    Calls by alternative medicine practitioners for vaccinated vs unvaccinated studies is not supported by evidence.
    Vaccine. 2016;34:3223-4.
    PubMed     Text format    


  451. URUENA A, Vizzotti C, San Juan JA
    Response to Orellano et al. regarding cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission.
    Vaccine. 2016;34:3222.
    PubMed     Text format    


  452. ORELLANO PW, Salomon OD
    Will dengue vaccination be cost-effective for Argentina? Reply to letter by Uruena et al. regarding "Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission".
    Vaccine. 2016;34:3221.
    PubMed     Text format    


  453. HANKIN-WEI A, Rein DB, Hernandez-Romieu A, Kennedy MJ, et al
    Cost-effectiveness analysis of catch-up hepatitis a vaccination among unvaccinated/partially-vaccinated children.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30464.
    PubMed     Text format     Abstract available


  454. TONTINI M, Romano MR, Proietti D, Balducci E, et al
    Preclinical studies on new proteins as carrier for glycoconjugate vaccines.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30463.
    PubMed     Text format     Abstract available


  455. TOWNSEND-PAYNE K, Ladhani SN, Findlow H, Slack M, et al
    Children with Haemophilus influenzae type b (Hib) vaccine failure have long-term bactericidal antibodies against virulent Hib strains with multiple capsular loci.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30457.
    PubMed     Text format     Abstract available


  456. WIYSONGE CS, Waggie Z, Hawkridge A, Schoub BD, et al
    The Cape Town Declaration on Vaccines 2012: Unlocking the full potential of vaccines in Africa.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30398.
    PubMed     Text format     Abstract available


  457. KLUG B, Robertson JS, Condit RC, Seligman SJ, et al
    Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)00157.
    PubMed     Text format     Abstract available


  458. LEE GJ, Quan FS
    Protection induced by early stage vaccination with pandemic influenza virus-like particles.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30410.
    PubMed     Text format     Abstract available


  459. SAADATIAN-ELAHI M, Aaby P, Shann F, Netea MG, et al
    Heterologous vaccine effects.
    Vaccine. 2016 Jun 13. pii: S0264-410X(16)30433.
    PubMed     Text format     Abstract available


  460. LI Z, Zhang Y, Wang Q, Li Z, et al
    Purification design and practice for pertactin, the third component of acellular pertussis vaccine, from Bordetella pertussis.
    Vaccine. 2016 Jun 11. pii: S0264-410X(16)30442.
    PubMed     Text format     Abstract available


  461. LANGLEY JM, MacDougall DM, Halperin BA, Swain A, et al
    Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study.
    Vaccine. 2016 Jun 11. pii: S0264-410X(16)30438.
    PubMed     Text format     Abstract available


  462. MULLINS TL, Zimet GD, Rosenthal SL, Morrow C, et al
    Human papillomavirus vaccine-related risk perceptions and subsequent sexual behaviors and sexually transmitted infections among vaccinated adolescent women.
    Vaccine. 2016 Jun 9. pii: S0264-410X(16)30439.
    PubMed     Text format     Abstract available


  463. ABDULLAHI LH, Kagina BM, Cassidy T, Adebayo EF, et al
    Knowledge, attitudes and practices on adolescent vaccination among adolescents, parents and teachers in Africa: A systematic review.
    Vaccine. 2016 Jun 8. pii: S0264-410X(16)30437.
    PubMed     Text format     Abstract available


  464. SILFVERDAL SA, Icardi G, Vesikari T, Flores SA, et al
    A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months.
    Vaccine. 2016 Jun 7. pii: S0264-410X(16)30380.
    PubMed     Text format     Abstract available


  465. STOWE J, Andrews N, Ladhani S, Miller E, et al
    The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation.
    Vaccine. 2016 Jun 7. pii: S0264-410X(16)30204.
    PubMed     Text format     Abstract available


  466. FELDSTEIN LR, Matrajt L, Elizabeth Halloran M, Keitel WA, et al
    Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.
    Vaccine. 2016 Jun 4. pii: S0264-410X(16)30393.
    PubMed     Text format     Abstract available


  467. KOWALCZYK A, Doener F, Zanzinger K, Noth J, et al
    Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30372.
    PubMed     Text format     Abstract available


  468. HELLERINGER S, Asuming PO, Abdelwahab J
    The effect of mass vaccination campaigns against polio on the utilization of routine immunization services: A regression discontinuity design.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30363.
    PubMed     Text format     Abstract available


  469. SOYSAL A, Karabag-Yilmaz E, Kepenekli E, Karaaslan A, et al
    The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30369.
    PubMed     Text format     Abstract available


  470. ORTIZ JM, Molinari MP, Gravisaco MJ, Paoletta MS, et al
    Evaluation of different heterologous prime-boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30379.
    PubMed     Text format     Abstract available


  471. ZHANG L, Wen Z, Lin J, Xu H, et al
    Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30375.
    PubMed     Text format     Abstract available


  472. STADLER J, Zoels S, Eddicks M, Kraft C, et al
    Assessment of safety and reproductive performance after vaccination with a modified live-virus PRRS genotype 1 vaccine in pregnant sows at various stages of gestation.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30368.
    PubMed     Text format     Abstract available


  473. HABIB MA, Soofi S, Mach O, Samejo T, et al
    Effect of booster doses of poliovirus vaccine in previously vaccinated children, Clinical Trial Results 2013.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30391.
    PubMed     Text format     Abstract available


  474. PEPRAH D, Palmer JJ, Rubin GJ, Abubakar A, et al
    Perceptions of oral cholera vaccine and reasons for full, partial and non-acceptance during a humanitarian crisis in South Sudan.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30364.
    PubMed     Text format     Abstract available


  475. COLLADO R, Prenafeta A, Gonzalez-Gonzalez L, Perez-Pons JA, et al
    Probing vaccine antigens against bovine mastitis caused by Streptococcus uberis.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30370.
    PubMed     Text format     Abstract available


  476. MURPHY TF, Kirkham C, Johnson A, Brauer AL, et al
    Sulfate-binding protein, CysP, is a candidate vaccine antigen of Moraxella catarrhalis.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30371.
    PubMed     Text format     Abstract available


  477. BEST EJ, Walls T, Souter M, Neeff M, et al
    Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30367.
    PubMed     Text format     Abstract available


  478. HOLT PG, Snelling T, White OJ, Sly PD, et al
    Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or cana
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30374.
    PubMed     Text format     Abstract available


  479. TOGASHI T, Sugizaki K, Mitsuya N, Kogawara O, et al
    Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30376.
    PubMed     Text format     Abstract available


  480. KAWAKAMI K, Kishino H, Kanazu S, Toshimizu N, et al
    Revaccination with 23-valent pneumococcal polysaccharide vaccine in the Japanese elderly is well tolerated and elicits immune responses.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30378.
    PubMed     Text format     Abstract available


  481. VILAJELIU A, Ferrer L, Munros J, Gonce A, et al
    Pertussis vaccination during pregnancy: Antibody persistence in infants.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30377.
    PubMed     Text format     Abstract available


  482. RADIN JM, Hawksworth AW, Myers CA, Ricketts MN, et al
    Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30324.
    PubMed     Text format     Abstract available


    May 2016
  483. GIESE C, Mereckiene J, Danis K, O'Donnell J, et al
    Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination.
    Vaccine. 2016 May 30. pii: S0264-410X(16)30318.
    PubMed     Text format     Abstract available


  484. MCCONEGHY KW, Wing C
    A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health.
    Vaccine. 2016 May 21. pii: S0264-410X(16)30241.
    PubMed     Text format     Abstract available


  485. HEQUET D, Pascual M, Lartey S, Pathirana RD, et al
    Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
    Vaccine. 2016 May 21. pii: S0264-410X(16)30311.
    PubMed     Text format     Abstract available


  486. GIRARD MP, Le-Grand R, Picot V, Longuet C, et al
    Report of the Cent Gardes HIV Vaccines Conference. Part 1: The antibody response; Fondation Merieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30314.
    PubMed     Text format     Abstract available


  487. DOS SANTOS G, Haguinet F, Cohet C, Webb D, et al
    Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30299.
    PubMed     Text format     Abstract available


  488. DREDZE M, Broniatowski DA, Hilyard KM
    Zika vaccine misconceptions: A social media analysis.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30291.
    PubMed     Text format    


  489. REGAN AK, Klerk N, Moore HC, Omer SB, et al
    Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: A retrospective cohort study.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30322.
    PubMed     Text format     Abstract available


  490. BORGGREN M, Nielsen J, Karlsson I, Dalgaard TS, et al
    A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.
    Vaccine. 2016 May 19. pii: S0264-410X(16)30320.
    PubMed     Text format     Abstract available


  491. LI J, Li J, Aipire A, Luo J, et al
    The combination of Pleurotus ferulae water extract and CpG-ODN enhances the immune responses and antitumor efficacy of HPV peptides pulsed dendritic cell-based vaccine.
    Vaccine. 2016 May 19. pii: S0264-410X(16)30312.
    PubMed     Text format     Abstract available


  492. HARAPAN H, Anwar S, Setiawan AM, Sasmono RT, et al
    Dengue vaccine acceptance and associated factors in Indonesia: A community-based cross-sectional survey in Aceh.
    Vaccine. 2016 May 18. pii: S0264-410X(16)30316.
    PubMed     Text format     Abstract available


  493. RAMEZANPOUR B, de Foucauld J, Kortekaas J
    Emergency deployment of genetically engineered veterinary vaccines in Europe.
    Vaccine. 2016 May 18. pii: S0264-410X(16)30296.
    PubMed     Text format     Abstract available


  494. YOKOKURA Y
    Special lecture "Strategies for the widespread application of vaccination".
    Vaccine. 2016 May 18. pii: S0264-410X(16)30213.
    PubMed     Text format    


  495. FOGEL I, Brosh-Nissimov T, Vager G, Aviv Y, et al
    Estimated prevalence of smallpox vaccine contraindications in Israeli adolescents.
    Vaccine. 2016 May 18. pii: S0264-410X(16)30315.
    PubMed     Text format     Abstract available


  496. HANNAMAN D, Dupuy LC, Ellefsen B, Schmaljohn CS, et al
    A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation.
    Vaccine. 2016 May 17. pii: S0264-410X(16)30242.
    PubMed     Text format     Abstract available


  497. PELLEGRINO M, Rodriguez N, Vivas A, Giraudo J, et al
    Staphylococcus aureus avirulent mutant vaccine induces humoral and cellular immune responses on pregnant heifers.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30297.
    PubMed     Text format     Abstract available


  498. THOMPSON MG, Gaglani MJ, Naleway AL, Dowell SH, et al
    Reduced serologic sensitivity to influenza A virus illness among inactivated influenza vaccinees.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30260.
    PubMed     Text format     Abstract available


  499. ZHANG Q, Liu Z, Hou J, Wang S, et al
    Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30295.
    PubMed     Text format     Abstract available


  500. MIYAHARA R, Jasseh M, Gomez P, Shimakawa Y, et al
    Barriers to timely administration of birth dose vaccines in The Gambia, West Africa.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30300.
    PubMed     Text format     Abstract available


  501. ASTURIAS EJ, Wharton M, Pless R, MacDonald NE, et al
    Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30301.
    PubMed     Text format     Abstract available


  502. PARRELLA A, Braunack-Mayer A, Collins J, Clarke M, et al
    Prioritizing government funding of adolescent vaccinations: recommendations from young people on a citizens' jury.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30302.
    PubMed     Text format     Abstract available


  503. GRAHAM BS
    Vaccines against respiratory syncytial virus: The time has finally come.
    Vaccine. 2016 May 13. pii: S0264-410X(16)30257.
    PubMed     Text format     Abstract available


  504. SUNAGAR R, Kumar S, Franz BJ, Gosselin EJ, et al
    Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.
    Vaccine. 2016 May 13. pii: S0264-410X(16)30208.
    PubMed     Text format     Abstract available


  505. BONA G, Castiglia P, Zoppi G, de Martino M, et al
    Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers.
    Vaccine. 2016 May 12. pii: S0264-410X(16)30292.
    PubMed     Text format     Abstract available


  506. KENNEDY RB, Poland GA, Ovsyannikova IG, Oberg AL, et al
    Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients.
    Vaccine. 2016 May 11. pii: S0264-410X(16)30277.
    PubMed     Text format     Abstract available


  507. GOMES MG, Gordon SB, Lalloo DG
    Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence.
    Vaccine. 2016 May 10. pii: S0264-410X(16)30230.
    PubMed     Text format    


  508. GALA RP, D'Souza M, Zughaier SM
    Evaluation of various adjuvant nanoparticulate formulations for meningococcal capsular oolysaccharide-based vaccine.
    Vaccine. 2016 May 10. pii: S0264-410X(16)30293.
    PubMed     Text format     Abstract available


  509. BLAGBOROUGH AM, Musiychuk K, Bi H, Jones RM, et al
    Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax.
    Vaccine. 2016 May 10. pii: S0264-410X(16)30290.
    PubMed     Text format     Abstract available


  510. VAN WERKHOVEN CH, Hollingsworth RC, Huijts SM, Bolkenbaas M, et al
    Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly.
    Vaccine. 2016 May 9. pii: S0264-410X(16)30274.
    PubMed     Text format     Abstract available


  511. HOTEZ PJ, Strych U, Lustigman S, Bottazzi ME, et al
    Human anthelminthic vaccines: Rationale and challenges.
    Vaccine. 2016 May 9. pii: S0264-410X(16)30259.
    PubMed     Text format     Abstract available


  512. BUMBAROV V, Golender N, Erster O, Khinich Y, et al
    Detection and isolation of Bluetongue virus from commercial vaccine batches.
    Vaccine. 2016 May 9. pii: S0264-410X(16)30094.
    PubMed     Text format     Abstract available


  513. MOWBRAY F, Marcu A, Godinho CA, Michie S, et al
    Communicating to increase public uptake of pandemic flu vaccination in the UK: Which messages work?
    Vaccine. 2016 May 8. pii: S0264-410X(16)30278.
    PubMed     Text format     Abstract available


  514. ZHAO Z, Smith PJ, Hill HA
    Evaluation of potentially achievable vaccination coverage with simultaneous administration of vaccines among children in the United States.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30272.
    PubMed     Text format     Abstract available


  515. OZAKI T, Asano Y
    Development of varicella vaccine in Japan and future prospects.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30214.
    PubMed     Text format     Abstract available


  516. KUSAKABE T, Ozasa K, Kobari S, Momota M, et al
    Intranasal hydroxypropyl-beta-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30121.
    PubMed     Text format     Abstract available


  517. DINDA AK, Bhat M, Srivastava S, Kottarath SK, et al
    Novel nanocarrier for oral Hepatitis B vaccine.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30258.
    PubMed     Text format     Abstract available


  518. BRONIATOWSKI DA, Hilyard KM, Dredze M
    Effective vaccine communication during the disneyland measles outbreak.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30198.
    PubMed     Text format     Abstract available


  519. XU J, Zhou F, Reed C, Chaves SS, et al
    Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women.
    Vaccine. 2016 May 5. pii: S0264-410X(16)30211.
    PubMed     Text format     Abstract available


  520. DUDEK K, Bednarek D, Ayling RD, Kycko A, et al
    An experimental vaccine composed of two adjuvants gives protection against Mycoplasma bovis in calves.
    Vaccine. 2016 May 5. pii: S0264-410X(16)30262.
    PubMed     Text format     Abstract available


  521. THOMPSON EL, Vamos CA, Sappenfield WM, Straub DM, et al
    Relationship status impacts primary reasons for interest in the HPV vaccine among young adult women.
    Vaccine. 2016 May 5. pii: S0264-410X(16)30228.
    PubMed     Text format     Abstract available


  522. MEALING N, Hayen A, Newall AT
    Assessing the impact of vaccination programmes on burden of disease: Underlying complexities and statistical methods.
    Vaccine. 2016 May 5. pii: S0264-410X(16)30143.
    PubMed     Text format     Abstract available


  523. JIANG X, Zhang C, Zhao Y, Kong X, et al
    Immune effects of the vaccine of live attenuated Aeromonas hydrophila screened by rifampicin on common carp (Cyprinus carpio L).
    Vaccine. 2016 May 4. pii: S0264-410X(16)30240.
    PubMed     Text format     Abstract available


  524. VENEREO-SANCHEZ A, Gilbert R, Simoneau M, Caron A, et al
    Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30264.
    PubMed     Text format     Abstract available


  525. FENG H, Segales J, Fraile L, Lopez-Soria S, et al
    Effect of high and low levels of maternally derived antibodies on porcine circovirus type 2 (PCV2) infection dynamics and production parameters in PCV2 vaccinated pigs under field conditions.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30263.
    PubMed     Text format     Abstract available


  526. ORENSTEIN WA, Simon R
    Introduction to issue of highlighted research presented at the 2015 National Foundation for Infectious Diseases Annual Conference on Vaccine Research.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30273.
    PubMed     Text format    


  527. WHITE JA, Estrada M, Flood EA, Mahmood K, et al
    Development of a stable liquid formulation of live attenuated influenza vaccine.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30239.
    PubMed     Text format     Abstract available


  528. SIVKO GS, Stark GV, Tordoff KP, Taylor KL, et al
    Evaluation of early immune response-survival relationship in cynomolgus macaques after anthrax vaccine adsorbed vaccination and Bacillus anthracis spore challenge.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30202.
    PubMed     Text format     Abstract available


  529. FRENCK RW JR, Fiquet A, Gurtman A, van Cleeff M, et al
    Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30268.
    PubMed     Text format     Abstract available


  530. GOLDENBERG D, Lublin A, Rosenbluth E, Heller ED, et al
    Optimized polypeptide for a subunit vaccine against avian reovirus.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30177.
    PubMed     Text format     Abstract available


  531. CORACE KM, Srigley JA, Hargadon DP, Yu D, et al
    Using behavior change frameworks to improve healthcare worker influenza vaccination rates: A systematic review.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30236.
    PubMed     Text format     Abstract available


  532. RIZZO C, Bella A, Alfonsi A, Puzelli S, et al
    Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30237.
    PubMed     Text format     Abstract available


  533. CONTRERAS M, de la Fuente J
    Control of Ixodes ricinus and Dermacentor reticulatus tick infestations in rabbits vaccinated with the Q38 Subolesin/Akirin chimera.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30267.
    PubMed     Text format     Abstract available


  534. TANIUCHI M, Platts-Mills JA, Begum S, Uddin MJ, et al
    Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants.
    Vaccine. 2016 May 3. pii: S0264-410X(16)30254.
    PubMed     Text format     Abstract available


  535. BRODER CC, Weir DL, Reid PA
    Hendra virus and Nipah virus animal vaccines.
    Vaccine. 2016 May 3. pii: S0264-410X(16)30072.
    PubMed     Text format     Abstract available


  536. SHEN CF, Jacob D, Zhu T, Bernier A, et al
    Optimization and scale-up of cell culture and purification processes for production of an adenovirus-vectored tuberculosis vaccine candidate.
    Vaccine. 2016 May 3. pii: S0264-410X(16)30265.
    PubMed     Text format     Abstract available


  537. BOTTERO D, Gaillard ME, Zurita E, Moreno G, et al
    Characterization of the immune response induced by pertussis OMVs-based vaccine.
    Vaccine. 2016 May 2. pii: S0264-410X(16)30244.
    PubMed     Text format     Abstract available


  538. FERNANDEZ-BELLON H, Vergara-Alert J, Almagro V, Rivas R, et al
    Vaccination against H5 avian influenza virus induces long-term humoral immune responses in flamingoes (Phoenicopterus spp.).
    Vaccine. 2016 May 2. pii: S0264-410X(16)30243.
    PubMed     Text format     Abstract available


    April 2016
  539. ALAGARASU K
    Introducing dengue vaccine: Implications for diagnosis in dengue vaccinated subjects.
    Vaccine. 2016 Apr 30. pii: S0264-410X(16)30235.
    PubMed     Text format     Abstract available


  540. DUTHIE MS, Favila M, Hofmeyer KA, Tutterrow YL, et al
    Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis.
    Vaccine. 2016 Apr 30. pii: S0264-410X(16)30232.
    PubMed     Text format     Abstract available


  541. MAERTENS K, Cabore RN, Huygen K, Vermeiren S, et al
    Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age.
    Vaccine. 2016 Apr 30. pii: S0264-410X(16)30231.
    PubMed     Text format     Abstract available


  542. BENEDICT KM, Kennedy ED, Santibanez TA, Black CL, et al
    Recommendations and offers for adult influenza vaccination, 2011-2012 season, United States.
    Vaccine. 2016 Apr 29. pii: S0264-410X(16)30226.
    PubMed     Text format     Abstract available


  543. SNAPPER CM
    Differential regulation of polysaccharide-specific antibody responses to isolated polysaccharides, conjugate vaccines, and intact Gram-positive versus Gram-negative extracellular bacteria.
    Vaccine. 2016 Apr 29. pii: S0264-410X(16)30068.
    PubMed     Text format     Abstract available


  544. IVANCIC-JELECKI J, Forcic D, Jagusic M, Kosutic-Gulija T, et al
    Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants.
    Vaccine. 2016;34:2383-9.
    PubMed     Text format     Abstract available


  545. LUNDGREN A, Jertborn M, Svennerholm AM
    Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine.
    Vaccine. 2016 Apr 28. pii: S0264-410X(16)30209.
    PubMed     Text format     Abstract available


  546. LEROUX-ROELS G, Van Damme P, Haazen W, Shakib S, et al
    Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults.
    Vaccine. 2016 Apr 28. pii: S0264-410X(16)30205.
    PubMed     Text format     Abstract available


  547. REGEV-YOCHAY G, Jaber H, Hamdan A, Daana M, et al
    Vaccine escape of piliated Streptococcus pneumoniae strains.
    Vaccine. 2016 Apr 28. pii: S0264-410X(16)30229.
    PubMed     Text format     Abstract available


  548. GROVER A, McLean JL, Troudt JM, Foster C, et al
    Heat killed Saccharomyces cerevisiae as an adjuvant for the induction of vaccine-mediated immunity against infection with Mycobacterium tuberculosis.
    Vaccine. 2016 Apr 28. pii: S0264-410X(16)30206.
    PubMed     Text format     Abstract available


  549. RABINOVITZ BC, Larzabal M, Vilte DA, Cataldi A, et al
    The intranasal vaccination of pregnant dams with Intimin and EspB confers protection in neonatal mice from Escherichia coli (EHEC) O157:H7 infection.
    Vaccine. 2016 Apr 27. pii: S0264-410X(16)30210.
    PubMed     Text format     Abstract available


  550. LI M, Li C, Song S, Kang H, et al
    Development and antigenic characterization of three recombinant proteins with potential for Glasser's disease prevention.
    Vaccine. 2016;34:2251-8.
    PubMed     Text format     Abstract available


  551. HAKIM H, Allison KJ, Van de Velde LA, Tang L, et al
    Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection.
    Vaccine. 2016 Apr 26. pii: S0264-410X(16)30207.
    PubMed     Text format     Abstract available


  552. REITER PL, McRee AL
    Correlates of receiving recommended adolescent vaccines among youth with special health care needs: Findings from a statewide survey.
    Vaccine. 2016 Apr 26. pii: S0264-410X(16)30227.
    PubMed     Text format     Abstract available


  553. TRAN CH, Brew J, Johnson N, Ryan KA, et al
    Sustainability of school-located influenza vaccination programs in Florida.
    Vaccine. 2016 Apr 25. pii: S0264-410X(16)30146.
    PubMed     Text format     Abstract available


  554. GITTINGS K, Matson KL
    Establishing herd immunity against Ebola through vaccination.
    Vaccine. 2016 Apr 25. pii: S0264-410X(16)30201.
    PubMed     Text format     Abstract available


  555. SANTIBANEZ TA, Kennedy ED
    Reasons given for not receiving an influenza vaccination, 2011-12 influenza season, United States.
    Vaccine. 2016 Apr 23. pii: S0264-410X(16)30191.
    PubMed     Text format     Abstract available


  556. ZHU FC, Sun KX, Pan HX, Yang ZH, et al
    The immunogenicity in healthy infants and efficiency to prevent mother to child transmission of Hepatitis B virus of a 10mug recombinant yeast-derived Hepatitis B vaccine (Hep-KSC).
    Vaccine. 2016 Apr 23. pii: S0264-410X(16)30196.
    PubMed     Text format     Abstract available


  557. PORAT N, Benisty R, Givon-Lavi N, Trefler R, et al
    The impact of pneumococcal conjugate vaccines on carriage of and disease caused by Streptococcus pneumoniae serotypes 6C and 6D in southern Israel.
    Vaccine. 2016 Apr 23. pii: S0264-410X(16)30197.
    PubMed     Text format     Abstract available


  558. ZHANG H, Liu C, Zhang F, Geng F, et al
    MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model.
    Vaccine. 2016 Apr 22. pii: S0264-410X(16)30199.
    PubMed     Text format     Abstract available


  559. MOREIRA M, Cintra O, Harriague J, Hausdorff WP, et al
    Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national immunization program.
    Vaccine. 2016 Apr 22. pii: S0264-410X(16)30126.
    PubMed     Text format     Abstract available


  560. FUKUMOTO H, Hishima T, Hasegawa H, Saeki H, et al
    Evaluation of Vero-cell-derived simian endogenous retrovirus infection in humans by detection of viral genome in clinicopathological samples and commercialized vaccines and by serology of Japanese general population.
    Vaccine. 2016 Apr 22. pii: S0264-410X(16)30172.
    PubMed     Text format     Abstract available


  561. GONCALVES G, Nunes C, Mesquita JR, Nascimento MS, et al
    Measles antibodies in cord blood in Portugal: Possible consequences for the recommended age of vaccination.
    Vaccine. 2016 Apr 22. pii: S0264-410X(16)30127.
    PubMed     Text format     Abstract available


  562. TAUIL MC, Sato AP, Waldman EA
    Factors associated with incomplete or delayed vaccination across countries: A systematic review.
    Vaccine. 2016 Apr 22. pii: S0264-410X(16)30145.
    PubMed     Text format     Abstract available


  563. NAIT MOHAMED FA, Laraba-Djebari F
    Development and characterization of a new carrier for vaccine delivery based on calcium alginate nanoparticles: Safe immunoprotective approach against scorpion envenoming.
    Vaccine. 2016 Apr 21. pii: S0264-410X(16)30176.
    PubMed     Text format     Abstract available


  564. CHRISTENSEN H, Hellenbrand W, Irving T, Koch J, et al
    Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero to reduce meningococcal group B disease in Germany.
    Vaccine. 2016 Apr 21. pii: S0264-410X(16)30124.
    PubMed     Text format     Abstract available


  565. LEVANDER S, Sallberg M, Ahlen G, Frelin L, et al
    A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines.
    Vaccine. 2016 Apr 21. pii: S0264-410X(16)30171.
    PubMed     Text format     Abstract available


  566. VALLEE E, Ridler AL, Heuer C, Collins-Emerson JM, et al
    Effectiveness of a commercial leptospiral vaccine on urinary shedding in naturally exposed sheep in New Zealand.
    Vaccine. 2016 Apr 21. pii: S0264-410X(16)30178.
    PubMed     Text format     Abstract available


  567. LONG JE, Drayson MT, Taylor AE, Toellner KM, et al
    Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial.
    Vaccine. 2016 Apr 21. pii: S0264-410X(16)30173.
    PubMed     Text format     Abstract available


  568. GIERSING B, Modjarrad K, Kaslow DC, Okwo-Bele JM, et al
    The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC).
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30195.
    PubMed     Text format    


  569. FULTON RW, d'Offay JM, Landis C, Miles DG, et al
    Detection and characterization of viruses as field and vaccine strains in feedlot cattle with bovine respiratory disease.
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30149.
    PubMed     Text format     Abstract available


  570. SADOH AE, Nwaneri DU, Ogboghodo BC, Sadoh WE, et al
    Effect of introduction of pentavalent vaccine as replacement for Diphtheria-Tetanus-Pertussis and Hepatitis B vaccines on vaccination uptake in a health facility in Nigeria.
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30164.
    PubMed     Text format     Abstract available


  571. BERAN J, Van Der Meeren O, Leyssen M, D'silva P, et al
    Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30174.
    PubMed     Text format     Abstract available


  572. DE WALS P, Deceuninck G, De Serres G
    Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.
    Vaccine. 2016;34:2053-4.
    PubMed     Text format    


  573. GOTTLIEB SL, Deal CD, Giersing B, Rees H, et al
    The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps.
    Vaccine. 2016 Apr 19. pii: S0264-410X(16)30170.
    PubMed     Text format     Abstract available


  574. HIGGINS D, Trujillo C, Keech C
    Advances in RSV vaccine research and development - A global agenda.
    Vaccine. 2016 Apr 19. pii: S0264-410X(16)30168.
    PubMed     Text format     Abstract available


  575. HARAKUNI T, Andoh K, Sakamoto RI, Tamaki Y, et al
    Fiber knob domain lacking the shaft sequence but fused to a coiled coil is a candidate subunit vaccine against egg-drop syndrome.
    Vaccine. 2016 Apr 19. pii: S0264-410X(16)30125.
    PubMed     Text format     Abstract available


  576. GIERSING BK, Dastgheyb SS, Modjarrad K, Moorthy V, et al
    Status of vaccine research and development of vaccines for Staphylococcus aureus.
    Vaccine. 2016 Apr 19. pii: S0264-410X(16)30169.
    PubMed     Text format     Abstract available


  577. FALLOON J, Ji F, Curtis C, Bart S, et al
    A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant.
    Vaccine. 2016 Apr 19. pii: S0264-410X(16)30122.
    PubMed     Text format     Abstract available


  578. TAFURI S, Gallone MS, Gallone MF, Pappagallo MT, et al
    Monitoring the process of measles elimination by serosurveillance data: The Apulian 2012 study.
    Vaccine. 2016;34:2092-5.
    PubMed     Text format     Abstract available


  579. LEE MS, Igari Y, Tsukui T, Ishii KJ, et al
    Current status of synthetic hemozoin adjuvant: A preliminary safety evaluation.
    Vaccine. 2016;34:2055-61.
    PubMed     Text format     Abstract available


  580. LEBENS M, Terrinoni M, Karlsson SL, Larena M, et al
    Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae.
    Vaccine. 2016;34:2121-8.
    PubMed     Text format     Abstract available


  581. PLENNEVAUX E, Sabchareon A, Limkittikul K, Chanthavanich P, et al
    Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: Utility for efficacy evaluation and impact of future vaccine introduction.
    Vaccine. 2016 Apr 18. pii: S0264-410X(16)30166.
    PubMed     Text format     Abstract available


  582. OLIVEIRA JR, Bouzas ML, Cardoso MA, Barral A, et al
    Frequency of complications and the effects of pneumococcal vaccination in young children with acute respiratory tract infection.
    Vaccine. 2016 Apr 18. pii: S0264-410X(16)30144.
    PubMed     Text format     Abstract available


  583. VAN DER MEEREN O, Behre U, Crasta P
    Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine.
    Vaccine. 2016 Apr 16. pii: S0264-410X(16)30142.
    PubMed     Text format     Abstract available


  584. CASEY WT, Spink N, Cia F, Collins C, et al
    Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis.
    Vaccine. 2016 Apr 15. pii: S0264-410X(16)30085.
    PubMed     Text format     Abstract available


  585. HUANG T, Zhao K, Tang C, Zhang X, et al
    DNA vaccination based on pyolysin co-immunized with IL-1beta enhances host antibacterial immunity against Trueperella pyogenes infection.
    Vaccine. 2016 Apr 15. pii: S0264-410X(16)30154.
    PubMed     Text format     Abstract available


  586. STEGMILLER NP, Barcelos EC, Leal JM, Covre LP, et al
    Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis.
    Vaccine. 2016 Apr 15. pii: S0264-410X(16)30147.
    PubMed     Text format     Abstract available


  587. FITZPATRICK MC, Wenzel NS, Scarpino SV, Althouse BM, et al
    Cost-effectiveness of next-generation vaccines: The case of pertussis.
    Vaccine. 2016 Apr 14. pii: S0264-410X(16)30130.
    PubMed     Text format     Abstract available


  588. MILLER ER, Moro PL, Cano M, Lewis P, et al
    Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013.
    Vaccine. 2016 Apr 14. pii: S0264-410X(16)30150.
    PubMed     Text format     Abstract available


  589. GRAVES SF, Kouriba B, Diarra I, Daou M, et al
    Strain-specific Plasmodium falciparum multifunctional CD4 T cell cytokine expression in Malian children immunized with the FMP2.1/AS02 vaccine candidate.
    Vaccine. 2016 Apr 14. pii: S0264-410X(16)30148.
    PubMed     Text format     Abstract available


  590. GOLDEN AR, Adam HJ, Zhanel GG
    Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.
    Vaccine. 2016 Apr 13. pii: S0264-410X(16)30041.
    PubMed     Text format     Abstract available


  591. MCBURNEY SP, Sunshine JE, Gabriel S, Huynh JP, et al
    Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates.
    Vaccine. 2016 Apr 13. pii: S0264-410X(16)30139.
    PubMed     Text format     Abstract available


  592. CARDEMIL CV, Estivariz C, Shrestha L, Sherchand JB, et al
    The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.
    Vaccine. 2016 Apr 13. pii: S0264-410X(16)00338.
    PubMed     Text format     Abstract available


  593. LAL M, Jarrahian C, Zhu C, Hosken NA, et al
    Stability of live attenuated rotavirus vaccine with selected preservatives and primary containers.
    Vaccine. 2016 Apr 13. pii: S0264-410X(16)30090.
    PubMed     Text format     Abstract available


  594. ALDERSON MR
    Status of vaccine research and development of pediatric vaccines for Streptococcus pneumoniae.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30104.
    PubMed     Text format     Abstract available


  595. MARTIN LB, Simon R, MacLennan CA, Tennant SM, et al
    Status of paratyphoid fever vaccine research and development.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30103.
    PubMed     Text format     Abstract available


  596. XU L, Bao L, Lau SY, Wu WL, et al
    Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30004.
    PubMed     Text format     Abstract available


  597. BUDRONI S, Kleinschmidt A, Boucher P, Medini D, et al
    Pooled-sera hSBA titres predict individual seroprotection in infants and toddlers vaccinated with 4CMenB.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30129.
    PubMed     Text format     Abstract available


  598. MODJARRAD K
    MERS-CoV vaccine candidates in development: The current landscape.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30101.
    PubMed     Text format     Abstract available


  599. GREENWOOD KP, Hafiz R, Ware RS, Lambert SB, et al
    A systematic review of human-to-human transmission of measles vaccine virus.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30089.
    PubMed     Text format     Abstract available


  600. ROH EY, Yoon JH, In JW, Lee N, et al
    Association of HLA-DP variants with the responsiveness to Hepatitis B virus vaccination in Korean Infants.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30087.
    PubMed     Text format     Abstract available


  601. CARDIN RD, Bravo FJ, Pullum DA, Orlinger K, et al
    Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
    Vaccine. 2016;34:1993-9.
    PubMed     Text format     Abstract available


  602. BEZAY N, Ayad A, Dubischar K, Firbas C, et al
    Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers.
    Vaccine. 2016 Apr 11. pii: S0264-410X(16)30095.
    PubMed     Text format     Abstract available


  603. WAIBOCI LW, Mott JA, Kikwai G, Arunga G, et al
    Which influenza vaccine formulation should be used in Kenya? A comparison of influenza isolates from Kenya to vaccine strains, 2007-2013.
    Vaccine. 2016 Apr 11. pii: S0264-410X(16)30092.
    PubMed     Text format     Abstract available


  604. AIZENSHTEIN E, Yosipovich R, Kvint M, Shadmon R, et al
    Practical aspects in the use of passive immunization as an alternative to attenuated viral vaccines.
    Vaccine. 2016 Apr 11. pii: S0264-410X(16)30034.
    PubMed     Text format     Abstract available


  605. LEUNG MK, You JH
    Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly.
    Vaccine. 2016 Apr 11. pii: S0264-410X(16)30128.
    PubMed     Text format     Abstract available


  606. NAWA N, Kogaki S, Ozono K
    Listening to public concerns on vaccinations in order to provide information in a timely manner.
    Vaccine. 2016 Apr 8. pii: S0264-410X(16)30100.
    PubMed     Text format    


  607. NISSEN TN, Birk NM, Kjaergaard J, Thostesen LM, et al
    Adverse reactions to the Bacillus Calmette-Guerin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
    Vaccine. 2016 Apr 7. pii: S0264-410X(16)30097.
    PubMed     Text format     Abstract available


  608. HU G, Wang N, Yu W, Wang Z, et al
    Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Vaccine. 2016;34:1896-903.
    PubMed     Text format     Abstract available


  609. PRENDERGAST KA, Counoupas C, Leotta L, Eto C, et al
    The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection.
    Vaccine. 2016 Apr 6. pii: S0264-410X(16)30086.
    PubMed     Text format     Abstract available


  610. SANAPALA S, Rahav H, Patel H, Sun W, et al
    Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
    Vaccine. 2016 Apr 6. pii: S0264-410X(16)30091.
    PubMed     Text format     Abstract available


  611. WILLIAMS EA, Lewis DJ, Bertholet S, Zazzi M, et al
    Anticipating policy considerations for a future HIV vaccine: a preliminary study.
    Vaccine. 2016 Apr 4. pii: S0264-410X(16)30083.
    PubMed     Text format     Abstract available


  612. HANITSCH LG, Lobel M, Mieves JF, Bauer S, et al
    Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
    Vaccine. 2016 Apr 4. pii: S0264-410X(16)30088.
    PubMed     Text format     Abstract available


  613. GESSNER BD, Wilder-Smith A
    Estimating the public health importance of the CYD-tetravalent dengue vaccine: Vaccine preventable disease incidence and numbers needed to vaccinate.
    Vaccine. 2016 Apr 4. pii: S0264-410X(16)00328.
    PubMed     Text format     Abstract available


  614. HESSELING AC, Blakney AK, Jones CE, Esser MM, et al
    Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants.
    Vaccine. 2016 Apr 4. pii: S0264-410X(16)30078.
    PubMed     Text format     Abstract available


  615. HUTCHINGS HA, Evans A, Barnes P, Healy MA, et al
    Does frequent residential mobility in early years affect the uptake and timeliness of routine immunisations? An anonymised cohort study.
    Vaccine. 2016;34:1773-7.
    PubMed     Text format     Abstract available


  616. SCHERER LD, Shaffer VA, Patel N, Zikmund-Fisher BJ, et al
    Can the vaccine adverse event reporting system be used to increase vaccine acceptance and trust?
    Vaccine. 2016 Apr 2. pii: S0264-410X(16)30084.
    PubMed     Text format     Abstract available


    March 2016
  617. HOTEZ PJ, Beaumier CM, Gillespie PM, Strych U, et al
    Advancing a vaccine to prevent hookworm disease and anemia.
    Vaccine. 2016 Mar 31. pii: S0264-410X(16)30075.
    PubMed     Text format     Abstract available


  618. KOLWAITE AR, Xeuatvongsa A, Ramirez-Gonzalez A, Wannemuehle K, et al
    Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR.
    Vaccine. 2016 Mar 31. pii: S0264-410X(16)30077.
    PubMed     Text format     Abstract available


  619. REGAN AK, Tracey LE, Blyth CC, Richmond PC, et al
    A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy.
    Vaccine. 2016 Mar 31. pii: S0264-410X(16)30081.
    PubMed     Text format     Abstract available


  620. TERRANELLA A, Rea V, Griffith M, Manning S, et al
    Vaccine effectiveness of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during a pertussis outbreak in Maine.
    Vaccine. 2016 Mar 30. pii: S0264-410X(16)30080.
    PubMed     Text format     Abstract available


  621. BERLANDA SCORZA F, Tsvetnitsky V, Donnelly JJ
    Universal influenza vaccines: Shifting to better vaccines.
    Vaccine. 2016 Mar 30. pii: S0264-410X(16)30082.
    PubMed     Text format     Abstract available


  622. VERHAGEN LM, Hermsen M, Rivera-Olivero I, Sisco MC, et al
    Stunting correlates with high salivary and serum antibody levels after 13-valent pneumococcal conjugate vaccination of Venezuelan Amerindian Children.
    Vaccine. 2016 Mar 29. pii: S0264-410X(16)30062.
    PubMed     Text format     Abstract available


  623. MERRIFIELD M, Hotez PJ, Beaumier CM, Gillespie P, et al
    Advancing a vaccine to prevent human schistosomiasis.
    Vaccine. 2016 Mar 29. pii: S0264-410X(16)30076.
    PubMed     Text format     Abstract available


  624. RIDDLE MS, Walker RI
    Status of vaccine research and development for norovirus.
    Vaccine. 2016 Mar 29. pii: S0264-410X(16)30074.
    PubMed     Text format     Abstract available


  625. STEER AC, Carapetis JR, Dale JB, Fraser JD, et al
    Status of research and development of vaccines for Streptococcus pyogenes.
    Vaccine. 2016 Mar 29. pii: S0264-410X(16)30070.
    PubMed     Text format     Abstract available


  626. NUNES S, Felix S, Valente C, Simoes AS, et al
    The impact of private use of PCV7 in 2009 and 2010 on serotypes and antimicrobial resistance of Streptococcus pneumoniae carried by young children in Portugal: Comparison with data obtained since 1996 generating a 15-year study prior to PCV13 introduc
    Vaccine. 2016;34:1648-56.
    PubMed     Text format     Abstract available


  627. CHAMPION OL, Gourlay LJ, Scott AE, Lassaux P, et al
    Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease.
    Vaccine. 2016;34:1665-71.
    PubMed     Text format     Abstract available


  628. TENNANT SM, MacLennan CA, Simon R, Martin LB, et al
    Nontyphoidal salmonella disease: Current status of vaccine research and development.
    Vaccine. 2016 Mar 28. pii: S0264-410X(16)30069.
    PubMed     Text format     Abstract available


  629. YENDO AC, de Costa F, Cibulski SP, Teixeira TF, et al
    A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge.
    Vaccine. 2016 Mar 28. pii: S0264-410X(16)30066.
    PubMed     Text format     Abstract available


  630. KUMAR R, Arora N, Santosham M
    South Asia symposium on pneumococcal disease and the promise of vaccines - Meeting report.
    Vaccine. 2016 Mar 26. pii: S0264-410X(16)30067.
    PubMed     Text format     Abstract available


  631. SMALLEY C, Erasmus JH, Chesson CB, Beasley DW, et al
    Status of research and development of vaccines for chikungunya.
    Vaccine. 2016 Mar 26. pii: S0264-410X(16)30073.
    PubMed     Text format     Abstract available


  632. WALSH DS, Owira V, Polhemus M, Otieno L, et al
    Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON-TB Gold (+) Kenyan adults without evidence of tuberculosis.
    Vaccine. 2016 Mar 26. pii: S0264-410X(16)30065.
    PubMed     Text format     Abstract available


  633. QIN Y, Zhang Y, Wu P, Feng S, et al
    Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15.
    Vaccine. 2016 Mar 26. pii: S0264-410X(16)30064.
    PubMed     Text format     Abstract available


  634. BEAUMIER CM, Gillespie PM, Strych U, Hayward T, et al
    Status of vaccine research and development of vaccines for Chagas disease.
    Vaccine. 2016 Mar 26. pii: S0264-410X(16)30071.
    PubMed     Text format    


  635. DOMEK GJ, Contreras-Roldan IL, O'Leary ST, Bull S, et al
    SMS text message reminders to improve infant vaccination coverage in Guatemala: A pilot randomized controlled trial.
    Vaccine. 2016 Mar 26. pii: S0264-410X(16)30061.
    PubMed     Text format     Abstract available


  636. GHERASIM A, Pozo F, de Mateo S, Gamarrad IA, et al
    Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30008.
    PubMed     Text format     Abstract available


  637. DULAL P, Wright D, Ashfield R, Hill AV, et al
    Potency of a thermostabilised chimpanzee adenovirus Rift Valley fever vaccine in cattle.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30057.
    PubMed     Text format     Abstract available


  638. VLASAK J, Hoang VM, Christanti S, Peluso R, et al
    Use of flow cytometry for characterization of human cytomegalovirus vaccine particles.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30063.
    PubMed     Text format     Abstract available


  639. WIESEN E, Diorditsa S, Li X
    Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30056.
    PubMed     Text format     Abstract available


  640. SUNDARAM ME, Mason SM, Basta NE
    HPV vaccine uptake among overweight and obese US adolescents: An analysis of the National Health and Nutrition Examination Survey (NHANES) 2009-2014.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30060.
    PubMed     Text format     Abstract available


  641. MA T, Liu Y, Cheng J, Liu Y, et al
    Liposomes containing recombinant E protein vaccine against duck Tembusu virus in ducks.
    Vaccine. 2016 Mar 23. pii: S0264-410X(16)30003.
    PubMed     Text format     Abstract available


  642. PLETZ MW, Ewig S, Rohde G, Schuette H, et al
    Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay.
    Vaccine. 2016 Mar 23. pii: S0264-410X(16)30035.
    PubMed     Text format     Abstract available


  643. WANG Y, Zhang T, Chen L, Greene C, et al
    Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China.
    Vaccine. 2016 Mar 23. pii: S0264-410X(16)30039.
    PubMed     Text format     Abstract available


  644. HABER P, Moro PL, Lewis P, Woo EJ, et al
    Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.
    Vaccine. 2016 Mar 22. pii: S0264-410X(16)30031.
    PubMed     Text format     Abstract available


  645. PALACIOS R, Poland GA, Kalil J
    Another emerging arbovirus, another emerging vaccine: Targeting Zika virus.
    Vaccine. 2016 Mar 22. pii: S0264-410X(16)30055.
    PubMed     Text format    


  646. PECETTA S, Tontini M, Faenzi E, Cioncada R, et al
    Carrier priming effect of CRM is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM and diphtheria toxoid.
    Vaccine. 2016 Mar 22. pii: S0264-410X(16)30038.
    PubMed     Text format     Abstract available


  647. CHIU SS, Feng S, Chan KH, Lo JY, et al
    Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)30005.
    PubMed     Text format     Abstract available


  648. OU H, Yao H, Yao W, Wu N, et al
    Analysis of the immunogenicity and bioactivities of a split influenza A/H7N9 vaccine mixed with MF59 adjuvant in BALB/c mice.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)30010.
    PubMed     Text format     Abstract available


  649. MORO PL, Cragan J, Tepper N, Zheteyeva Y, et al
    Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011-2015.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)30032.
    PubMed     Text format     Abstract available


  650. CHERNOKHAEVA LL, Rogova YV, Vorovitch MF, Romanova LI, et al
    Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)30024.
    PubMed     Text format     Abstract available


  651. DE BRUYN G, Saleh J, Workman D, Pollak R, et al
    Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)00339.
    PubMed     Text format     Abstract available


  652. LOUBET P, Guerrisi C, Turbelin C, Blondel B, et al
    Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)30007.
    PubMed     Text format     Abstract available


  653. DURRHEIM DN
    Every rabies death is a veterinary and health system failure until proven otherwise.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)30033.
    PubMed     Text format    


  654. LIU Z, Zhou G, Ren C, Xu K, et al
    Oral administration of myostatin-specific recombinant Saccharomyces cerevisiae vaccine in rabbit.
    Vaccine. 2016 Mar 19. pii: S0264-410X(16)30009.
    PubMed     Text format     Abstract available


  655. CHA SB, Kim WS, Kim JS, Kim H, et al
    Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K.
    Vaccine. 2016 Mar 19. pii: S0264-410X(16)00340.
    PubMed     Text format     Abstract available


  656. RAGONNAUD E, Andersson AC, Pedersen AE, Laursen H, et al
    An adenoviral cancer vaccine co-encoding a tumor associated antigen together with secreted 4-1BBL leads to delayed tumor progression.
    Vaccine. 2016 Mar 19. pii: S0264-410X(15)00902.
    PubMed     Text format     Abstract available


  657. LECOCQ H, Chatelet IP, Taha MK, Levy-Bruhl D, et al
    Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00331.
    PubMed     Text format     Abstract available


  658. CAMACHO LA
    On the need to wait 4 weeks between two live attenuated vaccines.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00337.
    PubMed     Text format    


  659. BARTSCH SM, Hotez PJ, Hertenstein DL, Diemert DJ, et al
    Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00329.
    PubMed     Text format     Abstract available


  660. TUNG FY, Tung JK, Pallikkuth S, Pahwa S, et al
    A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00332.
    PubMed     Text format     Abstract available


  661. SARMIENTO JD, Villada F, Orrego JC, Franco JL, et al
    Adverse events following immunization in patients with primary immunodeficiencies.
    Vaccine. 2016;34:1611-6.
    PubMed     Text format     Abstract available


  662. NICOLI F, Gallerani E, Skarlis C, Sicurella M, et al
    Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00333.
    PubMed     Text format     Abstract available


  663. REGINA-SILVA S, Feres AM, Franca-Silva JC, Dias ES, et al
    Field randomized trial to evaluate the efficacy of the Leish-Tec vaccine against canine visceral leishmaniasis in an endemic area of Brazil.
    Vaccine. 2016 Mar 17. pii: S0264-410X(16)00330.
    PubMed     Text format     Abstract available


  664. BALDWIN SL, Roeffen W, Singh SK, Tiendrebeogo RW, et al
    Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen.
    Vaccine. 2016 Mar 16. pii: S0264-410X(16)00327.
    PubMed     Text format     Abstract available


  665. KIM JH, Mogasale V, Burgess C, Wierzba TF, et al
    Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study.
    Vaccine. 2016 Mar 15. pii: S0264-410X(16)00282.
    PubMed     Text format     Abstract available


  666. GIERSING BK, Modjarrad K, Kaslow DC, Moorthy VS, et al
    Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015.
    Vaccine. 2016 Mar 15. pii: S0264-410X(16)00291.
    PubMed     Text format     Abstract available


  667. SAFRIT JT, Fast PE, Gieber L, Kuipers H, et al
    Status of vaccine research and development of vaccines for HIV-1.
    Vaccine. 2016 Mar 15. pii: S0264-410X(16)00280.
    PubMed     Text format     Abstract available


  668. MARTIN-ACEBES MA, Blazquez AB, Canas-Arranz R, Vazquez-Calvo A, et al
    A recombinant DNA vaccine protects mice deficient in the alpha/beta interferon receptor against lethal challenge with Usutu virus.
    Vaccine. 2016 Mar 15. pii: S0264-410X(16)00315.
    PubMed     Text format     Abstract available


  669. BIRKETT AJ
    Status of vaccine research and development of vaccines for malaria prepared for WHO PD-VAC.
    Vaccine. 2016 Mar 15. pii: S0264-410X(16)00294.
    PubMed     Text format     Abstract available


  670. SHELDON E, Kitchin N, Peng Y, Eiden J, et al
    A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults.
    Vaccine. 2016 Mar 15. pii: S0264-410X(16)00300.
    PubMed     Text format     Abstract available


  671. KHAN TM, Sahibzada MU
    Challenges to health workers and their opinions about parents' refusal of oral polio vaccination in the Khyber Pakhtoon Khawa (KPK) province, Pakistan.
    Vaccine. 2016 Mar 15. pii: S0264-410X(16)00298.
    PubMed     Text format     Abstract available


  672. LOUIS BOURGEOIS A, Wierzba TF, Walker RI
    Status of vaccine research and development for enterotoxigenic Escherichia coli.
    Vaccine. 2016 Mar 14. pii: S0264-410X(16)00287.
    PubMed     Text format     Abstract available


  673. HEATH PT
    Status of vaccine research and development of vaccines for GBS.
    Vaccine. 2016 Mar 14. pii: S0264-410X(16)00290.
    PubMed     Text format     Abstract available


  674. BLOMMAERT A, Bilcke J, Willem L, Verhaegen J, et al
    The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for Belgium.
    Vaccine. 2016 Mar 14. pii: S0264-410X(16)00281.
    PubMed     Text format     Abstract available


  675. ARYA BK, Bhattacharya SD, Sutcliffe CG, Saha MK, et al
    Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Vaccine. 2016 Mar 14. pii: S0264-410X(16)00302.
    PubMed     Text format     Abstract available


  676. HOPKINS RJ, Kalsi G, Montalvo-Lugo VM, Sharma M, et al
    Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults.
    Vaccine. 2016 Mar 12. pii: S0264-410X(16)00284.
    PubMed     Text format     Abstract available


  677. MANI S, Wierzba T, Walker RI
    Status of vaccine research and development for Shigella prepared for WHO PD-VAC.
    Vaccine. 2016 Mar 12. pii: S0264-410X(16)00286.
    PubMed     Text format     Abstract available


  678. ABU EL HAMMED W, Soufy H, El-Shemy A, Nasr SM, et al
    Use of allicin as feed additive to enhance vaccination capacity of Clostridium perfringens toxoid in rabbits.
    Vaccine. 2016 Mar 11. pii: S0264-410X(16)00278.
    PubMed     Text format     Abstract available


  679. RIDDLE MS, Guerry P
    Status of vaccine research and development for Campylobacter jejuni.
    Vaccine. 2016 Mar 11. pii: S0264-410X(16)00295.
    PubMed     Text format     Abstract available


  680. EVANS TG, Schrager L, Thole J
    Status of vaccine research and development of vaccines for tuberculosis.
    Vaccine. 2016 Mar 10. pii: S0264-410X(16)00292.
    PubMed     Text format     Abstract available


  681. VANNICE KS, Durbin A, Hombach J
    Status of vaccine research and development of vaccines for dengue.
    Vaccine. 2016 Mar 10. pii: S0264-410X(16)00293.
    PubMed     Text format     Abstract available


  682. SATTERFIELD BA, Dawes BE, Milligan GN
    Status of vaccine research and development of vaccines for Nipah virus: Prepared for WHO PD-VAC July 30, 2015.
    Vaccine. 2016 Mar 10. pii: S0264-410X(16)00296.
    PubMed     Text format    


  683. JOHNSTON C, Gottlieb SL, Wald A
    Status of vaccine research and development of vaccines for herpes simplex virus prepared for WHO PD-VAC.
    Vaccine. 2016 Mar 10. pii: S0264-410X(16)00297.
    PubMed     Text format     Abstract available


  684. YUEN CT, Asokanathan C, Cook S, Lin N, et al
    Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines.
    Vaccine. 2016 Mar 10. pii: S0264-410X(16)00285.
    PubMed     Text format     Abstract available


  685. REED Z, Cardosa MJ
    Status of research and development of vaccines for enterovirus 71.
    Vaccine. 2016 Mar 10. pii: S0264-410X(16)00288.
    PubMed     Text format     Abstract available


  686. GILLESPIE PM, Beaumier CM, Strych U, Hayward T, et al
    Status of vaccine research and development of vaccines for leishmaniasis.
    Vaccine. 2016 Mar 10. pii: S0264-410X(16)00289.
    PubMed     Text format    


  687. MIZUNO D, Kimoto T, Sakai S, Takahashi E, et al
    Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys.
    Vaccine. 2016 Mar 5. pii: S0264-410X(16)00256.
    PubMed     Text format     Abstract available


  688. DROLET M, Deeks SL, Kliewer E, Musto G, et al
    Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada.
    Vaccine. 2016 Mar 5. pii: S0264-410X(16)00264.
    PubMed     Text format     Abstract available


  689. GOUMA S, Hahne SJ, Gijselaar DB, Koopmans MP, et al
    Severity of mumps disease is related to MMR vaccination status and viral shedding.
    Vaccine. 2016 Mar 4. pii: S0264-410X(16)00265.
    PubMed     Text format     Abstract available


  690. HUDSON SM, Rondinelli J, Glenn BA, Preciado M, et al
    Human papillomavirus vaccine series completion: Qualitative information from providers within an integrated healthcare organization.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00261.
    PubMed     Text format     Abstract available


  691. PAGLIUSI S, Ting CC, Khomvilai S
    Quality vaccines for all people: Report of the annual general meeting of the developing countries vaccine manufacturers network, 05-07th October 2015, Bangkok, Thailand.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00262.
    PubMed     Text format     Abstract available


  692. LIM SI, Song JY, Kim J, Hyun BH, et al
    Safety of classical swine fever virus vaccine strain LOM in pregnant sows and their offspring.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00257.
    PubMed     Text format     Abstract available


  693. STORCKSDIECK GENANNT BONSMANN , Niezold T, Hannaman D, Uberla K, et al
    The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8 T cell responses.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00254.
    PubMed     Text format     Abstract available


  694. AGUEMON CT, Tarantola A, Zoumenou E, Goyet S, et al
    Rabies transmission risks during peripartum - Two cases and a review of the literature.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00260.
    PubMed     Text format     Abstract available


  695. FEIRING B, Laake I, Molden T, Haberg SE, et al
    Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00255.
    PubMed     Text format     Abstract available


  696. FUSTER F, Vargas JI, Jensen D, Sarmiento V, et al
    CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.
    Vaccine. 2016 Mar 2. pii: S0264-410X(16)00236.
    PubMed     Text format     Abstract available


  697. YOSHIKAWA T, Kawamura Y, Ohashi M
    Universal varicella vaccine immunization in Japan.
    Vaccine. 2016 Mar 2. pii: S0264-410X(16)00253.
    PubMed     Text format     Abstract available


    February 2016
  698. VOLZ A, Lim S, Kaserer M, Lulf A, et al
    Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
    Vaccine. 2016 Feb 29. pii: S0264-410X(16)00213.
    PubMed     Text format     Abstract available


  699. TALBOT HK, Nian H, Chen Q, Zhu Y, et al
    Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias.
    Vaccine. 2016 Feb 27. pii: S0264-410X(16)00200.
    PubMed     Text format     Abstract available


  700. SALAMA II, Sami SM, Salama SI, Rabah TM, et al
    Immune response to second vaccination series of hepatitis B virus among booster dose non-responders.
    Vaccine. 2016 Feb 27. pii: S0264-410X(16)00231.
    PubMed     Text format     Abstract available


  701. JONES J, Poole A, Lasley-Bibbs V, Johnson M, et al
    LGBT health and vaccinations: Findings from a community health survey of Lexington-Fayette County, Kentucky, USA.
    Vaccine. 2016 Feb 27. pii: S0264-410X(16)00235.
    PubMed     Text format     Abstract available


  702. LEROUX-ROELS G, Maes C, Willekens J, De Boever F, et al
    A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women.
    Vaccine. 2016 Feb 26. pii: S0264-410X(16)00215.
    PubMed     Text format     Abstract available


  703. HUO X, Shi G, Li X, Lai X, et al
    Knowledge and attitudes about Ebola vaccine among the general population in Sierra Leone.
    Vaccine. 2016 Feb 26. pii: S0264-410X(16)00227.
    PubMed     Text format     Abstract available


  704. GONCALVES BP, Prevots DR, Kabyemela E, Fried M, et al
    Preparing for future efficacy trials of severe malaria vaccines.
    Vaccine. 2016 Feb 25. pii: S0264-410X(16)00234.
    PubMed     Text format     Abstract available


  705. LIU XC, Bell CA, Simmonds KA, Svenson LW, et al
    Adverse events following HPV vaccination, Alberta 2006-2014.
    Vaccine. 2016 Feb 24. pii: S0264-410X(16)00203.
    PubMed     Text format     Abstract available


  706. CHINTOAN-UTA C, Cassady-Cain RL, Stevens MP
    Evaluation of flagellum-related proteins FliD and FspA as subunit vaccines against Campylobacter jejuni colonisation in chickens.
    Vaccine. 2016 Feb 24. pii: S0264-410X(16)00233.
    PubMed     Text format     Abstract available


  707. BENGTSSON KL, Song H, Stertman L, Liu Y, et al
    Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
    Vaccine. 2016 Feb 24. pii: S0264-410X(16)00196.
    PubMed     Text format     Abstract available


  708. SAMO M, Choudhary NR, Riebe KJ, Shterev I, et al
    Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface.
    Vaccine. 2016;34:1193-200.
    PubMed     Text format     Abstract available


  709. VOYSEY M, Barker CI, Snape MD, Kelly DF, et al
    Sex-dependent immune responses to infant vaccination: An individual participant data meta-analysis of antibody and memory B cells.
    Vaccine. 2016 Feb 23. pii: S0264-410X(16)00199.
    PubMed     Text format     Abstract available


  710. WEINBERGER R, van der Linden M, Imohl M, von Kries R, et al
    Vaccine effectiveness of PCV13 in a 3+1 vaccination schedule.
    Vaccine. 2016 Feb 23. pii: S0264-410X(16)00214.
    PubMed     Text format     Abstract available


  711. FENG S, Cowling BJ, Sullivan SG
    Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings.
    Vaccine. 2016 Feb 23. pii: S0264-410X(16)00202.
    PubMed     Text format     Abstract available


  712. FANG R, Lv M, Wu J, Pang X, et al
    The free vaccination policy of influenza in Beijing, China: The vaccine coverage and its associated factors.
    Vaccine. 2016 Feb 22. pii: S0264-410X(16)00174.
    PubMed     Text format     Abstract available


  713. MULLIN J, Ahmed MS, Sharma R, Upile N, et al
    Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.
    Vaccine. 2016 Feb 19. pii: S0264-410X(16)00170.
    PubMed     Text format     Abstract available


  714. KUMAR M, Upadhyay A, Singh J, Chhabra M, et al
    Effect of change in sequence of administration of DTwP and Hepatitis B vaccines on perception of pain in infants: A randomized control trial.
    Vaccine. 2016 Feb 19. pii: S0264-410X(16)00173.
    PubMed     Text format     Abstract available


  715. D'ARDENNE KK, Darrow J, Furniss A, Chavez C, et al
    Use of rapid needs assessment as a tool to identify vaccination delays in Guatemala and Peru.
    Vaccine. 2016 Feb 19. pii: S0264-410X(16)00123.
    PubMed     Text format     Abstract available


  716. KAMIYA H, Cho BH, Messonnier M, Clark TA, et al
    Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United States.
    Vaccine. 2016 Feb 17. pii: S0264-410X(16)00169.
    PubMed     Text format     Abstract available


  717. DIAO WQ, Shen N, Yu PX, Liu BB, et al
    Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials.
    Vaccine. 2016 Feb 17. pii: S0264-410X(16)00165.
    PubMed     Text format     Abstract available


  718. SARTORI AM, de Soarez PC, Fernandes EG, Gryninger LC, et al
    Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Vaccine. 2016 Feb 17. pii: S0264-410X(16)00168.
    PubMed     Text format     Abstract available


  719. AKAN H, Yavuz E, Yayla E, Kulbay H, et al
    Factors affecting uptake of influenza vaccination among family physicians.
    Vaccine. 2016 Feb 17. pii: S0264-410X(16)00120.
    PubMed     Text format     Abstract available


  720. CZIBENER C, Del Giudice MG, Spera JM, Fulgenzi FR, et al
    Delta-pgm, a new live-attenuated vaccine against Brucella suis.
    Vaccine. 2016 Feb 17. pii: S0264-410X(16)00167.
    PubMed     Text format     Abstract available


  721. KRAICER-MELAMED H, O'Donnell S, Quach C
    The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis.
    Vaccine. 2016 Feb 17. pii: S0264-410X(16)00166.
    PubMed     Text format     Abstract available


  722. SALVERDA ML, Meinderts SM, Hamstra HJ, Wagemakers A, et al
    Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Vaccine. 2016;34:1025-33.
    PubMed     Text format     Abstract available


  723. DROPPA-ALMEIDA D, Vivas WL, Silva KK, Rezende AF, et al
    Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain.
    Vaccine. 2016;34:1091-6.
    PubMed     Text format     Abstract available


  724. CHIANG CY, Liu SJ, Hsieh CH, Chen MY, et al
    Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice.
    Vaccine. 2016;34:1054-61.
    PubMed     Text format     Abstract available


  725. FEUNOU PF, Mielcarek N, Locht C
    Reciprocal interference of maternal and infant immunization in protection against pertussis.
    Vaccine. 2016;34:1062-9.
    PubMed     Text format     Abstract available


  726. FAUST H, Toft L, Sehr P, Muller M, et al
    Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines.
    Vaccine. 2016 Feb 16. pii: S0264-410X(16)00161.
    PubMed     Text format     Abstract available


  727. MOSTERIN HOPPING A, Fonville JM, Russell CA, James S, et al
    Influenza B vaccine lineage selection-An optimized trivalent vaccine.
    Vaccine. 2016 Feb 16. pii: S0264-410X(16)00094.
    PubMed     Text format     Abstract available


  728. SAHA A, Khan A, Salma U, Jahan N, et al
    The oral cholera vaccine Shanchol when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants.
    Vaccine. 2016 Feb 16. pii: S0264-410X(16)00162.
    PubMed     Text format     Abstract available


  729. GLANZ JM, Newcomer SR, Jackson ML, Omer SB, et al
    White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink.
    Vaccine. 2016;34 Suppl 1:A1-A29.
    PubMed     Text format     Abstract available


  730. HARPER M, John M, Edmunds M, Wright A, et al
    Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure.
    Vaccine. 2016 Feb 15. pii: S0264-410X(16)00159.
    PubMed     Text format     Abstract available


  731. CASKEY R, Andes S, Walton SM
    HPV vaccine: Less is more.
    Vaccine. 2016 Feb 15. pii: S0264-410X(16)00164.
    PubMed     Text format    


  732. SANDER B, Wong WW, Yeung MW, Ormanidhi O, et al
    The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting - Can we do better?
    Vaccine. 2016 Feb 15. pii: S0264-410X(16)00158.
    PubMed     Text format     Abstract available


  733. MITRA S, Sinha R, Mitobe J, Koley H, et al
    Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain.
    Vaccine. 2016 Feb 12. pii: S0264-410X(16)00160.
    PubMed     Text format     Abstract available


  734. HAN JX, Ng GZ, Cecchini P, Chionh YT, et al
    Heat shock protein complex vaccines induce antibodies against Neisseria meningitidis via a MyD88-independent mechanism.
    Vaccine. 2016 Feb 11. pii: S0264-410X(16)00127.
    PubMed     Text format     Abstract available


  735. SPEDICATO M, Carmine I, Teodori L, Leone A, et al
    Innocuity of a commercial live attenuated vaccine for epizootic hemorrhagic disease virus serotype 2 in late-term pregnant cows.
    Vaccine. 2016 Feb 11. pii: S0264-410X(16)00129.
    PubMed     Text format     Abstract available


  736. THOMPSON MG, Naleway A, Fry AM, Ball S, et al
    Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.
    Vaccine. 2016;34:981-8.
    PubMed     Text format     Abstract available


  737. ZHU R, Liu J, Chen C, Ye X, et al
    A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice.
    Vaccine. 2016 Feb 9. pii: S0264-410X(16)00133.
    PubMed     Text format     Abstract available


  738. YAM KK, Gupta J, Allen EK, Burt KR, et al
    Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice.
    Vaccine. 2016 Feb 9. pii: S0264-410X(16)00138.
    PubMed     Text format     Abstract available


  739. LI R, Li CG, Li Y, Liu Y, et al
    Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Vaccine. 2016 Feb 9. pii: S0264-410X(16)00136.
    PubMed     Text format     Abstract available


  740. HALSTEAD SB, Russell PK
    Protective and immunological behavior of chimeric yellow fever dengue vaccine.
    Vaccine. 2016 Feb 9. pii: S0264-410X(16)00130.
    PubMed     Text format     Abstract available


  741. SPRINGER MJ, Ni Y, Finger-Baker I, Ball JP, et al
    Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation.
    Vaccine. 2016 Feb 9. pii: S0264-410X(16)00154.
    PubMed     Text format     Abstract available


  742. FOWLKES AL, Witte D, Beeler J, Audet SA, et al
    Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules.
    Vaccine. 2016 Feb 9. pii: S0264-410X(16)00118.
    PubMed     Text format     Abstract available


  743. KAPCZYNSKI DR, Tumpey TM, Hidajat R, Zsak A, et al
    Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.
    Vaccine. 2016 Feb 8. pii: S0264-410X(16)00137.
    PubMed     Text format     Abstract available


  744. GOIN-KOCHEL RP, Mire SS, Dempsey AG, Fein RH, et al
    Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset?
    Vaccine. 2016 Feb 8. pii: S0264-410X(16)00134.
    PubMed     Text format     Abstract available


  745. WANG LD, Lam WW, Fielding R
    Hong Kong Chinese parental attitudes towards vaccination and associated socio-demographic disparities.
    Vaccine. 2016 Feb 8. pii: S0264-410X(16)00132.
    PubMed     Text format     Abstract available


  746. KASTING ML, Wilson S, Dixon BE, Downs SM, et al
    A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine.
    Vaccine. 2016 Feb 6. pii: S0264-410X(16)00102.
    PubMed     Text format     Abstract available


  747. MOROZ E, Albrecht RA, Aden B, Beeder AB, et al
    Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine.
    Vaccine. 2016 Feb 6. pii: S0264-410X(16)00103.
    PubMed     Text format     Abstract available


  748. PURTLE L, Mattick D, Schneider C, Smith L, et al
    One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista once SQ vaccine.
    Vaccine. 2016 Feb 6. pii: S0264-410X(16)00135.
    PubMed     Text format     Abstract available


  749. CASTILLA J, Navascues A, Fernandez-Alonso M, Reina G, et al
    Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00117.
    PubMed     Text format     Abstract available


  750. DITSUNGNOEN D, Greenbaum A, Prapasiri P, Dawood FS, et al
    Knowledge, attitudes and beliefs related to seasonal influenza vaccine among pregnant women in Thailand.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00119.
    PubMed     Text format     Abstract available


  751. CHAMBERLAIN AT, Berkelman RL, Ault KA, Rosenberg ES, et al
    Trends in reasons for non-receipt of influenza vaccination during pregnancy in Georgia, 2004-2011.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00121.
    PubMed     Text format     Abstract available


  752. TUCKERMAN J, Thomas N, Marshall HS
    Should professionals caring for children be vaccinated? Community perspectives on health care and child care worker immunisation.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00122.
    PubMed     Text format     Abstract available


  753. MINHINNICK A, Satti I, Harris S, Wilkie M, et al
    A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00125.
    PubMed     Text format     Abstract available


  754. SMITH PJ, Stokley S, Bednarczyk RA, Orenstein WA, et al
    HPV vaccination coverage of teen girls: The influence of health care providers.
    Vaccine. 2016 Feb 4. pii: S0264-410X(16)00124.
    PubMed     Text format     Abstract available


  755. ITABORAHY RM, Mancini DA, Medeiros SF
    Response to the influenza vaccine based on estradiol use in menopausal women.
    Vaccine. 2016 Feb 4. pii: S0264-410X(16)00115.
    PubMed     Text format     Abstract available


  756. JANG YH, Jung EJ, Lee KH, Byun YH, et al
    Genetic analysis of attenuation markers of cold-adapted X-31 influenza live vaccine donor strain.
    Vaccine. 2016 Feb 4. pii: S0264-410X(16)00116.
    PubMed     Text format     Abstract available


  757. LEHMANN BA, Chapman GB, Franssen FM, Kok G, et al
    Changing the default to promote influenza vaccination among health care workers.
    Vaccine. 2016 Feb 3. pii: S0264-410X(16)00098.
    PubMed     Text format     Abstract available


  758. SAKTHI S, Palaniyandi K, Gupta UD, Gupta P, et al
    Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs.
    Vaccine. 2016;34:735-43.
    PubMed     Text format     Abstract available


  759. MENEZES AP, Azevedo J, Leite MC, Campos LC, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae among children in an urban setting in Brazil prior to PCV10 introduction.
    Vaccine. 2016;34:791-7.
    PubMed     Text format     Abstract available


  760. YANG TU, Kim E, Park YJ, Kim D, et al
    Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.
    Vaccine. 2016 Feb 2. pii: S0264-410X(16)00095.
    PubMed     Text format     Abstract available


  761. SANTIBANEZ TA, Vogt T, Zhai Y, McIntyre A, et al
    Place of influenza vaccination among children-United States, 2010-11 through 2013-14 influenza seasons.
    Vaccine. 2016 Feb 2. pii: S0264-410X(16)00076.
    PubMed     Text format     Abstract available


  762. WIETEN RW, Jonker EF, Pieren DK, Hodiamont CJ, et al
    Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication.
    Vaccine. 2016 Feb 1. pii: S0264-410X(16)00081.
    PubMed     Text format     Abstract available


  763. KHAN TM, Khan AU, Ali I, Chia DW, et al
    Knowledge, attitude and awareness among healthcare professionals about influenza vaccination in Peshawar, Pakistan.
    Vaccine. 2016 Feb 1. pii: S0264-410X(16)00097.
    PubMed     Text format     Abstract available


  764. OSTERGAARD L, Lucksinger GH, Absalon J, Beeslaar J, et al
    A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults.
    Vaccine. 2016 Feb 1. pii: S0264-410X(16)00096.
    PubMed     Text format     Abstract available


  765. PECETTA S, Vijayakrishnan B, Romano MR, Proietti D, et al
    Evaluation of the non-toxic mutant of the diphtheria toxin K51E/E148K as carrier protein for meningococcal vaccines.
    Vaccine. 2016 Feb 1. pii: S0264-410X(16)00084.
    PubMed     Text format     Abstract available


  766. HERRERO FS, Cardona CG, Palop NT, Fabrellas EF, et al
    The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired pneumonia.
    Vaccine. 2016 Feb 1. pii: S0264-410X(16)00082.
    PubMed     Text format     Abstract available


  767. LIU X, Da Z, Wang Y, Niu H, et al
    A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice.
    Vaccine. 2016 Feb 1. pii: S0264-410X(16)00101.
    PubMed     Text format     Abstract available


    January 2016
  768. BEARSON BL, Bearson SM, Kich JD
    A DIVA vaccine for cross-protection against Salmonella.
    Vaccine. 2016 Jan 30. pii: S0264-410X(16)00080.
    PubMed     Text format     Abstract available


  769. TAMAKI Y, Harakuni T, Yamaguchi R, Miyata T, et al
    Cholera toxin B subunit pentamer reassembled from Escherichia coli inclusion bodies for use in vaccination.
    Vaccine. 2016 Jan 29. pii: S0264-410X(16)00078.
    PubMed     Text format     Abstract available


  770. PARK HM, Cho HI, Shin CA, Shon HJ, et al
    Zoledronic acid induces dose-dependent increase of antigen-specific CD8 T-cell responses in combination with peptide/poly-IC vaccine.
    Vaccine. 2016 Jan 29. pii: S0264-410X(16)00070.
    PubMed     Text format     Abstract available


  771. RAPPAZZO CG, Watkins HC, Guarino CM, Chau A, et al
    Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.
    Vaccine. 2016 Jan 29. pii: S0264-410X(16)00072.
    PubMed     Text format     Abstract available


  772. INGELMAN-SUNDBERG HM, Laestadius A, Chrapkowska C, Mordrup K, et al
    Diverse effects on vaccine-specific serum IgG titres and memory B cells upon methotrexate and anti-TNF-alpha therapy in children with rheumatic diseases: A cross-sectional study.
    Vaccine. 2016 Jan 28. pii: S0264-410X(16)00071.
    PubMed     Text format     Abstract available


  773. LEE HJ, Choe YJ, Hong YJ, Kim KH, et al
    Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine in healthy adolescents in Korea-A randomised trial.
    Vaccine. 2016 Jan 28. pii: S0264-410X(16)00077.
    PubMed     Text format     Abstract available


  774. TAN HX, Gilbertson BP, Jegaskanda S, Alcantara S, et al
    Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses.
    Vaccine. 2016 Jan 28. pii: S0264-410X(16)00074.
    PubMed     Text format     Abstract available


  775. SONG JY, Woo HJ, Cheong HJ, Noh JY, et al
    Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax) in healthy adults.
    Vaccine. 2016 Jan 27. pii: S0264-410X(16)00075.
    PubMed     Text format     Abstract available


  776. HUANG Y, Zhang L, Jolliffe D, Hovden AO, et al
    A case for preART-adjusted endpoints in HIV therapeutic vaccine trials.
    Vaccine. 2016 Jan 27. pii: S0264-410X(16)00069.
    PubMed     Text format     Abstract available


  777. SURADHAT S, Wongyanin P, Sirisereewan C, Nedumpun T, et al
    Transdermal delivery of plasmid encoding truncated nucleocapsid protein enhanced PRRSV-specific immune responses.
    Vaccine. 2016;34:609-15.
    PubMed     Text format     Abstract available


  778. KUMAR S, Koul M
    Newcastle disease virus: A constant threat to the poultry industry in India.
    Vaccine. 2016;34:597-8.
    PubMed     Text format    


  779. GILKEY MB, Calo WA, Moss JL, Shah PD, et al
    Provider communication and HPV vaccination: The impact of recommendation quality.
    Vaccine. 2016 Jan 23. pii: S0264-410X(16)00058.
    PubMed     Text format     Abstract available


  780. SAADATIAN-ELAHI M, Horstick O, Breiman RF, Gessner BD, et al
    Beyond efficacy: The full public health impact of vaccines.
    Vaccine. 2016 Jan 22. pii: S0264-410X(16)00056.
    PubMed     Text format     Abstract available


  781. HATTASINGH W, Pengsaa K, Thisyakorn U
    Report on: "The 1st Workshop on National Immunization Programs and Vaccine Coverage in ASEAN Countries, April 30, 2015, Pattaya, Thailand".
    Vaccine. 2016 Jan 21. pii: S0264-410X(16)00040.
    PubMed     Text format     Abstract available


  782. ALSHAIKHAHMED K, Roy P
    Generation of virus-like particles for emerging epizootic haemorrhagic disease virus: Towards the development of safe vaccine candidates.
    Vaccine. 2016 Jan 21. pii: S0264-410X(16)00019.
    PubMed     Text format     Abstract available


  783. SAITO S, Ainai A, Suzuki T, Harada N, et al
    The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine.
    Vaccine. 2016 Jan 20. pii: S0264-410X(16)00055.
    PubMed     Text format     Abstract available


  784. AVILA MOURA A, de Mello MJ, Correia JB
    Serological statuses of pregnant women in an urban Brazilian population before and after the 2008 rubella immunization campaign.
    Vaccine. 2016;34:445-50.
    PubMed     Text format     Abstract available


  785. DINELLI MI, Ono E, Viana PO, Spina FG, et al
    Response to immunization in children born to renal transplant recipients using immunosuppressive drugs during gestation.
    Vaccine. 2016;34:404-7.
    PubMed     Text format     Abstract available


  786. KENDALL BA, Dascomb KK, Mehta RR, Stockmann C, et al
    Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
    Vaccine. 2016;34:474-8.
    PubMed     Text format     Abstract available


  787. ARANYOS AM, Roff SR, Pu R, Owen JL, et al
    An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.
    Vaccine. 2016 Jan 20. pii: S0264-410X(16)00043.
    PubMed     Text format     Abstract available


  788. HISANO M, Kato T, Inoue E, Sago H, et al
    Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
    Vaccine. 2016 Jan 19. pii: S0264-410X(16)00041.
    PubMed     Text format     Abstract available


  789. WANG ZZ, Li MQ, Wang P, Yang ZX, et al
    Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China.
    Vaccine. 2016 Jan 19. pii: S0264-410X(16)00044.
    PubMed     Text format     Abstract available


  790. BENEDICTUS L, Rutten VP, Koets AP
    Pregnancy boosts vaccine-induced Bovine Neonatal Pancytopenia-associated alloantibodies.
    Vaccine. 2016 Jan 18. pii: S0264-410X(16)00039.
    PubMed     Text format     Abstract available


  791. DAVIDSON I, Raibshtein I, Altori A, Elkin N, et al
    Infectious laryngotracheitis virus (ILTV) vaccine intake evaluation by detection of virus amplification in feather pulps of vaccinated chickens.
    Vaccine. 2016 Jan 16. pii: S0264-410X(16)00025.
    PubMed     Text format     Abstract available


  792. AGNOLON V, Bruno C, Galletti B, Mori E, et al
    Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines.
    Vaccine. 2016 Jan 16. pii: S0264-410X(16)00038.
    PubMed     Text format     Abstract available


  793. AHMED T, Borthwick NJ, Gilmour J, Hayes P, et al
    Control of HIV-1 replication in vitro by vaccine-induced human CD8 T cells through conserved subdominant Pol epitopes.
    Vaccine. 2016 Jan 16. pii: S0264-410X(15)01793.
    PubMed     Text format     Abstract available


  794. ARRIOLA CS, Vasconez N, Thompson M, Mirza S, et al
    Factors associated with a successful expansion of influenza vaccination among pregnant women in Nicaragua.
    Vaccine. 2016 Jan 15. pii: S0264-410X(16)00002.
    PubMed     Text format     Abstract available


  795. THOMSON A, Watson M
    Vaccine hesitancy: A vade mecum v1.0.
    Vaccine. 2016 Jan 14. pii: S0264-410X(15)01846.
    PubMed     Text format    


  796. PETROVA EK, Dmitrieva AA, Trifonova EA, Nikitin NA, et al
    The key role of rubella virus glycoproteins in the formation of immune response, and perspectives on their use in the development of new recombinant vaccines.
    Vaccine. 2016 Jan 14. pii: S0264-410X(16)00029.
    PubMed     Text format     Abstract available


  797. NAWA N, Kogaki S, Takahashi K, Ishida H, et al
    Analysis of public concerns about influenza vaccinations by mining a massive online question dataset in Japan.
    Vaccine. 2016 Jan 14. pii: S0264-410X(16)00027.
    PubMed     Text format     Abstract available


  798. SYDLER T, Bragger S, Handke M, Hartnack S, et al
    Latent porcine circovirus type 2-infected domestic pigs: A potential infection model for the effective development of vaccines against latent or chronic virus induced diseases.
    Vaccine. 2016 Jan 13. pii: S0264-410X(16)00024.
    PubMed     Text format     Abstract available


  799. PEREZ DE VAL B, Vidal E, Lopez-Soria S, Marco A, et al
    Assessment of safety and interferon gamma responses of Mycobacterium bovis BCG vaccine in goat kids and milking goats.
    Vaccine. 2016 Jan 13. pii: S0264-410X(16)00023.
    PubMed     Text format     Abstract available


  800. COMEAU JL, Gagneur A, Quach C
    Impact of a publicly funded monovalent rotavirus vaccination program in the Province of Quebec (Canada).
    Vaccine. 2016 Jan 12. pii: S0264-410X(16)00026.
    PubMed     Text format     Abstract available


  801. LANE CR, Carville KS, Pierse N, Kelly HA, et al
    Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach.
    Vaccine. 2016 Jan 12. pii: S0264-410X(16)00021.
    PubMed     Text format     Abstract available


  802. JIANG J, Fisher EM, Concannon M, Lustigman S, et al
    Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1.
    Vaccine. 2016 Jan 12. pii: S0264-410X(16)00022.
    PubMed     Text format     Abstract available


  803. GOLDSTEIN ND, LeVasseur MT, Purtle J
    Is this thing on? Getting the public to listen to the pro-vaccine message.
    Vaccine. 2016 Jan 12. pii: S0264-410X(16)00020.
    PubMed     Text format    


  804. TASHER D, Rahav G, Levine H, Sofer D, et al
    How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience.
    Vaccine. 2016;34:299-301.
    PubMed     Text format    


  805. HUGHES MM, Katz J, Englund JA, Khatry SK, et al
    Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.
    Vaccine. 2016 Jan 11. pii: S0264-410X(15)01872.
    PubMed     Text format     Abstract available


  806. XIA M, Wei C, Wang L, Cao D, et al
    A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus.
    Vaccine. 2016 Jan 9. pii: S0264-410X(16)00017.
    PubMed     Text format     Abstract available


  807. INBAR R, Weiss R, Tomljenovic L, Arango MT, et al
    Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.
    Vaccine. 2016 Jan 8. pii: S0264-410X(16)00016.
    PubMed     Text format     Abstract available


  808. KRISTENSEN DD, Lorenson T, Bartholomew K, Villadiego S, et al
    Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.
    Vaccine. 2016 Jan 8. pii: S0264-410X(16)00018.
    PubMed     Text format     Abstract available


  809. WAGENVOORT GH, Sanders EA, Vlaminckx BJ, Elberse KE, et al
    Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands.
    Vaccine. 2016 Jan 8. pii: S0264-410X(16)00003.
    PubMed     Text format     Abstract available


  810. BATES JT, Pickens JA, Schuster JE, Johnson M, et al
    Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.
    Vaccine. 2016 Jan 7. pii: S0264-410X(15)01842.
    PubMed     Text format     Abstract available


  811. CHATTOPADHYAY S, Dash SK, Mandal D, Das B, et al
    Metal based nanoparticles as cancer antigen delivery vehicles for macrophage based antitumor vaccine.
    Vaccine. 2016 Jan 7. pii: S0264-410X(15)01864.
    PubMed     Text format     Abstract available


  812. BACKES S, Jager C, Dembek CJ, Kosinska AD, et al
    Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice.
    Vaccine. 2016 Jan 6. pii: S0264-410X(15)01871.
    PubMed     Text format     Abstract available


  813. KIM SH, Kim M, Choi GE, Lee JH, et al
    Stability and efficacy of the 3'-UTR A4G-G5A variant of viral hemorrhagic septicemia virus (VHSV) as a live attenuated immersion VHSV vaccine in olive flounder (Paralichthys olivaceus).
    Vaccine. 2016 Jan 6. pii: S0264-410X(15)01848.
    PubMed     Text format     Abstract available


  814. VAN DAMME P, Bonanni P, Bosch FX, Joura E, et al
    Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines.
    Vaccine. 2016 Jan 6. pii: S0264-410X(15)01874.
    PubMed     Text format     Abstract available


  815. SLOTVED HC, Dalby T, Hoffmann S
    The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark.
    Vaccine. 2016 Jan 6. pii: S0264-410X(15)01867.
    PubMed     Text format     Abstract available


  816. LE LUDUEC JB, Debeer S, Piras F, Andreoni C, et al
    Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine.
    Vaccine. 2016 Jan 6. pii: S0264-410X(15)01869.
    PubMed     Text format     Abstract available


  817. LIU DP, Wang TA, Huang WT, Chang LY, et al
    Disease burden of enterovirus infection in Taiwan: Implications for vaccination policy.
    Vaccine. 2016 Jan 6. pii: S0264-410X(15)01798.
    PubMed     Text format     Abstract available


  818. HOPF S, Garner-Spitzer E, Hofer M, Kundi M, et al
    Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine.
    Vaccine. 2016 Jan 5. pii: S0264-410X(15)01868.
    PubMed     Text format     Abstract available



  819. Varicella and herpes zoster vaccines: WHO position paper, June 2014 - Recommendations.
    Vaccine. 2016;34:198-9.
    PubMed     Text format     Abstract available


  820. KHARBANDA EO, Vazquez-Benitez G, Lipkind HS, Klein NP, et al
    Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.
    Vaccine. 2016 Jan 4. pii: S0264-410X(15)01843.
    PubMed     Text format     Abstract available


  821. CAO W, Liepkalns J, Hassan AO, Kamal R, et al
    A highly immunogenic vaccine against A(H7N9) influenza virus.
    Vaccine. 2016 Jan 4. pii: S0264-410X(15)01873.
    PubMed     Text format     Abstract available


  822. PENDLETON ME, Ruffin MT 4th, Harper DM
    No evidence in US of HPV16/18 cancer precursor reduction.
    Vaccine. 2016;34:200.
    PubMed     Text format    


  823. KRISTENSEN M, van Lier A, Eilers R, McDonald SA, et al
    Burden of four vaccine preventable diseases in older adults.
    Vaccine. 2016 Jan 2. pii: S0264-410X(15)01863.
    PubMed     Text format     Abstract available


  824. MERCKX J, McCormack D, Quach C
    Improving influenza vaccination in chronically ill children using a tertiary-care based vaccination clinic: Is there a role for the live-attenuated influenza vaccine (LAIV)?
    Vaccine. 2016 Jan 2. pii: S0264-410X(15)01866.
    PubMed     Text format     Abstract available


  825. COLLANGE F, Fressard L, Pulcini C, Sebbah R, et al
    General practitioners' attitudes and behaviors toward HPV vaccination: A French national survey.
    Vaccine. 2016 Jan 2. pii: S0264-410X(15)01865.
    PubMed     Text format     Abstract available


  826. HUO YF, Huang QH, Lu M, Wu JQ, et al
    Attenuation mechanism of virulent infectious bronchitis virus strain with QX genotype by continuous passage in chicken embryos.
    Vaccine. 2016;34:83-9.
    PubMed     Text format     Abstract available


  827. PAYAKACHAT N, Hadden KB, Ragland D
    Promoting Tdap immunization in pregnancy: Associations between maternal perceptions and vaccination rates.
    Vaccine. 2016;34:179-86.
    PubMed     Text format     Abstract available


    December 2015
  828. KHAN SA, Polkinghorne A, Waugh C, Hanger J, et al
    Humoral immune responses in koalas (Phascolarctos cinereus) either naturally infected with Chlamydia pecorum or following administration of a recombinant chlamydial major outer membrane protein vaccine.
    Vaccine. 2015 Dec 30. pii: S0264-410X(15)01847.
    PubMed     Text format     Abstract available


  829. HALSEY NA, Talaat KR, Greenbaum A, Mensah E, et al
    The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.
    Vaccine. 2015;33 Suppl 5:F1-F67.
    PubMed     Text format     Abstract available


  830. NICHOLLS TR, Leach AJ, Morris PS
    The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials.
    Vaccine. 2015 Dec 29. pii: S0264-410X(15)01845.
    PubMed     Text format     Abstract available


  831. DETERMANN D, de Bekker-Grob EW, French J, Voeten HA, et al
    Future pandemics and vaccination: Public opinion and attitudes across three European countries.
    Vaccine. 2015 Dec 28. pii: S0264-410X(15)01832.
    PubMed     Text format     Abstract available


  832. STASSIJNS J, Bollaerts K, Baay M, Verstraeten T, et al
    A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children.
    Vaccine. 2015 Dec 28. pii: S0264-410X(15)01796.
    PubMed     Text format     Abstract available


  833. MARSHALL HS, Chen G, Clarke M, Ratcliffe J, et al
    Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
    Vaccine. 2015 Dec 28. pii: S0264-410X(15)01769.
    PubMed     Text format     Abstract available


  834. ABD-ELGHAFFAR AA, Ali AE, Boseila AA, Amin MA, et al
    Inactivation of rabies virus by hydrogen peroxide.
    Vaccine. 2015 Dec 27. pii: S0264-410X(15)01838.
    PubMed     Text format     Abstract available


  835. GHOSH B, Nguyen TD, Crosbie PB, Nowak BF, et al
    Oral vaccination of first-feeding Atlantic salmon, Salmo salar L., confers greater protection against yersiniosis than immersion vaccination.
    Vaccine. 2015 Dec 24. pii: S0264-410X(15)01841.
    PubMed     Text format     Abstract available


  836. ORELLANO PW, Reynoso JI, Stahl HC, Salomon OD, et al
    Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission.
    Vaccine. 2015 Dec 24. pii: S0264-410X(15)01837.
    PubMed     Text format     Abstract available


  837. ZHANG J, Zhang Z, Fan HY, Zhang J, et al
    Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell-dependent, cross-clade protection against H5N1 influenza virus in mice.
    Vaccine. 2015 Dec 23. pii: S0264-410X(15)01836.
    PubMed     Text format     Abstract available


  838. JAMSHED S, Walsh EE, Dimitroff LJ, Santelli JS, et al
    Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial.
    Vaccine. 2015 Dec 22. pii: S0264-410X(15)01834.
    PubMed     Text format     Abstract available


  839. MO AX, Colley DG
    Workshop report: Schistosomiasis vaccine clinical development and product characteristics.
    Vaccine. 2015 Dec 22. pii: S0264-410X(15)01823.
    PubMed     Text format     Abstract available


  840. LUO Z, Ma L, Zhang L, Martin L, et al
    Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.
    Vaccine. 2015 Dec 22. pii: S0264-410X(15)01835.
    PubMed     Text format     Abstract available


  841. DOEDEE AM, Kannegieter N, Ozturk K, van Loveren H, et al
    Higher numbers of memory B-cells and Th2-cytokine skewing in high responders to hepatitis B vaccination.
    Vaccine. 2015 Dec 22. pii: S0264-410X(15)01799.
    PubMed     Text format     Abstract available


  842. HERTZELL KB, Pauksens K, Rombo L, Knight A, et al
    Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study.
    Vaccine. 2015 Dec 21. pii: S0264-410X(15)01820.
    PubMed     Text format     Abstract available


  843. PITTMAN PR, McClain D, Quinn X, Coonan KM, et al
    Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.
    Vaccine. 2015 Dec 21. pii: S0264-410X(15)01821.
    PubMed     Text format     Abstract available


  844. HUMMEL IB, Zitzmann A, Erl M, Wenzel JJ, et al
    Characteristics of immune memory 10-15 years after primary hepatitis B vaccination.
    Vaccine. 2015 Dec 21. pii: S0264-410X(15)01824.
    PubMed     Text format     Abstract available


  845. MEE ET, Preston MD, Minor PD, Schepelmann S, et al
    Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing.
    Vaccine. 2015 Dec 19. pii: S0264-410X(15)01792.
    PubMed     Text format     Abstract available


  846. MUSIC N, Reber AJ, Kim MC, York IA, et al
    Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets.
    Vaccine. 2015 Dec 19. pii: S0264-410X(15)01795.
    PubMed     Text format     Abstract available


  847. TABYNOV K, Yespembetov B, Ryskeldinova S, Zinina N, et al
    Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.
    Vaccine. 2015 Dec 19. pii: S0264-410X(15)01819.
    PubMed     Text format     Abstract available


  848. PAJON R, Lujan E, Granoff DM
    A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine.
    Vaccine. 2015 Dec 19. pii: S0264-410X(15)01825.
    PubMed     Text format     Abstract available


  849. EICHELBERGER MC, Couzens L, Gao Y, Levine M, et al
    Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity.
    Vaccine. 2015 Dec 18. pii: S0264-410X(15)01794.
    PubMed     Text format     Abstract available


  850. OHTOLA JA, Khaskhely NM, Saul-Mcbeth JL, Iyer AS, et al
    Alterations in serotype-specific B cell responses to the 13-valent pneumococcal conjugate vaccine in aging HIV-infected adults.
    Vaccine. 2015 Dec 18. pii: S0264-410X(15)01785.
    PubMed     Text format     Abstract available


  851. REINER DM, Bhuyan P, Eiden JJ, Ginis J, et al
    Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers.
    Vaccine. 2015 Dec 18. pii: S0264-410X(15)01788.
    PubMed     Text format     Abstract available


  852. MELLATA M, Mitchell NM, Schodel F, Curtiss R I Ii, et al
    Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.
    Vaccine. 2015 Dec 18. pii: S0264-410X(15)01786.
    PubMed     Text format     Abstract available


  853. SCHUTTA C, Barrera J, Pisano M, Zsak L, et al
    Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using direct homologous challenge.
    Vaccine. 2015 Dec 18. pii: S0264-410X(15)01790.
    PubMed     Text format     Abstract available


  854. SALISBURY DM
    Commentary on: "Seasonal influenza vaccine dose distribution in 195 countries (2004-2013): Little progress in estimated global vaccination coverage".
    Vaccine. 2015 Dec 18. pii: S0264-410X(15)01777.
    PubMed     Text format    


  855. ALI M, You YA, Sur D, Kanungo S, et al
    Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design.
    Vaccine. 2015 Dec 17. pii: S0264-410X(15)01776.
    PubMed     Text format     Abstract available


  856. KPANAKE L, Sorum PC, Mullet E
    The potential acceptability of infant vaccination against malaria: A mapping of parental positions in Togo.
    Vaccine. 2015 Dec 17. pii: S0264-410X(15)01780.
    PubMed     Text format     Abstract available


  857. CHANG DH, Bednarczyk RA, Becker ER, Hockenberry JM, et al
    Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996-2011.
    Vaccine. 2015 Dec 17. pii: S0264-410X(15)01774.
    PubMed     Text format     Abstract available


  858. KANG G, Tate JE, Parashar UD
    Evaluation of rotavirus disease burden and vaccine effectiveness in India.
    Vaccine. 2015;33:7143.
    PubMed     Text format    


  859. PIPLE JK, Puliyel J
    116E rotavirus vaccine may have less impact in India than projected.
    Vaccine. 2015;33:7142.
    PubMed     Text format    


  860. KIM JH, Liepkalns J, Reber AJ, Lu X, et al
    Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains.
    Vaccine. 2015 Dec 16. pii: S0264-410X(15)01772.
    PubMed     Text format     Abstract available


  861. SGAMBATTI S, Minamisava R, Bierrenbach AL, Toscano CM, et al
    Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance.
    Vaccine. 2015 Dec 16. pii: S0264-410X(15)01779.
    PubMed     Text format     Abstract available


  862. PITTMAN PR, Norris SL, Brown ES, Ranadive MV, et al
    Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
    Vaccine. 2015 Dec 16. pii: S0264-410X(15)01775.
    PubMed     Text format     Abstract available


  863. LANKESTER F, Russell GC, Lugelo A, Ndabigaye A, et al
    A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.
    Vaccine. 2015 Dec 16. pii: S0264-410X(15)01781.
    PubMed     Text format     Abstract available


  864. GATERA M, Bhatt S, Ngabo F, Utamuliza M, et al
    Successive introduction of four new vaccines in Rwanda: High coverage and rapid scale up of Rwanda's expanded immunization program from 2009 to 2013.
    Vaccine. 2015 Dec 15. pii: S0264-410X(15)01770.
    PubMed     Text format     Abstract available


  865. KARDANI K, Bolhassani A, Shahbazi S
    Prime-boost vaccine strategy against viral infections: Mechanisms and benefits.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01743.
    PubMed     Text format     Abstract available


  866. SONG BM, Kang HM, Lee EK, Jung SC, et al
    Supplemented vaccination with tandem repeat M2e virus-like particles enhances protection against homologous and heterologous HPAI H5 viruses in chickens.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01768.
    PubMed     Text format     Abstract available


  867. JING M, Wang J, Zhu S, Ao F, et al
    Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01750.
    PubMed     Text format     Abstract available


  868. KUMAR A, Das S, Mullick R, Lahiri P, et al
    Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01727.
    PubMed     Text format     Abstract available


  869. WASKO I, Hong E, De Paola R, Stella M, et al
    High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland.
    Vaccine. 2015 Dec 11. pii: S0264-410X(15)01764.
    PubMed     Text format     Abstract available


  870. PEREZ-CASAL J, Potter AA
    Glyceradehyde-3-phosphate dehydrogenase as a suitable vaccine candidate for protection against bacterial and parasitic diseases.
    Vaccine. 2015 Dec 10. pii: S0264-410X(15)01766.
    PubMed     Text format     Abstract available


  871. BUTTENHEIM AM, Fiks AG, Burson Ii RC, Wang E, et al
    A behavioral economics intervention to increase pertussis vaccination among infant caregivers: A randomized feasibility trial.
    Vaccine. 2015 Dec 10. pii: S0264-410X(15)01749.
    PubMed     Text format     Abstract available


  872. WATSON PS, Turner DP
    Clinical experience with the meningococcal B vaccine, Bexsero: Prospects for reducing the burden of meningococcal serogroup B disease.
    Vaccine. 2015 Dec 10. pii: S0264-410X(15)01723.
    PubMed     Text format     Abstract available


  873. CHONWATTANA W, Raengsakulrach B, Holtz TH, Wasinrapee P, et al
    Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
    Vaccine. 2015 Dec 9. pii: S0264-410X(15)01765.
    PubMed     Text format     Abstract available


  874. PIERSE N, Kelly H, Thompson MG, Bissielo A, et al
    Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014.
    Vaccine. 2015 Dec 9. pii: S0264-410X(15)01767.
    PubMed     Text format     Abstract available


  875. MCNUTT LA, Desemone C, DeNicola E, El Chebib H, et al
    Affluence as a predictor of vaccine refusal and underimmunization in California private kindergartens.
    Vaccine. 2015 Dec 8. pii: S0264-410X(15)01744.
    PubMed     Text format     Abstract available


  876. THOMSON A, Robinson K, Vallee-Tourangeau G
    The 5As: A practical taxonomy for the determinants of vaccine uptake.
    Vaccine. 2015 Dec 7. pii: S0264-410X(15)01746.
    PubMed     Text format     Abstract available


  877. HAYASHI M, Aoshi T, Kogai Y, Nomi D, et al
    Optimization of physiological properties of hydroxyapatite as a vaccine adjuvant.
    Vaccine. 2015 Dec 5. pii: S0264-410X(15)01725.
    PubMed     Text format     Abstract available


  878. SAMAD L, Cortina-Borja M, Sutcliffe AG, Marven S, et al
    National hospital data for intussusception: Data linkage and retrospective analysis to assess quality and use in vaccine safety surveillance.
    Vaccine. 2015 Dec 5. pii: S0264-410X(15)01683.
    PubMed     Text format     Abstract available


  879. HOPPING AM, McElhaney J, Fonville JM, Powers DC, et al
    The confounded effects of age and exposure history in response to influenza vaccination.
    Vaccine. 2015 Dec 5. pii: S0264-410X(15)01724.
    PubMed     Text format     Abstract available


  880. BOSCH AA, van Houten MA, Bruin JP, Wijmenga-Monsuur AJ, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands.
    Vaccine. 2015 Dec 5. pii: S0264-410X(15)01726.
    PubMed     Text format     Abstract available


  881. MBAWUIKE IN, Atmar RL, Patel SM, Corry DB, et al
    Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.
    Vaccine. 2015 Dec 4. pii: S0264-410X(15)01705.
    PubMed     Text format     Abstract available


  882. HARIRI S, Markowitz LE, Unger ER
    Response to Pendleton et al. regarding reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States.
    Vaccine. 2015 Dec 2. pii: S0264-410X(15)01608.
    PubMed     Text format    


  883. BROADBENT AJ, Santos CP, Anafu A, Wimmer E, et al
    Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets.
    Vaccine. 2015 Dec 2. pii: S0264-410X(15)01704.
    PubMed     Text format     Abstract available


  884. NEWALL AT, Reyes JF, McIntyre P, Menzies R, et al
    Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical.
    Vaccine. 2015 Dec 1. pii: S0264-410X(15)01703.
    PubMed     Text format     Abstract available


  885. ODONE A, Signorelli C
    When vaccine hesitancy makes headlines.
    Vaccine. 2015 Dec 1. pii: S0264-410X(15)01701.
    PubMed     Text format    


  886. BERNSTEIN DI, Munoz FM, Callahan ST, Rupp R, et al
    Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.
    Vaccine. 2015 Dec 1. pii: S0264-410X(15)01706.
    PubMed     Text format     Abstract available


    November 2015
  887. NAKAMURA K, Shirakura M, Suzuki Y, Naito T, et al
    Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.
    Vaccine. 2015 Nov 30. pii: S0264-410X(15)01700.
    PubMed     Text format     Abstract available


  888. UDDIN MJ, Shamsuzzaman M, Horng L, Labrique A, et al
    Use of mobile phones for improving vaccination coverage among children living in rural hard-to-reach areas and urban streets of Bangladesh.
    Vaccine. 2015 Nov 29. pii: S0264-410X(15)01666.
    PubMed     Text format     Abstract available


  889. GRONDAHL-YLI-HANNUKSELA K, Kauko L, Van Der Meeren O, Mertsola J, et al
    Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults.
    Vaccine. 2015 Nov 28. pii: S0264-410X(15)01699.
    PubMed     Text format     Abstract available


  890. NOLAN T, Chotpitayasunondh T, Capeding MR, Carson S, et al
    Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multi-center, observer-blind study.
    Vaccine. 2015 Nov 28. pii: S0264-410X(15)01682.
    PubMed     Text format     Abstract available


  891. ALFARO-MURILLO JA, Townsend JP, Galvani AP
    Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US.
    Vaccine. 2015 Nov 27. pii: S0264-410X(15)01681.
    PubMed     Text format     Abstract available


  892. LECHENNE M, Oussiguere A, Naissengar K, Mindekem R, et al
    Operational performance and analysis of two rabies vaccination campaigns in N'Djamena, Chad.
    Vaccine. 2015 Nov 27. pii: S0264-410X(15)01675.
    PubMed     Text format     Abstract available


  893. SHRIVASTWA N, Gillespie BW, Kolenic GE, Lepkowski JM, et al
    Predictors of vaccination in India for children aged 12-36 months.
    Vaccine. 2015;33 Suppl 4:D99-D105.
    PubMed     Text format     Abstract available


  894. LU PJ, O'Halloran A, Williams WW, Lindley MC, et al
    Racial and ethnic disparities in vaccination coverage among adult populations in the U.S.
    Vaccine. 2015;33 Suppl 4:D83-91.
    PubMed     Text format     Abstract available


  895. WALTON LR, Orenstein WA, Pickering LK
    Lessons learned from making and implementing vaccine recommendations in the U.S.
    Vaccine. 2015;33 Suppl 4:D78-82.
    PubMed     Text format     Abstract available


  896. SALMON DA, Dudley MZ, Glanz JM, Omer SB, et al
    Vaccine hesitancy: Causes, consequences, and a call to action.
    Vaccine. 2015;33 Suppl 4:D66-71.
    PubMed     Text format     Abstract available


  897. DEMPSEY AF, Zimet GD
    Interventions to Improve Adolescent Vaccination: What May Work and What Still Needs to Be Tested.
    Vaccine. 2015;33 Suppl 4:D106-13.
    PubMed     Text format     Abstract available


  898. SHI S, Chen S, Han W, Wu B, et al
    Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines.
    Vaccine. 2015 Nov 27. pii: S0264-410X(15)01694.
    PubMed     Text format     Abstract available


  899. THOMAS RE
    The case for ILI surveillance.
    Vaccine. 2015;33:6515-6.
    PubMed     Text format    


  900. ZHU L, Feng Y, Zhang G, Jiang H, et al
    Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
    Vaccine. 2015 Nov 25. pii: S0264-410X(15)01698.
    PubMed     Text format     Abstract available


  901. PARK C, Jeong J, Choi K, Chae C, et al
    Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera PCV MH) under experimental conditions.
    Vaccine. 2015 Nov 25. pii: S0264-410X(15)01676.
    PubMed     Text format     Abstract available


  902. FORD AQ, Touchette N, Hall BF, Hwang A, et al
    Global vaccine and immunization research forum: Opportunities and challenges in vaccine discovery, development, and delivery.
    Vaccine. 2015 Nov 25. pii: S0264-410X(15)01680.
    PubMed     Text format     Abstract available


  903. XIN H
    Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
    Vaccine. 2015 Nov 24. pii: S0264-410X(15)01677.
    PubMed     Text format     Abstract available


  904. MEUNIER M, Chemaly M, Dory D
    DNA vaccination of poultry: The current status in 2015.
    Vaccine. 2015 Nov 24. pii: S0264-410X(15)01685.
    PubMed     Text format     Abstract available


  905. WIESEN E, Lagani W, Sui G, Arava J, et al
    Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014.
    Vaccine. 2015 Nov 24. pii: S0264-410X(15)01686.
    PubMed     Text format     Abstract available


  906. KANDEIL A, Moatasim Y, Gomaa MR, Shehata MM, et al
    Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
    Vaccine. 2015 Nov 24. pii: S0264-410X(15)01679.
    PubMed     Text format     Abstract available


  907. YUEN CY, Dodgson JE, Tarrant M
    Perceptions of Hong Kong Chinese women toward influenza vaccination during pregnancy.
    Vaccine. 2015 Nov 23. pii: S0264-410X(15)01674.
    PubMed     Text format     Abstract available


  908. ALHARBI NK, Spencer AJ, Salman AM, Tully CM, et al
    Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter.
    Vaccine. 2015 Nov 23. pii: S0264-410X(15)01670.
    PubMed     Text format     Abstract available


  909. KOROU LM, Tasioudi KE, Tzani M, Konstantinidis A, et al
    Evaluation of the first oral rabies vaccination campaign of the red foxes in Greece.
    Vaccine. 2015 Nov 23. pii: S0264-410X(15)01673.
    PubMed     Text format     Abstract available


  910. WANG S, Rustandi RR, Lancaster C, Hong LG, et al
    Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.
    Vaccine. 2015 Nov 21. pii: S0264-410X(15)01668.
    PubMed     Text format     Abstract available


  911. SU FH, Huang YL, Sung FC, Su CT, et al
    Annual influenza vaccination reduces total hospitalization in patients with chronic hepatitis B virus infection: A population-based analysis.
    Vaccine. 2015 Nov 21. pii: S0264-410X(15)01585.
    PubMed     Text format     Abstract available


  912. COUDEVILLE L, Baurin N, Vergu E
    Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies.
    Vaccine. 2015 Nov 21. pii: S0264-410X(15)01665.
    PubMed     Text format     Abstract available


  913. MCCOMB RC, Martchenko M
    Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-The first step toward a rationally designed anthrax vaccine.
    Vaccine. 2015 Nov 21. pii: S0264-410X(15)01667.
    PubMed     Text format     Abstract available


  914. COWLING BJ, Feng S, Finelli L, Steffens A, et al
    Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.
    Vaccine. 2015 Nov 21. pii: S0264-410X(15)01636.
    PubMed     Text format     Abstract available


  915. ESPOSITO S, Giavoli C, Trombetta C, Bianchini S, et al
    Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children.
    Vaccine. 2015 Nov 19. pii: S0264-410X(15)01639.
    PubMed     Text format     Abstract available


  916. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducte
    Vaccine. 2015 Nov 18. pii: S0264-410X(15)01635.
    PubMed     Text format     Abstract available


  917. WONG VW, Lok KY, Tarrant M
    Interventions to increase the uptake of seasonal influenza vaccination among pregnant women: A systematic review.
    Vaccine. 2015 Nov 18. pii: S0264-410X(15)01640.
    PubMed     Text format     Abstract available


  918. SINCOCK SA, Hall ER, Woods CM, O'Dowd A, et al
    Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates.
    Vaccine. 2015 Nov 17. pii: S0264-410X(15)01637.
    PubMed     Text format     Abstract available


  919. MAERTENS K, Cabore RN, Huygen K, Hens N, et al
    Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study.
    Vaccine. 2015 Nov 16. pii: S0264-410X(15)01556.
    PubMed     Text format     Abstract available


  920. FADDA M, Allam A, Schulz PJ
    Arguments and sources on Italian online forums on childhood vaccinations: Results of a content analysis.
    Vaccine. 2015 Nov 16. pii: S0264-410X(15)01606.
    PubMed     Text format     Abstract available


  921. KUROSKY SK, Davis KL, Krishnarajah G
    Completion and compliance of childhood vaccinations in the United States.
    Vaccine. 2015 Nov 14. pii: S0264-410X(15)01616.
    PubMed     Text format     Abstract available


  922. CASPARD H, Gaglani M, Clipper L, Belongia EA, et al
    Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States.
    Vaccine. 2015 Nov 14. pii: S0264-410X(15)01615.
    PubMed     Text format     Abstract available


  923. MA R, Lu L, Zhangzhu J, Chen M, et al
    A measles outbreak in a middle school with high vaccination coverage and evidence of prior immunity among cases, Beijing, P.R. China.
    Vaccine. 2015 Nov 14. pii: S0264-410X(15)01605.
    PubMed     Text format     Abstract available


  924. OSORIO JE, Partidos CD, Wallace D, Stinchcomb DT, et al
    Development of a recombinant, chimeric tetravalent dengue vaccine candidate.
    Vaccine. 2015 Nov 14. pii: S0264-410X(15)01655.
    PubMed     Text format     Abstract available


  925. SANTINI-OLIVEIRA M, Coler RN, Parra J, Veloso V, et al
    Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults.
    Vaccine. 2015 Nov 10. pii: S0264-410X(15)01442.
    PubMed     Text format     Abstract available


  926. MARTI M
    Reducing pain at the time of vaccination: WHO position paper, September 2015-Recommendations.
    Vaccine. 2015 Nov 10. pii: S0264-410X(15)01604.
    PubMed     Text format     Abstract available


  927. ODEGARD JM, Flynn PA, Campbell DJ, Robbins SH, et al
    A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs.
    Vaccine. 2015 Nov 10. pii: S0264-410X(15)01600.
    PubMed     Text format     Abstract available


  928. DEISS RG, Arnold JC, Chen WJ, Echols S, et al
    Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease.
    Vaccine. 2015 Nov 9. pii: S0264-410X(15)01603.
    PubMed     Text format     Abstract available


  929. GIUNTINI S, Beernink PT, Granoff DM
    Effect of complement factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine.
    Vaccine. 2015 Nov 9. pii: S0264-410X(15)01597.
    PubMed     Text format     Abstract available


  930. PANG H, Chen L, Hoare R, Huang Y, et al
    Identification of DLD, by immunoproteomic analysis and evaluation as a potential vaccine antigen against three Vibrio species in Epinephelus coioides.
    Vaccine. 2015 Nov 9. pii: S0264-410X(15)01599.
    PubMed     Text format     Abstract available


  931. MARTI M
    Pertussis vaccines: WHO position paper, August 2015-Recommendations.
    Vaccine. 2015 Nov 9. pii: S0264-410X(15)01598.
    PubMed     Text format     Abstract available


  932. NAKAYAMA T, Sawada A, Yamaji Y, Ito T, et al
    Recombinant measles AIK-C vaccine strain expressing heterologous virus antigens.
    Vaccine. 2015 Nov 9. pii: S0264-410X(15)01583.
    PubMed     Text format     Abstract available


  933. FERNANDEZ-RUIZ M, Humar A, Baluch A, Keshwani S, et al
    Baseline serum interleukin-6 to interleukin-2 ratio is associated with the response to seasonal trivalent influenza vaccine in solid organ transplant recipients.
    Vaccine. 2015 Nov 7. pii: S0264-410X(15)01596.
    PubMed     Text format     Abstract available


  934. SWAMINATHAN G, Thoryk EA, Cox KS, Meschino S, et al
    A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
    Vaccine. 2015 Nov 7. pii: S0264-410X(15)01594.
    PubMed     Text format     Abstract available


  935. DANIELE F, Fabrizio M, Mauro P
    Getting the most from the Ebola vaccine success.
    Vaccine. 2015 Nov 7. pii: S0264-410X(15)01592.
    PubMed     Text format    


  936. DIAZGRANADOS CA, Saway W, Gouaux J, Baron M, et al
    Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50-64 years of age.
    Vaccine. 2015 Nov 7. pii: S0264-410X(15)01593.
    PubMed     Text format     Abstract available


  937. CHEN Z, Gupta T, Xu P, Phan S, et al
    Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice.
    Vaccine. 2015 Nov 6. pii: S0264-410X(15)01580.
    PubMed     Text format     Abstract available


  938. CHENG PJ, Huang SY, Su SY, Peng HH, et al
    Increasing postpartum rate of vaccination with tetanus, diphtheria, and acellular pertussis vaccine by incorporating pertussis cocooning information into prenatal education for group B streptococcus prevention.
    Vaccine. 2015 Nov 5. pii: S0264-410X(15)01577.
    PubMed     Text format     Abstract available


  939. YIH WK, Greene SK, Zichittella L, Kulldorff M, et al
    Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females.
    Vaccine. 2015 Nov 5. pii: S0264-410X(15)01377.
    PubMed     Text format     Abstract available


  940. PHARES CR, Date K, Travers P, Deglise C, et al
    Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand.
    Vaccine. 2015 Nov 5. pii: S0264-410X(15)01568.
    PubMed     Text format     Abstract available


  941. CARIGNAN D, Therien A, Rioux G, Paquet G, et al
    Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine.
    Vaccine. 2015 Nov 5. pii: S0264-410X(15)01579.
    PubMed     Text format     Abstract available


  942. NALEWAY AL, Crane B, Smith N, Daley MF, et al
    Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011.
    Vaccine. 2015 Nov 5. pii: S0264-410X(15)01417.
    PubMed     Text format     Abstract available


  943. SEKI F, Someya K, Komase K, Takeda M, et al
    A chicken homologue of nectin-4 functions as a measles virus receptor indicating a role for the propagation of MV vaccines in CEFs.
    Vaccine. 2015 Nov 5. pii: S0264-410X(15)01565.
    PubMed     Text format     Abstract available


  944. BLYTH CC, Cheng AC, Finucane C, Jacoby P, et al
    The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia.
    Vaccine. 2015 Nov 5. pii: S0264-410X(15)01578.
    PubMed     Text format     Abstract available


  945. GHOSH P, Shippy DC, Talaat AM
    Superior protection elicited by live-attenuated vaccines in the murine model of paratuberculosis.
    Vaccine. 2015 Nov 4. pii: S0264-410X(15)01572.
    PubMed     Text format     Abstract available


  946. KOSMIDIS C, Powell G, Borrow R, Morris J, et al
    Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosis.
    Vaccine. 2015 Nov 3. pii: S0264-410X(15)01570.
    PubMed     Text format     Abstract available


  947. DOLL MK, Buckeridge DL, Morrison KT, Gagneur A, et al
    Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
    Vaccine. 2015 Nov 3. pii: S0264-410X(15)01574.
    PubMed     Text format     Abstract available


  948. LIN CC, Tsai CC, Lee JM, Fang CH, et al
    The efficacy of a novel vaccine approach using tumor cells that ectopically express a codon-optimized murine GM-CSF in a murine tumor model.
    Vaccine. 2015 Nov 3. pii: S0264-410X(15)01562.
    PubMed     Text format     Abstract available


  949. DELRIEU I, Gessner BD, Baril L, Bahmanyar ER, et al
    From current vaccine recommendations to everyday practices: An analysis in five sub-Saharan African countries.
    Vaccine. 2015 Nov 3. pii: S0264-410X(15)01563.
    PubMed     Text format     Abstract available


  950. PITTMAN PR, Reisler RB, Lindsey CY, Guerena F, et al
    Safety and immunogenicity of ricin vaccine, RVEc, in a Phase 1 clinical trial.
    Vaccine. 2015 Nov 3. pii: S0264-410X(15)01550.
    PubMed     Text format     Abstract available


  951. ORR MT, Beebe EA, E Hudson T, Argilla D, et al
    Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
    Vaccine. 2015 Nov 3. pii: S0264-410X(15)01571.
    PubMed     Text format     Abstract available


  952. WEINBERGER R, Falkenhorst G, Bogdan C, van der Linden M, et al
    Incidence of invasive pneumococcal disease in 5-15 year old children with and without comorbidities in Germany after the introduction of PCV13: Implications for vaccinating children with comorbidities.
    Vaccine. 2015 Nov 1. pii: S0264-410X(15)01558.
    PubMed     Text format     Abstract available


    October 2015
  953. MAUNDER HE, Taylor G, Leppard KN, Easton AJ, et al
    Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01561.
    PubMed     Text format     Abstract available


  954. BINKS MJ, Moberley SA, Balloch A, Leach AJ, et al
    PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01557.
    PubMed     Text format     Abstract available


  955. WANG G, Zhu R, Yang L, Wang K, et al
    Non-thermal plasma for inactivated-vaccine preparation.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01555.
    PubMed     Text format     Abstract available


  956. COLEMAN BL, McNeil SA, Langley JM, Halperin SA, et al
    Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01551.
    PubMed     Text format     Abstract available


  957. HA HT, Leuridan E, Maertens K, Nguyen TD, et al
    Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01554.
    PubMed     Text format     Abstract available


  958. SURYADEVARA M, Handel A, Bonville CA, Cibula DA, et al
    Pediatric provider vaccine hesitancy: An under-recognized obstacle to immunizing children.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01552.
    PubMed     Text format     Abstract available


  959. IZIKSON R, Leffell DJ, Bock SA, Patriarca PA, et al
    Randomized comparison of the safety of Flublok versus licensed inactivated influenza vaccine in healthy, medically stable adults >/=50 years of age.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01553.
    PubMed     Text format     Abstract available


  960. CHENG AC, Kotsimbos T, Kelly PM
    Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01431.
    PubMed     Text format     Abstract available


  961. JAYASINGHE S, Chiu C, Menzies R, Lehmann D, et al
    Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.
    Vaccine. 2015 Oct 28. pii: S0264-410X(15)01532.
    PubMed     Text format     Abstract available


  962. ARAKANE R, Annaka R, Takahama A, Ishida K, et al
    Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A randomized controlled phase III study.
    Vaccine. 2015 Oct 28. pii: S0264-410X(15)01531.
    PubMed     Text format     Abstract available


  963. NGABO F, Levin A, Wang SA, Gatera M, et al
    A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda.
    Vaccine. 2015 Oct 28. pii: S0264-410X(15)01437.
    PubMed     Text format     Abstract available


  964. MORO PL, Winiecki S, Lewis P, Shimabukuro TT, et al
    Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01527.
    PubMed     Text format     Abstract available


  965. MIYAZU M, Kikuchi H, Hamada A, Fukushima S, et al
    A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01529.
    PubMed     Text format     Abstract available


  966. SAUERWEIN RW, Richie TL
    Malaria vaccines getting close to clinical reality.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01548.
    PubMed     Text format    


  967. FARRELL P, Sun J, Champagne PP, Lau H, et al
    The use of dissolved oxygen-controlled, fed-batch aerobic cultivation for recombinant protein subunit vaccine manufacturing.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01500.
    PubMed     Text format     Abstract available


  968. CAO A, Liu Y, Wang J, Li X, et al
    Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01506.
    PubMed     Text format     Abstract available


  969. GLANZ JM, Newcomer SR, Daley MF, McClure DL, et al
    Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01505.
    PubMed     Text format     Abstract available


  970. VALENTINI D, Marcellini V, Bianchi S, Villani A, et al
    Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01526.
    PubMed     Text format     Abstract available


  971. PEARSON FE, Muller DA, Roalfe L, Zancolli M, et al
    Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01524.
    PubMed     Text format     Abstract available


  972. WANG E, Baras Y, Buttenheim AM
    "Everybody just wants to do what's best for their child": Understanding how pro-vaccine parents can support a culture of vaccine hesitancy.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01533.
    PubMed     Text format     Abstract available


  973. CERUTTI M, De Lonlay P, Menni F, Parini R, et al
    Vaccination coverage of patients with inborn errors of metabolism and the attitudes of their parents towards vaccines.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01502.
    PubMed     Text format     Abstract available


  974. CLARKE M, Thomas N, Giles L, Marshall H, et al
    Community awareness and predictors of uptake of pertussis booster vaccine in South Australian adults.
    Vaccine. 2015 Oct 26. pii: S0264-410X(15)01497.
    PubMed     Text format     Abstract available


  975. MCCOMB RC, Ho CL, Bradley KA, Grill LK, et al
    Presentation of peptides from Bacillus anthracis protective antigen on Tobacco Mosaic Virus as an epitope targeted anthrax vaccine.
    Vaccine. 2015 Oct 26. pii: S0264-410X(15)01504.
    PubMed     Text format     Abstract available


  976. CROSS AS, Greenberg N, Billington M, Zhang L, et al
    Phase 1 testing of detoxified LPS/group B meningococcal outer membrane protein vaccine with and without synthetic CPG 7909 adjuvant for the prevention and treatment of sepsis.
    Vaccine. 2015 Oct 26. pii: S0264-410X(15)01501.
    PubMed     Text format     Abstract available


  977. CHENG C, Wang L, Ko SY, Kong WP, et al
    Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development.
    Vaccine. 2015 Oct 26. pii: S0264-410X(15)01438.
    PubMed     Text format     Abstract available


  978. MCVOY MA, Lee R, Saccoccio FM, Hartikka J, et al
    A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.
    Vaccine. 2015 Oct 24. pii: S0264-410X(15)01521.
    PubMed     Text format     Abstract available


  979. LAPKE N, Tartz S, Lee KH, Jacobs T, et al
    The application of anti-Toso antibody enhances CD8 T cell responses in experimental malaria vaccination and disease.
    Vaccine. 2015 Oct 24. pii: S0264-410X(15)01494.
    PubMed     Text format     Abstract available


  980. KERKHOVE MD, Cooper MJ, Eick-Cost AA, Sanchez JL, et al
    Risk factors for severe outcomes among members of the United States military hospitalized with pneumonia and influenza, 2000-2012.
    Vaccine. 2015 Oct 19. pii: S0264-410X(15)01426.
    PubMed     Text format     Abstract available


  981. HU W, Sawlwin DC
    Reply to Letter to the Editor.
    Vaccine. 2015;33:5493.
    PubMed     Text format    


  982. ABU RAYA B, Srugo I, Bamberger E, Kessel A, et al
    The avidity of pertussis antibodies following gestational acellular pertussis immunization: Reply to Maertens.
    Vaccine. 2015;33:5490-1.
    PubMed     Text format    


    September 2015
  983. KILLICK MA, Grant ML, Cerutti NM, Capovilla A, et al
    Env-2dCD4 complexes act as super immunogens and elicit potent, broadly neutralizing antibodies against clinically relevant human immunodeficiency virus type 1 (HIV-1).
    Vaccine. 2015 Sep 30. pii: S0264-410X(15)01332.
    PubMed     Text format     Abstract available


  984. BECK Z, Matyas GR, Jalah R, Rao M, et al
    Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.
    Vaccine. 2015 Sep 12. pii: S0264-410X(15)01244.
    PubMed     Text format     Abstract available


    July 2015
  985. KOUL PA, Bali NK
    Influenza vaccination in India: Challenges for universal adoption.
    Vaccine. 2015 Jul 18. pii: S0264-410X(15)00965.
    PubMed     Text format    


  986. REGAN AK, Blyth CC, Tracey L, Mak DB, et al
    Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation.
    Vaccine. 2015;33:3689-94.
    PubMed     Text format     Abstract available


  987. KORIOTH-SCHMITZ B, Perley CC, Sixsmith JD, Click EM, et al
    Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.
    Vaccine. 2015 Jul 17. pii: S0264-410X(15)00944.
    PubMed     Text format     Abstract available


  988. GAVILLET BM, Mondoulet L, Dhelft V, Eberhardt CS, et al
    Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept.
    Vaccine. 2015;33:3450-5.
    PubMed     Text format     Abstract available


    June 2015
  989. RUIZ JB, Barnett GA
    Exploring the presentation of HPV information online: A semantic network analysis of websites.
    Vaccine. 2015;33:3354-9.
    PubMed     Text format     Abstract available


  990. RUDD C, Mwenda J, Chilengi R
    Rotavirus landscape in Africa-Towards prevention and control: A report of the 8th African rotavirus symposium, Livingstone, Zambia.
    Vaccine. 2015;33:3263-7.
    PubMed     Text format     Abstract available


  991. OMER SB, Richards JL, Madhi SA, Tapia MD, et al
    Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: Methods and expectations.
    Vaccine. 2015 Jun 18. pii: S0264-410X(15)00750.
    PubMed     Text format     Abstract available


  992. CHUA YX, Ang LW, Low C, James L, et al
    An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore.
    Vaccine. 2015;33:3150-7.
    PubMed     Text format     Abstract available


  993. PRENTICE S, Jallow MW, Prentice AM
    The effect of BCG on iron metabolism in the early neonatal period: A controlled trial in Gambian neonates.
    Vaccine. 2015;33:2963-7.
    PubMed     Text format     Abstract available


  994. ROSCOE C, Gilles R, Reed AJ, Messerschmidt M, et al
    Poliovirus immunity in newly resettled adult refugees in Idaho, United States of America.
    Vaccine. 2015;33:2968-70.
    PubMed     Text format     Abstract available


  995. ZAHID M, Lunsdorf H, Rinas U
    Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing.
    Vaccine. 2015 Jun 12. pii: S0264-410X(15)00729.
    PubMed     Text format     Abstract available


  996. HAYDEN CA, Fischer ME, Andrews BL, Chilton HC, et al
    Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.
    Vaccine. 2015;33:2881-6.
    PubMed     Text format     Abstract available


  997. STURKENBOOM MC
    The narcolepsy-pandemic influenza story: Can the truth ever be unraveled?
    Vaccine. 2015;33 Suppl 2:B6-B13.
    PubMed     Text format     Abstract available


    May 2015
  998. BOTTAI D, Frigui W, Clark S, Rayner E, et al
    Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system.
    Vaccine. 2015;33:2710-8.
    PubMed     Text format     Abstract available


  999. GE J, Wang X, Tian M, Gao Y, et al
    Recombinant Newcastle disease viral vector expressing hemagglutinin or fusion of canine distemper virus is safe and immunogenic in minks.
    Vaccine. 2015;33:2457-62.
    PubMed     Text format     Abstract available


  1000. VIZZOTTI C, Pippo T, Uruena A, Altuna J, et al
    Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina.
    Vaccine. 2015;33 Suppl 1:A227-32.
    PubMed     Text format     Abstract available


  1001. SEELE J, Hillermann LM, Beineke A, Seitz M, et al
    The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against serotype 2.
    Vaccine. 2015;33:2207-12.
    PubMed     Text format     Abstract available


  1002. ZHOU Y, Wang Y, Deng L, Zheng C, et al
    Evaluation of the protective efficacy of four novel identified membrane associated proteins of Streptococcus suis serotype 2.
    Vaccine. 2015;33:2254-60.
    PubMed     Text format     Abstract available


  1003. GARRIDO-ESTEPA M, Nunez OG, Leon-Gomez I, Cano R, et al
    Meningococcal C conjugate age-dependant long-term loss of effectiveness.
    Vaccine. 2015;33:2221-7.
    PubMed     Text format     Abstract available


  1004. NGUYEN HN, Steede NK, Robinson JE, Landry SJ, et al
    Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120.
    Vaccine. 2015 May 2. pii: S0264-410X(15)00568.
    PubMed     Text format     Abstract available


    April 2015
  1005. WIEDMANN RT, Reisinger KS, Hartzel J, Malacaman E, et al
    M-M-R((R))II manufactured using recombinant human albumin (rHA) and M-M-R((R))II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children.
    Vaccine. 2015;33:2132-40.
    PubMed     Text format     Abstract available


  1006. DE GOEDE AL, Andeweg AC, van den Ham HJ, Bijl MA, et al
    DC immunotherapy in HIV-1 infection induces a major blood transcriptome shift.
    Vaccine. 2015 Apr 23. pii: S0264-410X(15)00511.
    PubMed     Text format     Abstract available


  1007. WALTHER K, Burckhardt MA, Erb T, Heininger U, et al
    Implementation of pertussis immunization in health-care personnel.
    Vaccine. 2015;33:2009-14.
    PubMed     Text format     Abstract available


  1008. KUIPERS K, Daleke-Schermerhorn MH, Jong WS, ten Hagen-Jongman CM, et al
    Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization.
    Vaccine. 2015;33:2022-9.
    PubMed     Text format     Abstract available


  1009. GLADSTONE RA, Jefferies JM, Tocheva AS, Beard KR, et al
    Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.
    Vaccine. 2015;33:2015-21.
    PubMed     Text format     Abstract available


  1010. ZUO S, Cairns L, Hutin Y, Liang X, et al
    Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003-2009.
    Vaccine. 2015;33:2050-5.
    PubMed     Text format     Abstract available


    March 2015
  1011. HUNSAWONG T, Sunintaboon P, Warit S, Thaisomboonsuk B, et al
    A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice.
    Vaccine. 2015;33:1702-10.
    PubMed     Text format     Abstract available


  1012. ROSATI M, Alicea C, Kulkarni V, Virnik K, et al
    Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques.
    Vaccine. 2015 Mar 20. pii: S0264-410X(15)00267.
    PubMed     Text format     Abstract available


  1013. DUMAS FR, N'Diaye DS, Paireau J, Gautret P, et al
    Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France.
    Vaccine. 2015 Mar 19. pii: S0264-410X(15)00286.
    PubMed     Text format     Abstract available


  1014. ZUEST R, Valdes I, Skibinski D, Lin Y, et al
    Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in mice.
    Vaccine. 2015;33:1474-82.
    PubMed     Text format     Abstract available


  1015. RODRIGUEZ-DEL RIO E, Marradi M, Calderon-Gonzalez R, Frande-Cabanes E, et al
    A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax delta inulin adjuvant induces robust T-cell protection against listeria infection.
    Vaccine. 2015;33:1465-73.
    PubMed     Text format     Abstract available


  1016. SANDER P, Clark S, Petrera A, Vilaplana C, et al
    Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.
    Vaccine. 2015;33:1353-9.
    PubMed     Text format     Abstract available


  1017. GARG R, Latimer L, Gerdts V, Potter A, et al
    The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies.
    Vaccine. 2015;33:1338-44.
    PubMed     Text format     Abstract available


    February 2015
  1018. SERWANGA J, Nakiboneka R, Mugaba S, Magambo B, et al
    Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.
    Vaccine. 2015 Feb 26. pii: S0264-410X(15)00226.
    PubMed     Text format     Abstract available


    January 2015
  1019. QIN T, Yin Y, Wang X, Liu H, et al
    Whole inactivated avian Influenza H9N2 viruses induce nasal submucosal dendritic cells to sample luminal viruses via transepithelial dendrites and trigger subsequent DC maturation.
    Vaccine. 2015 Jan 19. pii: S0264-410X(15)00041.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: